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Introduction 
 
 
Congenital cardiac defects are by far the most common congenital anomalies. Of all 
live births around the world, approximately 1% is born with congenital heart disease.1 
This number is even higher if patients with a bicuspid aortic valve are included.2 
Accordingly, in the Netherlands every year around 1800 children are born with a 
congenital heart defect. Of these, about 50% cure spontaneously or do well without 
medical or surgical treatment. In the 1960’s, before the development of cardiac 
surgery with cardiopulmonary bypass, about 50% of the children with congenital 
heart disease requiring therapy died within the first year of live and less than 15% 
reached adulthood.3 Especially patients with transposition of the great arteries had a 
very poor survival: 90% of the patients died in the first month of life and less than 1% 
reached adult age. Of tetralogy of Fallot patients 10% survived until adult age. 
 
Rapid progress has been made over the past 30 years in the diagnosis and 
surgical treatment of congenital heart disease. Survival into adulthood became 
possible since the introduction of open-heart surgery with the use of cardiopulmonary 
bypass. Currently, instead of 85% mortality in the first 20 years of life, in the group of 
patients that require therapy, the 20-years survival became 85% or more. More 
accurate diagnosis, improved surgical skills and dedicated postoperative care have 
lead to a decline in peri-operative mortality and provided treatment options for 
complex congenital cardiac defects that had been considered as inoperable until 
recently. As a consequence, the number of patients requiring follow-up has 
increased, as well as the complexity of their residual defects.4,5 Total correction is 
rare and most patients have residual lesions and sequelae, requiring life-long follow-
up. 
Because many patients now reach adult life and adult cardiologists – not 
trained for the diagnosis and treatment of congenital heart defects - are inheriting 
these patients from their pediatric colleagues, a new subspecialty in cardiology has 
been created: adult congenital heart disease. Pioneers in this field like Joe Perloff 
and Jane Somerville have made a plea for dedicated care in specialised centres to 
establish optimal care and to collect follow-up data to provide rational advice about 
lifestyle and future outlooks.6,7 In the 1990’s, the Canadians were the first to put 
together guidelines for adult congenital heart disease and based on these, guidelines 
were composed and published by the working group for congenital heart disease of 
the Netherlands Society of Cardiology in 2000.8 
In the Netherlands, it is estimated that at least 25.000 adults, but maybe as 
much as 70.000 adults with different types of congenital heart disease are alive; 
accurate statistics on prevalence rates are lacking. This is one of the reasons why in 
the Netherlands a nation-wide database is being created for adults with congenital 
heart disease: the Concor database. Estimates from the United Kingdom suggest 
that in the year 2000 there were close to 150.000 adults with congenital heart 
disease in Great Brittain.9 This number is growing with 5% per year. Whereas in the 
past 30 years the majority of patients with a congenital heart defect were children, 
nowadays the adult population has outnumbered the paediatric population and the 
distribution of healthcare resources will need to be modified. The health care systems 
in most developed countries have not yet properly addressed the needs of these 
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adult patients.10 There is a serious shortage of professionals trained to take 
responsibility for these adult patients. New resources should be allocated to this 
growing population. Expert skills are required for cardiologists and cardiac surgeons 
working in this field, but also additional services in magnetic resonance imaging, 
interventional catheterisation, electrophysiology, high risk pregnancy and 
reproductive counselling are required.  
In Rotterdam there has been a large increase in adults visiting the cardiology 
department, requiring and seeking specialised care over the past 15 years. The 
adolescents and adults are being referred from the Sophia Children’s hospital, but 
also about 50% of the patients are referred from other hospitals. A stable growth 
occurred in the number of patients seen annually (Figure 1). With a total number of 
2400 adult congenital patients, the Thoraxcentre is one of the larger centres for adult 
congenital heart disease. 
 
Figure 1 Adults with a congenital heart disease, outpatient clinic 
 
The prevalence of the various congenital hearts defects in adults is continuously 
monitored in the Netherlands. All large centres for adult congenital heart disease in 
the Netherlands participate and include their patients, with permission, in this nation-
wide database. Figure 2 shows the prevalence of the different diagnosis in the 
Concor database. Also DNA material was gathered in these patients. 
 
Although we are grateful for the progress that has been made, residual defects 
and late complications are not uncommon and it remains unclear whether life 
expectancy in these patients is normal. Besides long-term survival, also morbidity is 
of great interest. Many patients have residual lesions requiring additional medical or 
surgical treatment during follow-up, in particular for arrhythmias, ventricular 
dysfunction, and valve regurgitation. A clear need exists to understand better the late 
pathophysiology after surgery and define the mode and optimal timing of further 
interventions including drug therapy, catheter interventions and surgical procedures.  
The collection and analysis of long-term follow up data is an important method 
of gaining more knowledge in this field and will help paediatric cardiologists and 
surgeons to modify early management to optimise later outcome.  
Furthermore, as patients with congenital heart disease reach their 20s, insurability 
increasingly becomes an issue. Prospects for insurance for young adults with 
complex congenital heart lesions are poor. Current practise is not based closely on 
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the limited available knowledge of natural history of congenital heart disease. As 
additional long-term survival data become available on the natural and post operative 
survival of these congenital defects, it is hoped that insurance requirements will be 
modified to afford this group the insurance coverage needed to obtain adequate 
medical and financial security. 
 
Figure 2 Concor database 
 
 
Besides mortality and morbidity, psychosocial problems play an important role 
in this particular patient population. Chronic illness, scars, and limitation of activities 
may interfere with a normal social life. Our efforts should also focus on the quality of 
life. Advice is often sought on sports participation, driver license, sexual intercourse, 
employment, and insurance. Many affected women want to have children of their on. 
Pregnancy however, is associated with profound physiological cardiovascular 
changes. Maternal cardiac defects and cardiovascular function have a mutual impact 
on the course and outcome of pregnancy.11 
The aim of the present thesis is to present the long-term outcome after surgery 
for congenital heart disease of patients operated at young age, who are now adults 
and to give an overview of the problems seen in adult patients with congenital heart 
defects.  
Specifically the aim of the present study is: 
1. To present the long-term outcome of patients with congenital heart disease, 
including mortality, incidence of arrhythmias, need for reintervention and 
functional status. 
2. To determine the changes over time in adults with congenital heart disease in an 
unselected cohort of operated patients. 
3. To assess the importance of the different determinants (for example age at 
operation and cardiac diagnosis) on long-term survival and morbidity.  
4. To describe the psychosocial functioning in adults with congenital heart disease. 
5. To give information on pregnancy in adults with congenital heart disease.  
Chapter I 
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We studied the long-term outcome of all patients operated in Rotterdam at young 
age (<15 years) between 1968, the year that open-heart surgery started in 
Rotterdam, and 1980. In this “Quality of life” study, the total cohort of consecutively 
operated patients with the 5 most common heart defects was systematically studied, 
to avoid selection bias of worse cases. The long period of follow-up (22-34 years) 
allows good insight in problems occurring during childhood and (young) adulthood. At 
follow-up in 1990 12,13 and again in 2001 the patients underwent an extensive clinical 
evaluation and were studied with electrocardiography, echocardiography, exercise 
testing, and 24-hour Holter monitoring. What further distinguishes this study from 
other studies is the psychological evaluation of patient’s “quality of life”. Susan van 
Rijen, psychologist, has presented the psychological part of this study as a thesis in 
2003.14 
 
The 5 most common anomalies operated in childhood forming the basis of the 
“Rotterdam Quality of life study” are atrial septal defect (ASD), ventricular septal 
defect (VSD), transposition of the great arteries operated with a Mustard procedure 
(Mustard), tetralogy of Fallot (TOF) and pulmonary stenosis (PS). The number of 
patients in the different diagnosis groups is shown in Figure 3.  
 
Figure 3 Number of patients operated upon in the period 1968-1980; the larger diagnosis groups 
 
 
We studied late survival, but also the incidence of problems such as reoperations, 
major arrhythmias, and heart failure and we analysed the functional status. Apart 
from the “Rotterdam quality of life study” other groups of adult patients with 
congenital heart disease deserve attention. Coarctation of the aorta used to be 
thought of as a correctable lesion, but also these patients have residual lesions.15 
Particular attention is necessary for associated bicuspid aortic valve pathology and 
aortic arch problems. Furthermore, the first results of adult patients with complex 
heart disease treated with a Fontan circulation are presented. An overview of the 
psychological results of the “Quality of life study” is given and the aspects of 
congenital heart disease concerning the management of pregnancy and inheritance 
risks are discussed.  
 
ASD VSD Mustard Tetralogy
of Fallot
Pulm. stenose
0
100
200
Nu
m
be
r 
o
f p
at
ie
n
ts 135
176
91
142
83
Introduction 
15
References 
 
1. Mitchell SC, Korones SB, Berends HW. Congenital heart disease in 56.109 births. Circulation 
1971;43:323 
2. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J. of Am. Col. Cardiol  
2002;39:1890-1900 
3. Engle MA, Adams FH, Betson C, DuShane JW, Elliott LT, McNamara DG, Rashkind WJ, Talner S. 
Resources for the optimal acute care of patients with congenital heart disease. Circulation 
1971;43:A-123 
4. Wren C, O’Sullivan JJ. Survival with congenital heart disease and need for follow-up in adult life. 
Heart 2001;85:438-43 
5. Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JIE, Somerville J, Wiliams 
RG, Webb GD. 32nd Bethesda Conference. Care of the adult with congenital heart disease. J. of 
Am. Col. Cardiol  2001;37:1161-98 
6. Perloff JK. Congenital heart disease in adults: a new cardiovascular specialty. Circulation 
1991;84:1881-90 
7. Somerville J, Webb GD, Skorton DJ, et al. Medical center experiences. J Am Coll Cardiol 
1991;18:315-18 
8. Working group “Congenitale Cardiologie bij Volwassenen”of the Ducht Society of Cardiology. 
Adult Congenital Heart Disease. Guidelines 2000. ISBN 90-75131-32-1 
9. Report of the British Cardiac Society Working Party. Grown-up congenital heart disease: current 
needs and provision of services for adolescents and adults with congenital heart disease in the 
UK. Heart 2002;88(Suppl.1):11-114 
10. Webb GD. Challenges in the care of adult patients with congenital heart defects. Heart 
2003;89:465-469 
11. Kaemmerer H, Bauer U, Stein JI, Lemp S, Bartmus D, et al. Pregnancy in congenital cardiac 
disease: an increasing challenge for cardiologists and obstetricians-a prospective multicenter 
study. Z Kardiol 2003;92:16-23 
12. F.J. Meijboom. Long-term outcome after surgery for congenital heart disease in infancy and 
childhood. Thesis 1995. ISBN 90-9008271-9 
13. E.M.W.J. Utens, F.C. Verhulst, R.A.M. Erdman, F.J. Meijboom, H.J. Duivenvoorden, E.Bos, 
R.T.C. Roelandt, J. Hess. Psychosocial functioning of young adults after surgical correction for 
congenital heart disease in childhood; a follow-up study. J of Psy Res. 1994;38:745-758 
14. E.H.M. van Rijen. Psychosocial aspects of congenital heart disease in adulthood. A longitudinal 
cohort study of 30-33 year follow-up. Thesis 2003. ISBN 90-6734-319-6 
15. Stark J. Do we really correct congenital heart defects? J Thorac Cardiovasc Surg 1989;97:1-9 
  
 
&
KD
SW
HU

  
 
 19  
 
Excellent survival and low incidence of arrhythmias, stroke 
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Abstract 
 
Aims  
Although studies have suggested good long-term results, arrhythmias, pulmonary 
hypertension and left ventricular dysfunction are mentioned as sequelae long-term 
after surgical atrial septal defect closure at young age. Most studies were performed 
only by questionnaire and in a retrospective manner. The long-term outcome is very 
important with regard to employability and insurability. 
 
Methods and Results  
One hundred thirty five consecutive ASD-patients, operated in childhood, were 
studied longitudinally with ECG, echocardiography, exercise testing and Holter-
recording 15 (10-22) and 26 (21-33) years after surgery. During follow-up no 
cardiovascular mortality, stroke, heart failure and no pulmonary hypertension 
occurred. Symptomatic supraventricular tachyarrhythmias were present in 6% after 
15 years, and an additional 2% occurred in the last decade; 5% needed pacemaker 
implantation. No relation was found between arrhythmias and the type of ASD, 
baseline data, right ventricular dimensions, or age at operation. Left and right 
ventricular function and dimension remained unchanged. Slightly more patients had 
right atrial dilatation at last follow-up. Exercise capacity was comparable with the 
normal Dutch population. 
 
Conclusions  
The long-term outcome after ASD closure at young age shows excellent survival and 
low morbidity. The incidences of supraventricular arrhythmias is lower then in natural 
history studies of ASD patients and also lower then after surgical correction at adult 
age.  
 
 
Introduction 
 
Secundum type atrial septal defect can cause volume overload of the right heart with 
late development of right heart failure, elevated pulmonary vascular resistance, atrial 
arrhythmias, or systemic embolism.1 - 4 Closure is recommended to avoid these 
sequelae. More recently atrial septal defect closure with a device using cardiac 
catheterization has gained acceptance.5 Small residual shunts are often found with 
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this technique.6 For comparison of surgical and device closure it is important to have 
good insight in the long-term outcome of surgical correction. Results of medium-term 
follow-up study after surgical correction are good, but prospective studies of long-
term follow-up focussing on arrhythmias, cardiac failure, exercise capacity, residual 
shunts and stroke are rare. It has been postulated, that after early repair of atrial 
septal defect, the survival is good, but sinus node dysfunction, atrial fibrillation and 
flutter, right ventricular dilatation, pulmonary hypertension and left ventricular 
dysfunction are mentioned as sequelae,7 - 13 although the incidence of these 
sequelae in consecutive series of patients who were operated at young age is not 
known. Murphy et al studied the 27-32 years outcome after surgical repair of ASD in 
all age groups and the incidence of postoperative atrial arrhythmias appeared related 
to the age of the patient at the time of repair.8 However, this study included only 33 
patients operated at young age (operated <11 years) and was performed 
retrospectively and by written questionnaires and telephone interviews. Meijboom et 
al reported a good outcome 9-20 years after ASD closure at young age, with a low 
incidence of symptomatic arrhythmias, however signs of sinus node disease and 
ventricular ectopy were found on 24-hour Holter recordings in up to 45% of the 
patients.14 
The aim of this study is to provide data on mortality and morbidity, which is 
critically important with regard to the employability and insurability of the long-term 
survivors of repair of atrial septal defects, and also can be used for comparison with 
the recently developed device closure techniques.  
We present the longitudinal follow-up of 21-33 years (mean 27 years) after 
surgical closure of an atrial septal defect in all 135 patients who underwent this 
operation at the Thoraxcentre between 1968 and 1980 and were < 15 years of age at 
the time of surgery. Stroke, heartfailure, incidence of arrhythmias, changes in ECG, 
exercise capacity and echocardiographic parameters were studied. Furthermore, the 
predictive value of the asymptomatic arrhythmias seen on the Holter recordings ten 
years ago is determined. 14 
 
 
Methods 
 
Patients 
All patients who underwent surgical repair for secundum type ASD or sinus venosus 
type ASD at our institution between 1968 and 1980 and who were < 15 years of age 
at the time of the operation were included in the study. The first follow-up study was 
performed in 1990,14 the second follow-up study from September 2000 to December 
2001. The cardiac examination included medical history, physical examination, 
standard 12-lead electrocardiography (Holter), 24-hour ambulatory 
electrocardiography, echocardiography, and bicycle ergometry. If the patient refused 
to visit the clinic, a written questionnaire was sent to the patients to obtain information 
on morbidity. The institutional Medical Ethical Committee approved the study. All 
patients gave their consent. 
 
Electrocardiography 
Standard 12-lead surface electrocardiograms were analysed for the height of the P 
wave (measured in lead II), duration of the P wave and the PR interval (measured 
from the initial deflection of the P wave to the initial deflection of the QRS complex). 
A first-degree atrioventricular block was defined by a PR interval > 200 milliseconds. 
Outcome after surgical ASD closure 
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Furthermore, the widest QRS duration was determined (from the initial deflection of 
the QRS complex to where the terminal deflection crosses the baseline, taken in any 
chest lead with the widest complex and where the deflections were acute enough to 
permit accurate assessment). A QRS duration > 120 msec was defined to be a 
complete bundle branch block. A single observer made all ECG measurements (JR-
H).  
 
Holter monitoring 
A three-channel recorder was used. Sinus node dysfunction was assessed during 24 
hour Holter monitoring using the modified Kugler criteria: nodal escape rhythm, 
sinusarrest > 3 sec or severe sinusbradycardia (<40 beats/min at night or <50 
beats/min during daytime).13 
 
Echocardiography 
Two-dimensional echocardiography and echo-Doppler studies were performed using 
a Hewlett-Packard Sonos 5500 echocardiograph. All echocardiographic studies were 
performed on the same machine. Left atrial dimension and left ventricular end-
diastolic and end-systolic dimensions were assessed using M-mode 
echocardiography in the parasternal view. A left atrium dimension > 45 mm and a left 
ventricular end-diastolic dimension of > 58 mm were considered enlarged. A 
fractional shortening less then 0.30 was defined as decreased. Parasternal, apical 
four-chamber and subcostal views were used to assess right atrium and right 
ventricular dimensions. This was done by means of visual estimate by two 
experienced cardiologists (FM and SS). Multiple echocardiographic views were 
examined using colour flow to identify residual shunts. Doppler-echocardiography 
was used for the assessment of blood flow velocities. Right ventricular systolic 
pressure was estimated from tricuspid regurgitation jet velocity; diastolic pulmonary 
pressure from the pulmonary regurgitation flow velocity. Pulmonary hypertension was 
defined as a tricuspid regurgitation flow velocity > 3.0 or a pulmonary regurgitation 
flow velocity > 2.5 m/sec.  
 
Bicycle ergometry 
Maximal exercise capacity was assessed by bicycle ergometry with stepwise 
increments of workload by 20 Watts per minute. Exercise capacity was compared to 
that in normal individuals corrected for age, sex, and body height. Exercise capacity 
< 85% of the predicted value was considered to be decreased. 
Arrhythmias were defined to be symptomatic if antiarrhythmic medication was 
prescribed, cardioversion was necessary, catheter ablation or surgical arrhythmia 
treatment had been applied, or pacemaker implantation had been necessary. Major 
Events were defined as cardiac surgery, stroke, symptomatic arrhythmia, or an 
episode of heart failure. 
 
Data analysis 
Data are presented as mean values and standard deviation, unless indicated 
otherwise. The Chi-square and Fisher’s exact test were used for the comparison of 
discrete variables. The Student t-test was used to compare continuous variables. The 
level of significance was chosen at p < 0.05.  
Tests were performed for the total group of patients, as well as separately for 
the secundum type ASD and the sinus venosus type group. Results of the total group 
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will be presented, unless significant differences were observed between these 2 sub-
groups. 
 
 
Results 
 
Patients 
All 135 patients who had undergone primary surgical ASD (secundum and sinus 
venosus type) repair in the Thoraxcentre between 1968 and 1980 at age < 15 years, 
were included. A secundum type ASD was present in 105, and a sinus venosus type 
ASD in 30 patients. Age at operation was 7.5 ± 3.5 years (range 0 to 14). There was 
no in-hospital or early mortality. The baseline characteristics off all 135 patients are 
described in Table 1.  
 
Table 1 Demographic data, data of pre-operative cardiac catheterisation and surgical data showing 
the group in total, the group investigated in 1990 and in 2001 and finally the group who did not 
participate in the second follow-up study (no second study) 
 Total 1990 2001 No second study
Number of patients 135 104 94 41 
Male         59 (44%)        44 (42%)           39 (41%)           20 (49%) 
Female         76 (56%)        60 (58%)           55 (59%)           21 (51%) 
     
Cardiac catheterisation     
QP-QS ratio     2.3:1     2.3:1     2.3:1     2.3:1 
Peak syst. Press PA 26 26 26 26 
PAPVD    27%    26%    26%    27% 
     
Surgical data     
Age at operation (yr)           7.5 ± 3.5  7.3   7.5 7.5 
Complete CPB (% of pts) 96 96 96 96 
Direct closure (% of pts) 76 75 75 76 
Closure with patch (% of pts) 24 25 25 24 
Sinus venosus type ASD (% of pts) 22 22 23 21 
     
Follow-up since surgery  15 26 - 
Age at the time of study  22 33 - 
QP-QS ratio = ratio pulmonary flow -systemic flow; PA = pulmonary artery; PAPVD = partially 
abnormal pulmonary venous drainage; CPB = cardiopulmonary bypass 
 
 
The details of preoperative clinical findings, including cardiac catheterisation, data on 
surgical technique and postoperative course have been described earlier.14 
Information on survival was obtained in all 135 patients. During follow-up, no 
cardiovascular mortality occurred, 1 patient died, due to suicide, 15 years after his 
operation, 134 survived. Survival and survival free of major events are given in 
Figure 1.  
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After a mean follow-up of 15 years (range 10-22), 104 patients (77%) participated in 
the first follow-up study.14 Of these, 94 patients (70% of the original 135 patients and 
90% of the 104 patients studied in 1990) fully participated in the second follow-up 
study after a mean follow-up of 26 years (range 21-33) after surgery with a mean age 
at the time of study of 33 years.  
No significant differences were found between the baseline characteristics of 
the patients who participated and the patients who did not participate in the follow-up 
studies (Table 1).  
The four patients who received the written questionnaire returned this, and 
they are in good clinical health, have not been admitted to the hospital and have not 
experienced tachyarrhythmias. 
 
Major cardiac events 
Before 1990 one additional cardiac operation was performed for closure of a patent 
arterial duct. No cardiac operations were necessary between 1990 and 2001. No 
stroke and no episodes of heart failure occurred during follow-up. No patient was 
using diuretics. In 1990 symptomatic supraventricular arrhythmias were present in 7 
patients (6%): 3 were treated medically for periods of atrial flutter or fibrillation, and 4 
others needed pacemaker implantation. Of these 7 patients, 3 were readmitted 
between 1990 and 2001: one patient suffered from pacemaker endocarditis, he was 
treated with antibiotics for six weeks and the pacing system was replaced, while 2 
other patients needed pacemaker battery replacement. Between 1990 and 2001, 
three additional patients had new symptomatic arrhythmias: one needed pacemaker 
implantation for sinus node disease, one patient had recurrent atrial flutter treated 
with several electrical cardioversions and radiofrequency catheter ablation, and one 
patient received medical therapy for supraventricular arrhythmias.  
Analyses were performed, investigating the role of localisation of the ASD 
(secundum type or sinus venosus type), baseline data (such as pre-operative shunt 
size, age at operation, year of operation, and surgical techniques), right ventricular 
and atrial dimensions at follow-up, age at follow-up and duration of follow-up in 
relation to the presence or absence of symptomatic arrhythmias. No relation was 
found. 
 
Medical history and physical examination  
When questioned about their current general health, 88.3% considered their health 
as very good or good, and 11.7% as moderate. Nobody judged it as bad. This is not 
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different from the health assessment of the normal Dutch population.16 Patient’s own 
appreciation of the physical condition was in 13% better, 51% the same, 33% slightly 
worse and 3% much worse compared with that of eleven years ago.14 On the 
question whether the patients suffered from palpitations 20% answered yes in 1990 
and 28% in 2001. Physical examination revealed that the mean length of the patients 
remained unchanged (172.4 mm in 1990 and 172.5 mm in 2000), whereas the mean 
weight rose from 64.1 kg in 1990 to 73.7 kg in 2000 (p<0.0001). The mean pulse rate 
lowered from 72 to 67 beats per minute (p=0.0004). Signs of heart failure were not 
found. 
 
Electrocardiography 
Twelve-lead electrocardiograms and 24-hour ambulatory electrocardiograms data 
are presented in Table 2.  
 
Table 2  Standard 12-lead electrocardiogram and 24 hour Holter electrocardiogram 
 1990 2001 P value 
ECG    
Rhythm    
Sinus      90%     89% ns 
Atrial    6    5  
Nodal    1    2  
Atrial flutter    -    1  
Pacemaker    3    3  
PR interval   153.7   153.2 ns 
PR > 200 ms         5% ns 
QRS duration      88.3      96.1      <0.0001 
QTc segment 350 388 ns 
P-wave duration   84   85 ns 
P-wave height in II           0.30          0.29 ns 
P-wave morph. normal       87%      81% ns 
P-wave axis    46’   40’ ns 
QRS axis    63‘   54’        0.0006 
No LVH or RVH          95.9%   95.4% ns 
    
24-hour Holter    
Supraventricular arrhythmias    45 36    0.02 
Sinusnode disease    39 27    0.03 
SVT      6 18  0.3 
Paroxysmal A fibrillation      0   0 ns 
Paroxysmal A flutter      0   2 ns 
Ventricular arrhythmias   43 25    0.02 
Multi PVC/doublets   39 23    0.01 
VT 3-10 complex     3   4 ns 
VT > 10 complex     -   -  
Conduction disturbances  17   8    0.01 
First degree AV block  14   8 ns 
Second AV block    2   - ns 
Third AV block    -   -  
SVT=supraventricular tachycardia; PVC=premature ventricular complexes; AV=atrioventricular 
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Sinus rhythm was seen in 1990 in 90% of the patients and 89% in 2001. The PR-
interval did not change during this 10-year period. P-wave duration and p wave 
height did not change significantly in 10 years time. The QRS-duration increased, but 
no new bundle branch block occurred. 
 
Holtermonitoring 
On 24-hour Holter 2 patients showed paroxysmal atrial flutter in 2001, which was not 
present in 1990. These 2 patients did not differ from other patients with regard to 
right atrial enlargement, right ventricular dilatation or left atrial enlargement. Signs of 
sinus node dysfunction were found in 39% in 1990, and 27% in 2001. One of the 
patients needed pacemaker implantation in the period 1990-2001. Ventricular 
arrhythmias including multiform premature ventricular complexes, doublets and short 
ventricular tachycardias (3-10 complexes) were seen on Holter in 1990 in 43% of the 
patients. During the following ten years, none of these patients experienced 
symptomatic ventricular arrhythmias or sudden death and the incidence of ventricular 
arrhythmias on 24-hour holter diminished to 25% in 2001. 
 
Echocardiography 
Echocardiographic findings are summarised in Table 3 and 4. Residual shunts were 
not found. Dimension of right ventricle, left atrium and left ventricle remained 
unchanged over time. The percentage of patients with right atrium dilatation 
increased from 5.8% in 1990 to 18.7% in 2001 (p=0.5).  
 
Table 3 Echocardiograpic parameters comparing 1990 and 2001 
 1990 2001 P value 
RA dilatation 5.8% 18.7% 0.5 
RV dilatation 26.0% 23.5% 0.7 
LA dilatation 10.0% 5.9% 0.5 
LV dilatation 9.5% 5.7% 0.5 
LV systolic function normal 97.1% 95.5% ns 
RV systolic function normal 100% 100% ns 
Valve insufficiency (more then trace)    
AoI 0% 1.1% ns 
MI 11.5% 13.5% ns 
PI 44.2% 45.0% ns 
TI 42.3% 48.3% ns 
Vmax TI 2.1 m/s 2.2 m/s ns 
Vmax PI 1.6 m/s 1.5 m/s ns 
RA=right atrium, RV=right ventricle, LA=left atrium, LV=left ventricle, AoI=aortainsufficiency, MI=mitral 
insufficiency, PI=pulmonic insufficiency, TI=tricuspid insufficiency, Vmax=maximal velocity found with 
doppler echocardiography  
 
 
Mitral valve regurgitation did not progress in ten years and none of the patients 
developed substantial pulmonary regurgitation. Hemodynamically insignificant 
pulmonary and tricuspid regurgitation did not progress, but one patient developed 
severe aortic regurgitation. No pulmonary hypertension was found and estimated 
pulmonary artery pressure was stable over time. Left and right ventricular function 
remained unchanged over the last ten years, and none of the patients was having a 
left ventricular shortening fraction less then 20% at last follow-up. Although 20% of 
Chapter II 
26 
the patients had a left ventricular shortening fraction between 20 and 30%, most of 
these patients had post-operative abnormal septal motions, but were judged to have 
a further normal systolic function, only 4.5% of the total group was judged as having 
diminished systolic left ventricular function. Only one patient showed paradoxical 
septal motion. 
 
Table 4 Echocardiographic parameters 2001 in detail 
  enlarged    
Chamber size normal  mild  moderate 
RA 67%  14.3%  18.7% 
RV 76.9%  11.0%  12.1% 
LA 85.5%  5.5%  7.7% 
LV 93.3%  4.4%  2.2% 
Hypertrophy      
LVH 94.8%  2.6%  2.6% 
RVH 94.5%  5.5%  - 
Function      
LV function 95.5%  4.5%  - 
RV function 100%  -  - 
 >30%  20-30%  >20% 
Left ventricular fractional shortening 80%  20  - 
Valve regurgitation no trace 1+ 2+ 3/4+ 
Aol 98.8 1.1 - - 1.1 
MI 52.8 33.7 9.0 3.4 1.1 
PI 29.2 25.8 36.0 9.0 - 
TI 13.5 38.2 28.1 14.6 5.6 
 <2.5 m/s  2.5-3.0 
m/s 
 >3.0 m/s 
Vmax TI 88.5%  11.5%  - 
 <1.5 m/s  1.5-2.0 
m/s 
 >2.0 m/s 
Vmax PI 46.5%  49.3%  4.2% 
See legend Table 3. LVH=left ventricular hypertrophy, RVH=right ventricular hypertrophy 
 
 
Bicycle ergometry 
The results of exercise testing in 1990 and 2001 are given in Table 5. The exercise 
capacity, corrected for age, sex and body height, diminished by 9% in ten years, but 
remained comparable with the total Dutch population. During exercise testing, no 
new arrhythmias were revealed. Pre-operative findings, surgical procedures, 
echocardiographic parameters, age at the time of operation or duration of follow-up 
were not predictive for diminished exercise capacity. 
 
Table 5 Bicycle ergometry 
 1990 2001 
number of patients 101 91 
max heart rate 92% 92% 
max exercise capacity 104% 95% 
significant arrhythmia - - 
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Type ASD 
Sinus venosus type ASD and secundum type ASD differed with regard to sex: the 
sinus venosus type ASD-patients were predominantly males (66%), whereas in the 
secundum type ASD group we found predominantly females (63%), (p-value=0.004). 
Furthermore the patients with sinus venosus type ASD had greater shunts (shuntratio 
2.6:1 versus 2.2:1 in the secundum type ASD patients, p=0.04), had more often 
partially abnormal pulmonary veins, and more often a patch was used during surgery 
(100% in the sinus venosus group versus 3% in the secundum ASD group). The 
sinus venosus type and secundum type ASD did not differ significantly with regard to 
the incidence of arrhythmias, the exercise performance or the outcome on echo-
Doppler parameters (dimensions, ventricular function, valve insufficiency, or 
pulmonary artery pressure). 
 
 
Discussion 
 
The long-term outcome (21-33 years) of children who had undergone surgical 
closure of hemodynamically significant ASD was investigated in this study. Although 
the general opinion is that the long-term results will be good, no hard data are 
available. We present a unique longitudinal study of consecutive patients with long-
term (21-33 years) follow-up, studied, not only with written questionnaire or telephone 
interview, but also with a thorough clinical investigation. We found an excellent 
survival with no cardiovascular mortality. Complications such as right heart failure, 
stroke or elevated pulmonary vascular resistance did not occur. Only one additional 
cardiac operation was performed (for closure of a patent arterial duct). No residual 
ASD was found. Pacemaker implantation was performed in 4 patients before 1990 
and in 1 patient between 1990 and 2001. One pacemaker patient developed 
endocarditis.  
The development of atrial arrhythmias is described after ASD closure, and has 
been studied thoroughly in adults.8,17,18 Studies of long term follow-up in adults 
demonstrate that the incidence of new atrial arrhythmias is unchanged following 
surgical closure of ASD compared to those treated conservatively. Some studies 
suggest that older age at operation is a risk factor for persistent atrial arrhythmias 
and development of new atrial arrhythmias after surgery,17-19 while the incidence of 
atrial arrhythmias appears lower in patients operated at younger age. Nevertheless, 
Meijboom et al reports up to 45 % of the patients having some form of asymptomatic 
atrial arrhythmias on Holter recording, 15 years after surgery.8,14 In this same cohort 
of patients we observed a low incidence (2%) of symptomatic arrhythmias in the 
subsequent decade and 36% asymptomatic atrial arrhythmias. No patient had 
chronic atrial fibrillation, one patient developed persistent atrial flutter, one needed 
pacemaker implantation, and one patient received antiarrhythmic medication for 
supraventricular tachycardias. Thus, the predictive value of the asymptomatic 
arrhythmias seen on Holter recording seems limited. The prevalence of atrial 
fibrillation in the general population is studied mainly in older age groups and is 
estimated to be 3/1000 in those aged 45-49 years.20 The reported incidence of atrial 
fibrillation and flutter in natural history studies of ASD patients is 15-40 percent in 30-
35 year-olds and comparable with the incidence of arrhythmias after surgical ASD 
closure at adult age, and this is substantially higher then the 3% found in our study, 
suggesting that early closure is beneficial indeed.1,17,18,20  
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The aetiology of late atrial arrhythmias following surgical closure of ASD is not 
well explained. Long standing volume overload, varying degrees of pulmonary 
hypertension, ventricular dysfunction, congenital defects in the atrial conduction 
tissue, and surgical scars have all been implicated.22,23 Our data imply that it is 
unlikely that the congenital defect in the conduction tissue is an important factor in 
the aetiology of the arrhythmias, since few symptomatic arrhythmias occurred. It is 
possible that the atria of young patients have greater remodelling potential and that 
this patient population may therefore be at lower risk for the development of late atrial 
arrhythmia's.6 Transcatheter device closure may have an extra advantage over 
surgical closure on the incidence of arrhythmias, but improvement of right heart 
morphology after device closure and the effect of avoidance of an atriotomy scar 
remain to be determined.24 Electrocardiographic parameters such as P wave height 
and PR interval, which may predict the occurrence of atrial arrhythmias, remained 
stable for ten years. This, together with the low incidence of new symptomatic 
arrhythmias in the last ten years, leads to the prediction that only few additional 
arrhythmias will develop in these patients. Continuing follow-up is warranted to verify 
this assumption. 
The clinical condition of the patients appeared excellent at follow-up: the 
exercise capacity was comparable with normal individuals corrected for age, sex and 
body height. Furthermore, the incidence of right ventricular dilatation and valve 
regurgitation on echocardiographic images was low, and not different from ten years 
ago. The percentage of patients with a dilated right atrium increased from 5.8 in 1990 
to 18.7% in 2001. This was not a significant increase (p=0.5), but also others 
reported a remaining dilatation of the right atrium after ASD closure compared to 
controls.24 
Whether transcatheter device closure will have the same excellent results 
remains to be determined, especially while up to 50% of the patients have residual 
shunts after device closure after one year of follow-up.6  
In our study we found no differences in outcome between the patients with 
sinus venosus type ASD and secundum type ASD with regard to the incidence of 
arrhythmias, exercise capacity and hemodynamic status.  
 
Study limitations 
In this study the follow-up is incomplete. After 15 years 104 (77%) and after 26 years, 
94 (70%) from the originally 135 operated patients participated in the study. Since 
1990 1 patient died, 5 were lost and 4 were unwilling to come to the hospital. 
Nevertheless, the latter 4 patients did return the questionnaire, and reported to be in 
good clinical health. Furthermore, we found no difference in characteristics between 
the patients who did and who did not participate in the follow-up study, so we expect 
that the incomplete follow-up will have no impact on the outcome of the study.  
 
 
Conclusion 
 
The long-term outcome after ASD closure at young age shows an excellent survival 
with no cardiovascular mortality and low morbidity. The development of 
supraventricular arrhythmias is lower then in natural history studies of ASD patients 
and also lower then after surgical correction at adult age. The clinical condition of the 
patients is very good and stable. 
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These excellent long-term results are critically important for the employability 
and insurability, and ASD patients should encounter no obstacles in finding jobs and 
have life insurance policies consistent with standard rates.  
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Abstract 
 
Background 
Long-term survival and clinical outcome after surgical closure of a ventricular septal 
defect is poorly documented. Such data are important for the future perspectives, 
medical care, employability, and insurability of these patients. 
 
Methods 
One-hundred-seventy-six consecutive patients underwent surgical closure of an 
isolated VSD between 1968 and 1980 in our hospital. A systematic follow-up study 
was performed in 1990 and again in 2001. 
 
Findings 
Late survival was poorer than in the general population. Pulmonary hypertension and 
right ventricular hypertrophy were present in the 4 patients who died suddenly, late 
after operation. During follow-up no new pulmonary hypertension became manifest. 
Re-operations were necessary in 6%. Some patients (4%) developed sinus node 
disease late after repair, requiring pacemaker implantation. At last follow-up (91 
survivors) 92% of the patients were in NYHA class I. Pulmonary hypertension was 
found in 4%, and aortainsufficiency in 16%. Patients experience difficulties in 
application for insurance. 
 
Conclusion 
Among patients with surgically repaired ventricular septal defects, late results were 
good, although some late sudden deaths occurred in the patients with pulmonary 
hypertension. Furthermore, some patients developed sinus node disease late after 
repair, requiring pacemaker implantation. Employability is good, but pregnancy and 
insurance matters need further attention. 
 
 
Introduction 
 
Isolated ventricular septal defect (VSD) is by far the most common congenital heart 
defect, and surgical closure of a VSD is the most common open-heart procedure 
performed in pediatric cardiac surgery.1 Apart from a high perioperative mortality, 
patients operated in the 1950’s and 1960’s showed a higher-than-normal prevalence 
Chapter III 
34 
of sudden death and serious arrhythmia during follow-up.2 Since then, significant 
changes have taken place such as early correction of a large VSD to avoid 
pulmonary vascular disease and broader indications for closure in patients with 
moderate shunts. Furthermore, many improvements in operative and perioperative 
care were achieved. It has been postulated that patients with surgically closed VSDs 
in the1970’s do well, with a normal life expectancy. Most adult patients have been 
discharged from routine cardiological follow-up.3,4 Partly as a result of this policy, 
data on late survival, sequelae such as arrhythmias, pulmonary hypertension and 
aortic insufficiency and employability and insurability is sparse.5 - 10 This report 
describes the long-term survival and clinical course in a single center cohort of 176 
consecutive patients operated upon in our institution between 1968 and 1980 at 
young age, with 22-34 years follow-up. Changes in ECG, exercise capacity and 
echocardiographic parameters were examined. Employability and insurability issues 
were addressed. 
 
 
Methods 
 
Patients 
All 176 patients with surgical repair of an isolated ventricular septal defect at our 
institution between 1968 and 1980 at young age (<15 years) were included in this 
study. The year 1968 was chosen as starting point because in this year cardiac 
surgery was started in our center and 1980 was chosen to have more than 20 years 
follow-up. The details of preoperative clinical findings, including cardiac 
catheterisation, localization and type of ventricular septal defect, data on surgical 
technique and postoperative course have been described earlier and are 
summarized in Table 1.4 After a median follow-up of 15 years (range 11-23 years), 
109 patients (79% of those eligible for follow-up) participated in the first follow-up 
study performed in 1991.4 
The target population of the second follow-up (2001) consisted of the 109 
patients of the first follow-up. 
The follow-up status was determined by examination at our institution and the cardiac 
examination included medical history, physical examination, standard 12-lead 
electrocardiography, 24-hour ambulatory electrocardiography (Holter), 
echocardiography and bicycle ergometry. Furthermore, a psychological interview was 
performed. 
The Medical Ethical Committee approved the study. All patients gave their 
written consent. 
 
Electrocardiography 
Standard 12-lead electrocardiograms were analyzed for cardiac rhythm, the height of 
the P wave (measured in lead II), duration of the P wave and the PR interval. A first-
degree atrioventricular block was defined by a PR interval > 200 milliseconds. 
Furthermore the Median frontal plane P wave axis and QRS axis were 
determined, as was the widest QRS duration. A QRS duration > 120 msec was 
defined to be a complete bundle branch block: a positive QRS complex in lead V1 
was categorized as right bundle branch block and a negative QRS complex as left 
bundle branch block. A single observer made all ECG measurements. 
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Holter monitoring 
Sinus node dysfunction was assessed during 24 hour Holter monitoring using the 
modified Kugler criteria: nodal escape rhythm, sinusarrest > 3 sec or severe 
sinusbradycardia (<30 beats/min at night or <40 beats/min during daytime).11 
Ventricular tachycardia was defined as 3 or more consecutive ventricular beats with a 
heartrate of > 100 beats/minute. 
 
Two-dimensional echocardiography 
Echocardiography was performed using a Hewlett-Packard Sonos 5500 
echocardiograph. M-Mode measurements of left atrial and left ventricular end-
diastolic and end-systolic dimensions were made in the parasternal view. A left 
atrium > 45 mm and left ventricle end-diastolic dimension > 58 mm were considered 
enlarged. A fractional shortening of the left ventricle of < 30% was considered 
abnormal. Right ventricular dimensions and function were judged by visual estimate 
by two experienced cardiologists. Dimensions were scored as normal, mildly, 
moderately or severely dilated. Right ventricular function was graded as normal, 
mildly, moderately or severely impaired. Of each patient the study of 1990 was 
compared with that of 2001. The degree of tricuspid regurgitation (minimal, 
moderate, or severe) was estimated with color-Doppler by the width and length of the 
regurgitant jet. Pulmonary hypertension was defined by an early diastolic pulmonary 
regurgitation flow velocity of > 2.5 m/s or, in the absence of right ventricular outflow 
obstruction, a tricuspid regurgitation flow velocity > 3.0 m/sec. Multiple 
echocardiographic views were examined using color flow to identify residual shunts. 
 
Bicycle ergometry 
Maximal exercise capacity was assessed by bicycle ergometry with stepwise 
increments of the workload of 20 Watts per minute. Exercise capacity was compared 
to that in normal individuals corrected for age, sex and body height. 
 
Cardiovascular events 
Cardiovascular events are defined as any of the following: re-operation, 
pacemakerimplantation, tachyarrhythmia requiring treatment (medication, electrical 
cardioversion or ablation), endocarditis or congestive heart failure. 
 
Data analysis 
Data are presented as median and range, unless indicated otherwise. The Chi-
square and Fisher’s exact test were used for the comparison of discrete variables. 
The Student t-test was used to compare continuous variables. All tests used were 
two-tailed. The Mc Nemar test of symmetry was used to compare the 15- and 26 
years outcome. Cumulative survival curves were constructed using the Kaplan-Meier 
method. Among patient subgroups the logrank test was used to compare survival 
curves. The level of significance was chosen at p < 0.05. Multivariable Cox-
regression analysis was performed for survival. 
The variables tested were birth weight, type of palliation, main pulmonary 
artery systolic pressure, pulmonary artery/aorta ratio, age at operation, year of 
operation, use of deep hypothermia, use of cold cardioplegia, aortic crossclamp time, 
right ventricular incision, peri-operative complications, residual lesions. Continuous 
variables were not categorised in the model. 
The proportional hazards assumptions were tested by constructing interaction 
terms between the variables and time to each end-point. Cox regression analyses 
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showed no statistically significant interactions with time (each p>0.05). The model 
selection is based on the stepwise principle, where the limit to enter and to remove a 
variable was both 0.05. 
 
 
Results 
 
Patients 
Median age at operation was 4 years (range 0 to 13). The baseline characteristics of 
all 176 patients are described in Table 1. 
 
Table 1 Baseline characteristics of 176 consecutive patients who underwent VSD closure between   
     1968 and 1980 
 Total group 1990 2001 p-value 
Number of patients 176 109 95  
Age at operation in years 4 (0-13) 4 (0-13) 4 (0-13) 0.9 
Age < 1 year in % 34 32 32 0.9 
Age at the time of follow-up in yrs - 19 (10-33) 30 (21-44)  
Time from OK to follow-up in yrs - 15 (11-23) 26 (22-34)  
Preop RV syst pressure in mmHg 67 (40-112) 66 (40-110) 66 (40-110) 0.8 
Pre op QP/QS 2.2 (0.7-6.0) 2.2(0.7-6.0) 2.2(0.8-6.0) 1.0 
Pulm resistance in dyne/sec cm -5 233(50-980) 246(62-825) 249(62-825) 0.9 
Aortic cross clamp time in min 39 (10-85) 35 (14-80) 35 (14-80) 0.9 
Type of VSD: perimemb in % 77 85 82 0.5 
Previous PA banding in % 9 6 5 0.8 
RV-incision in % 45 51 47 0.3 
Numbers between brackets give the range 
 
 
Information on survival is complete for the total cohort of 176 patients. Twenty-three 
(12%) patients died before 1991. Of the 109 patients who participated in the first 
follow-up study, 2 patients died, 7 were lost to follow-up and 5 participated only by 
written questionnaire. The remaining 95 patients (95% of those eligible for follow up) 
fully participated in the second follow-up study with a median follow-up of 26 years 
(range 22-34 years) after surgery, and with a median age at the time of study of 30 
years (range 21-44). No significant differences were found between the baseline 
characteristics of the patients who participated in the follow-up studies and the 
patients who did not (Table 1). There were 57 males (60%) and 38 females (40%). 
 
Mortality 
Nineteen patients died within 30 days after operation (Figure 1). Late death occurred 
in 6 patients (4%). Of these 6 patients who died late postoperatively 4 had 
documented residual pulmonary hypertension and they all died suddenly respectively 
3, 4, 16 and 18 years postoperatively. These 4 patients all showed right ventricular 
hypertrophy on their ECG. One patient died during re-operation for aortic valve 
surgery and 1 patient died of a non-cardiac cause (fire accident). 
 
Cardiovascular events 
The 25 years event-free survival for the hospital survivors was 80% (Figure 1). 
Reoperations were performed in 6 patients: 2 residual VSD (10 and 21 years after 
the initial operation), 1 discrete subaortic stenosis and 3 RV-outflow tract obstruction 
(at a median interval of 6 years after the initial operation). Additional cardiac surgery 
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was performed in 4 patients: 1 persisting arterial duct, 1 aortic valve replacement 
after endocarditis, and 2 aortic coarctation. Pacemaker implantation was performed 
in 6 patients; 2 for surgical atrioventricular block shortly after operation and 4 
because of sick sinus syndrome more than 15 years after surgery. One patient 
underwent radiofrequency catheterablation for intra-atrial reentry tachycardia. Two 
patients with co-morbidity, suffered from endocarditis late after VSD closure leading 
to aortic valve replacement in one, and pacemaker replacement in the other patient. 
Clinical evaluation 
Of the patients, 92% was in NYHA class 1, and 8% in class 2. Five patients (5%) 
were taking medication: oral anticoagulation in 1 (artificial aortic valve), betablockers 
in 2, and ace-inhibitors in 2 patients. Oxygen saturation (measured with Nellcor) was 
98% (range 94-100%). No patient showed signs of heart failure. 
 
Electrocardiography 
The ECG findings are described in Table 2. We found no difference between 
transatrial and transventricular approach (with right ventricular incision) regarding the 
incidence of a right bundle branch block on the ECG during follow-up. A prolongation 
of the QRS-complex and P-wave duration occurred between 1990 and 2001. 
 
Twenty-four hour ambulatory monitoring 
None of the patients had atrial flutter or fibrillation on the 24-hour ambulatory 
monitoring in 1990 or 2001. Junctional escape rhythm was found in 2001 in 23% of 
the patients, signs of sinus node disease were found in 9% of the patients, but no 
ventricular pauses longer than 3 seconds occurred. 
Ventricular tachycardia of more than 10 complexes were not found, and 8% 
showed ventricular tachycardia of 3-10 complexes. 
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Table 2 Standard 12-lead ECG long term after surgical VSD repair 
 1990 2001 p-value 
Number of patients 109 95  
Rhythm (%)    
Sinus 106 (97) 88 (93) 0.3 
Nodal 1 (1) 2 (2)  
Atrial 1 (1) 1 (1)  
Pacemaker 1 (1) 4 (4)  
Aflutter - -  
PR interval +SD (msec) 147 +30 152 +28 0.05 
PR > 200 msec (%) 2 5 0.2 
QRS duration +SD(msec) 101 +20 113 +26 0.01 
RBBB (%) 23 29 0.06 
QTc segment +SD(msec) 398 +40 398 +27 0.9 
QRS axis +SD (degree) 52 +30 43 +33 0.01 
P duration +SD (msec) 84 +15 91 +17 0.01 
P-wave height +SD (cm) 0.17 +0.07 0.17 +0.07 0.3 
P-wave axis +SD(degree) 39 +26 35 +27 0.09 
LVH (%) 7 11 0.05 
RVH (%) 8 7 0.5 
 
 
Echocardiography 
Echocardiography was performed in 95 patients (Table 3). Left ventricular 
dimensions were normal in 96% of the patients. Pulmonary hypertension was found 
in 4%. These 4% were not different from the total group concerning the age at 
operation. We found no change in median pulmonary artery pressure between 1990 
and 2001. Aortic regurgitation was present at last follow-up in 15 patients (16%): mild 
in 13 and moderate in 2 patients. Over the last ten years 2 patients showed 
progression from mild to moderate aortic regurgitation. No severe aortic valve 
regurgitation was encountered and no significant change in mitral-, tricuspid- or 
pulmonary regurgitation was noted (Table 3). Using Cox multivariable regression we 
found no relation between the presence of moderate aortic or mitral insufficiency and 
the duration of follow-up, age at surgery, right ventricular incision during surgery, type 
of VSD or left ventricular function (fractional shortening on echo). 
 
Exercise capacity 
Ninety-three patients exercised to maximal effort. The median exercise capacity in 
these patients was 91% (range 43 -226) of the predicted values in 2001, while it was 
100% in 1990. During the test 5 patients had an increase of ventricular extrasystoles 
and 1 patient developed supraventricular tachycardia. No ventricular tachycardia 
occurred. We found no relation between exercise capacity in 2001 and median 
pulmonary artery pressure before surgery, duration of aortic cross clamp time, 
presence or absence of a right bundle branch block on the ECG, young age (<1 year) 
at operation or left ventricular function (fractional shortening on echo). 
 
Risk factors for late death 
Multivariable Cox-regression revealed 2 predictors for late mortality (Table 4). A 
‘median pulmonary artery pressure of more than 70 mmHg before operation’ and 
‘perioperative complications’ (reoperation, arrhythmia, infection) were predictors for 
late mortality. 
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Table 3 Echocardiographic results in 95 patients after surgical VSD repair 
 1990 2001 p value 
Number of patients 109 95  
LA dimension +SD (mm) 32 +5 37 +6 0.2 
LVED dimension +SD (mm) 50 +4 52 +5 0.1 
    
LA dilatation (%) 4 (4) 9 (9) 0.02 
LV dilatation (%) 11(10) 4 (4) 0.01 
RA dilatation (%) 19 (20) 19 (20) 0.9 
RV dilatation (%) 13(14) 13(14) 0.7 
    
LVH (%) 5 (5) 9 (10) 0.1 
RVH (%) 4 (4) 7 (7) 0.3 
    
Mean FractShort.LV (%) 34 34 0.8 
    
Good RV syst function (%) 109 (100) 94 (99) 0.8 
    
Valve insuff (%)    
AoI 16 (15) 15 (16) 0.6 
mild 16 (15) 13 (14)  
moderate 0 2 (2)  
    
MI 13 (12) 11 (12) 0.9 
mild 13 (12) 11 (12)  
moderate 0 0  
    
PI 26 (24) 27 (28) 0.3 
mild 26 (24) 25 (26)  
moderate 0 2 (2)  
    
TI 45 (41) 40 (42) 0.7 
mild 43 (39) 36 (38)  
moderate 2 (2) 4 (4)  
    
Vmax TI +SD 2.4 +0.4 2.4 +0.4 0.8 
Vmax PI +SD 1.5 +0.3 1.6 +0.3 0.6 
Pulmonary hypertension (%) 7 (6) 4 (4) 0.4 
Small residual VSD (%) 9 (8) 8 (8) 0.8 
 
 
Table 4 Multivariable Cox regression 
End point: late death (>1 year after surgery) 
Independent predictors HR 95%CI 
   
- Median pulmonary artery pressure before surgery per 10 mmHg increase 1.29 [1.05-1.58] 
- Post-operative complications 7.8 [2.6-24.1] 
 
 
Social life 
Of the 95 patients seen at last follow-up, 70% had some sort of relationship (stable 
relation 16%, living together 19%, married 35%). A total of 72% had no children, 12% 
had 1 child and 16% had 2 or more children. Regarding the daily activities, 82% of 
the patients had a paid job. On the question if the patient had ever encountered 
difficulties with respect to insurance policies, 75% of the patients answered yes. With 
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respect to which insurance policy, 33% had problems with health insurance, 42% 
with mortgage, and 55% with life insurance. 
 
 
Discussion 
 
This series is unique in that it comprises a cohort of consecutive patients operated at 
young age at a single institution with longitudinal follow-up of 22-34 years. Apart from 
a considerable historical early mortality (13%), we experienced 4% (6 patients) late 
mortality. This study also provides new data documenting sinus node disease 
developing late after surgery and insurability of the patients. 
 
Mortality 
The operative mortality of 13% found in this study represents the patients with large 
VSDs operated upon in the time period of 1968-1980. At present these figures have 
improved dramatically. The focus of this study was on late events in hospital 
survivors, and statistical analyses were confined to this patient population. 
There was a 4% (6 patients) late mortality among the 153 patients who 
survived operation, and 5 of the 6 deaths were attributed to cardiovascular causes. 
This is higher than in the general population. For comparison, in patients undergoing 
surgical closure of atrial septal defect who were studied in the same manner, no 
cardiac deaths occurred during 26 years follow-up.12 The most likely explanation for 
this late mortality is right ventricular hypertrophy due to long-standing right ventricular 
pressure overload, causing ventricular arrhythmias. In all 4 patients who died 
suddenly late after operation, right ventricular hypertrophy was found. Cardiac 
hypertrophy is the common denominator in all cases reported in detail of VSD-
associated sudden death.13 It is known that the incidence of ventricular arrhythmias 
and sudden death in non-operated VSD-patients is high (20-90%), suggesting that, 
damage to the ventricle is due especially to pressure overload.2,13 Ventricular 
arrhythmias were found in 42% of our patients on ambulatory ECG monitoring in 
1990, none of these patients experienced clinical significant arrhythmias or sudden 
death in the following 11 years. Therefore, we conclude that there is no clear 
predictive value of ventricular ectopic activity found on 24-hour Holter monitoring. 
Others reported ventricular arrhythmias varying from 18 to 39%.8,10 
We did not find patients developing pulmonary hypertension late after surgery. 
Pulmonary pressure neither diminished, nor progressed during follow-up. Our study 
reports the late outcome of patients operated in the late 60s and 70s. Since then, 
changes have occurred and for some time, VSDs with large left to right shunts are 
treated in infancy and therefore in the present time pulmonary hypertension late after 
surgery will largely be prevented. The 4% of patients in our study with pulmonary 
hypertension at present are at risk for sudden death in the future and for these high-
risk patients intensified surveillance is justified and maybe prophylactic implantation 
of an internal defibrillator should be considered. 
Since no follow-up data are available for patients who died prior to the follow-
up, we only included the follow-up data of the surviving patients. This may lead to 
biased results. 
 
Clinical condition 
The functional outcome in late survivors was good with the vast majority of patients 
being in NYHA class I, a median exercise capacity of 91% and only five patients (5%) 
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using medication. Although a second cardiac operation was necessary in 10% of the 
patients, in only 2% it concerned a residual VSD. A small, hemodynamically 
insignificant residual VSD was found in 8% of the patients, which is in line with, or 
slightly better than in other reports.2,14 
Bacterial endocarditis occurred rarely (only 2 patients), and was not even 
directly related to the VSD: in 1 patient the aortic valve was involved and the other 
patient suffered from pacemaker-endocarditis. Also others report a very low 
incidence of endocarditis after VSD closure, so endocarditis prophylaxis should be 
given only in patients who have concomitant pathology such as pacemaker leads or 
valve disease or have a residual VSD. Routine-use of prophylaxis seems not 
indicated after successful closure of an isolated VSD. The occurrence of aortic 
insufficiency is one of the issues after VSD-surgery. The incidence in this cohort of 
patients was 16%, which is higher than in other reports.2 In most studies, however, 
no extensive cardiovascular examination was performed. The degree of aortic 
insufficiency was mild and did not change significantly in 10 years time. Aortic valve 
surgery was necessary in 1 patient only, and that was because of endocarditis. Left 
ventricular dilatation was found in a minority of patients only. No significant heart 
failure was found and no signs of left ventricular dysfunction, which is very important 
for the future perspectives of these patients. 
 
Conduction disturbances 
Pacemaker implantation was necessary in 6 patients (4%). The 2 patients with 
surgical block had a pacemaker implanted shortly after surgery. Striking is the fact 
that 4 patients developed sinus node disease with need for pacemaker implantation 
more than 15 years after surgery. A possible cause of this late sinus node 
dysfunction is cannulation of the right atrium for cardiopulmonary bypass, but it is 
after a surprisingly long period of time that this sinus node disease becomes 
manifest.15 In 1990 20% of the patients already had minor indicators of sinus node 
dysfunction, under which the 4 who needed the pacemaker implantation later on, 
confirming the progressive nature of the disease.4 Furthermore, the PR-interval 
increased and even so the incidence of a first degree AV block. The prolongation of 
the QRS-complex may indicate late myocardial reaction to the earlier ventricular 
overload. The late occurrence of clinically significant sinus node disease 
necessitating pacemaker implantation has not been reported before in this patient 
group, perhaps because most of these patients do not have regular cardiological 
follow-up. 
 
Social life 
Employability is excellent in our patient’s sample. It seems that finding a paid job is 
not a major issue in our group. However, starting a family seems more problematic. 
Only 28% of the patients had children, although the fast majority had a stable 
relationship. This is low compared with the general population.16 The explanation 
may be fear that pregnancy may cause damage to the female patient or fear for 
congenital heart disease in the offspring. Another explanation may be that fertility is 
negatively influenced by heart surgery at young age. The numbers are relatively 
small in our study and more research is necessary in this field. Probably, more 
attention should be paid to give proper information to these patients about the 
different aspects of pregnancy. Finally, because the long-term prognosis is excellent 
in the absence of pulmonary hypertension, application for insurance should be able 
without problems in the large majority of patients.17 However, 75% of the patients in 
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our study experienced obstacles to obtain insurance policies, especially with life 
insurance. Since the prognosis after surgical correction of VSD has further improved 
over the last 30 years, it is time that also insurability will improve in these patients. 
 
 
Conclusion 
 
Adults who underwent surgical VSD closure in childhood generally do well, but 
survival is lower than that of the general population. Late mortality was found in 4%, 
especially in the patients with pulmonary hypertension and right ventricular 
hypertrophy. In our study no new pulmonary hypertension late after surgery 
developed. 
The overall clinical condition of the survivors at last follow-up was satisfying and 
complications such as endocarditis, arrhythmias and clinical significant 
aortainsufficiency occurred rarely. Sinus node disease requiring pacemaker 
implantation was found in 4% of the patients, more than 15 years after surgery. This 
underscores the need to follow these patients, who have been subjected to open 
heart surgery before 1980, indefinitely with special attention for the development of 
sinus node disease. Employability is good, but pregnancy needs further attention. 
The results of this study can be used as a guideline for insurance policies. 
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Abstract 
 
Background 
Long-term (>20 years) survival and clinical outcome are only partly documented in 
patients who underwent surgical repair for isolated pulmonary stenosis. Yet, such 
data are of critical importance for the future perspectives, medical care, employability, 
and insurability of these patients. 
 
Methods 
Ninety consecutive patients underwent surgery for pulmonary stenosis between 1968 
and 1980 at the Thoraxcenter. A systematic follow-up study was performed in 1990 
and again in 2001.  
 
Findings 
Survival was 96% after 25 years. Reintervention was necessary in 15% of the 
patients, mainly for pulmonary regurgitation. Right atrial and ventricular dilatation and 
paradoxical septal motion were associated with the need for reoperation. No major 
ventricular arrhythmias occurred. Supraventricular arrhythmias occurred, only in 
patients with severe pulmonary insufficiency and disappeared after reoperation. At 
last follow-up 67% of the patients was in NYHA class 1 and maximal exercise 
capacity was 90% of normal. Pulmonary insufficiency was present in almost all 
patients (94%). 
 
Conclusion 
Although long-term survival and quality of life are good, pulmonary regurgitation is 
found in almost all patients 22-33 years after surgical repair for isolated pulmonary 
stenosis. Reoperation for pulmonary insufficiency was necessary in 9%, especially 
after the transannular patch technique. 
 
 
Introduction 
 
Surgical valvotomy or valvectomy was the treatment of choice for valvular pulmonary 
stenosis before the use of balloon angioplasty.1 The surgical approach evolved from 
closed valvulotomy, first performed in 1948, to open valvulotomy using inflow 
occlusion, and finally, open valvulotomy with the use of cardiopulmonary bypass.2 
With the latter technique the extent of surgery can be adapted to the needs of the 
individual patient and can vary from a simple commissurotomy, to a complete right 
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ventricular outflow tract reconstruction with a transannular patch or homograft. 
Current surgery is associated with low early mortality and good short to intermediate 
term results.3,4 However, there are few reports of late outcome of patients, operated 
upon with more modern surgical techniques.5,6 In fact, biased information has been 
gathered, because many adult patients have been discharged from routine 
cardiological follow-up and the adult cardiologist in particular sees patients who 
developed symptoms. Reliable information about the “natural history” after surgical 
valvotomy for isolated pulmonary valve stenosis can only be obtained if an 
unselected surgical cohort is investigated. Such information is important with regard 
to the future perspectives, employability and insurability of these patients. Our study 
presents the long-term survival (22-33 years) and clinical outcome of a single center 
cohort of consecutive patients operated for isolated pulmonary stenosis between 
1968 and 1980. 
 
 
Methods 
 
Patients 
Ninety patients had surgical repair of an isolated pulmonary stenosis at our institution 
between 1968 and 1980 at young age (<15 years). Preoperative clinical findings, 
including cardiac catheterisation, and details of the surgical procedure were collected 
from patients hospital records. Information on survival was obtained. 
A first follow-up study was performed in 1990: 51 patients were invited to 
participate in the study. By an administrative mistake, the other 39 patients were not 
invited! From the 51 invited patients, 45 (88%) participated in the first follow-up study 
in 1990. The patients of the 1990-study were invited for a detailed second follow-up 
study, in 2001 of whom 38 participated. The cardiac examination included medical 
history, physical examination, standard 12-lead electrocardiography (Holter), 24-hour 
ambulatory electrocardiography, echocardiography, and bicycle ergometry.  
The Medical Ethical Committee approved the study. All patients gave their written 
consent.  
An attempt was made to locate and contact all 90 patients. Five had died, 17 
were lost and the remaining 68 patients were alive. In addition to the 38 patients who 
participated in the detailed follow-up study, 21 patients returned a written 
questionnaire with information on morbidity. 
 
Electrocardiography 
Standard 12-lead electrocardiograms were analyzed for cardiac rhythm, the height 
and duration of the P wave (measured in lead II) and the PR interval. A first-degree 
atrioventricular block was defined by a PR interval > 200 milliseconds. Furthermore 
the median frontal plane P wave axis and QRS axis were determined, as was the 
longest QRS duration. A QRS duration > 120 msec was classified as a complete 
bundle branch block: a positive QRS complex in lead V1 was categorized as right 
bundle branch block and a negative QRS complex as left bundle branch block.  A 
single observer made all ECG measurements (JR-H).  
 
Holter monitoring 
Sinus node dysfunction was assessed during 24 hour Holter monitoring using the 
modified Kugler criteria: nodal escape rhythm, sinusarrest > 3 sec or severe 
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sinusbradycardia (<30 beats/min at night or <40 beats/min during daytime).7 
Ventricular tachycardia was defined as 3 or more consecutive ventricular beats with a 
heart rate of > 100 beats/minute. 
 
Two-dimensional echocardiography 
Echocardiography was performed using a Hewlett-Packard Sonos 5500 
echocardiograph. M-mode measurements of left atrial and left ventricular end-
diastolic and end-systolic dimensions were obtained in the parasternal long axis 
view. A left atrium > 45 mm and left ventricle end-diastolic dimension > 58 mm were 
considered enlarged. A fractional shortening of the left ventricle of < 30% was 
considered decreased. Right ventricular dimensions and function were assessed by 
visual estimate by two experienced cardiologists (FM and SS). Of each patient the 
study of 1990 was compared with that of 2001. The degree of valve regurgitation 
(minimal, moderate, or severe) was estimated with color-Doppler by the width and 
length of the regurgitant jet. A blood flow velocity across the pulmonary valve <1 
m/sec was considered normal. 
 
Bicycle ergometry 
Maximal exercise capacity was assessed by bicycle ergometry with stepwise 
increments of the workload of 20 Watts per minute. Exercise capacity was compared 
to that in normal individuals corrected for age, sex and body height.  
 
Data analysis 
Data are presented as median values and standard deviation, unless indicated 
otherwise. Chi-square and Fisher’s exact tests were used for the comparison of 
discrete variables. Student t-tests were used to compare continuous variables. The 
level of significance was chosen at p < 0.05. The Mc Neman test of symmetry was 
used to compare the 14- and 25 years outcome. Cumulative survival curves were 
constructed using the Kaplan-Meier method with the corresponding 95% confidence 
intervals.  
 
 
Results 
 
Patients 
Median age at operation was 5.0 ± 3.8 years (range 0 to 14). The pressure difference 
between right ventricle and pulmonary artery before surgery was 95 ± 39 mmHg 
(range 36-200). The surgical technique is summarized in Table 1.  
 
Table 1 Surgical technique and age at operation 
Surgical technique 1968-1974 1975-1980 total period  median age at operation (years)
Inflow occlusion     
- transpulmonary approach 33 14 47 7 
Cardiopulmonary bypass     
- transpulmonary approach 4 9 13 6 
- transventricular approach 10 7 17 5 
- transannular patch 1 11 12 1 
- homograft RV-PA  1 0 1 10 
     
All patients 49 41 90 5 
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The transpulmonary approach was used in most of the patients and a transannular 
patch was inserted in 13% of the patients. 
 
Survival 
Peri-operative mortality occurred in 2 patients. Late survival after PS repair was 96% 
at 25 years (Figure 1). 
Figure 1 post discharge survival after PS surgery 
Follow-up 
After a median follow-up of 16 ± 3 years, 45 patients participated in the first follow-up 
study. Of these, 2 patients died and 38 patients participated in the second follow-up 
study in 2001 with a median follow-up of 27 years (range 22-33 years) after surgery, 
and with a median age at the time of study of 32 years (range 22-44). Twenty 
patients were male (52%) and 18 female (48%).  The twenty-one who returned the 
written questionnaire are in good clinical health, have not been admitted to the 
hospital for reintervention or pacemaker implantation and only one patient have 
experienced a tachyarrhythmia treated with medication. The baseline characteristics 
of the patients who did and who did not fully participate in the follow-up study are 
described in Table 2.  
 
Table 2 Baseline characteristics of patients with and without follow-up 
 with follow-up without follow-up 
Number of patients    45   45 
Age at operation         5.0        5.1 
Surgical technique   
Inflow occlusion    
Transpulm    12   35 
Cardiopulm bypass   
Transpulm.      8     5 
Transventric.    14     3 
Transann patch    10     2 
Homograft RV-PA      1     0 
Cardioplegia       4     2 
RV-pressure pre-operative 125 103 
RV-pressure end procedure    54   55 
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Reinterventions 
Reinterventions were performed in 10 patients (15%). Two patients underwent 
balloon valvuloplasty because of a substantial residual pulmonary stenosis, 
respectively 16 and 18 years after surgery. Eight patients needed a reoperation: 2 
early, respectively 2 and 3 years after surgery because of residual right ventricular 
outflow tract obstruction and in 6 patients a pulmonary homograft was implanted 
because of severe pulmonary insufficiency late (median 20 years, range 16-24) after 
the initial operation. In 5 of these 6 patients the surgical technique of the primary 
operation included a transannular patch, while in 1 patient a simple valvotomy was 
performed. In 2 of the 6 patients in addition a tricuspid valve plasty was performed 
and in 1 an atrial septal defect was closed. The pre-operative transpulmonary 
gradient in the 6 patients who needed reoperation was not different from the patients 
without reoperation. However, right atrial and right ventricular dilatation and 
paradoxical septal motion were substantially more frequent in the patients who 
needed reoperation between 1990 and 2001 (Table 3).  
Pacemaker implantation was performed in 2 patients because of sick sinus 
syndrome with a median interval after surgery of 17 years.  
 
Table 3 Echocardiographic results in 1990 of patients with and without need for reoperation in the next 
decade (1990-2001) 
 without reop with reop p-value 
number of patients 39 6  
Vmax pulmonary valve 1.6m/s 1.7m/s 0.7 
Right atrium dilatation 15% 100% <0.0001 
Right ventricular dilatation 10% 67% <0.05 
Paradox septal motion 5% 83% <0.0001 
Severe tricuspid insufficiency 26% 83% <0.05 
Severe pulmonic insufficiency 38% 83% <0.05 
 
 
Clinical evaluation 
In 1990, 77% of the patients was in NYHA class 1, and 23% in class 2. In 2001, 67% 
was in NYHA class 1, 30% in class 2 and 3% in class 3 (p=ns). The outcome of 
patients own health assessment, compared with that of the normal population, is 
shown in Table 4. One patient was taking cardiac medication: oral anticoagulation 
and a betablocker. Half of the patients had regular follow-up at a cardiology 
outpatient clinic. Three patients with severe pulmonary insufficiency needed 
(repeated) electrical cardioversion for atrial fibrillation or flutter. None of these 3 had 
a recurrence of arrhythmia after pulmonary valve replacement. No patient showed 
clinical signs of heart failure. No endocarditis occurred. Of the 18 female patients, 9 
had successful pregnancies. None of the offsprings had cardiac defects.  
 
Table 4 Personal health assessment of patients 22-33 years after surgery for pulmonary stenosis 
compared with the normal Dutch population < 35 years 
 patients normal Dutch population patients 
numbers 38 1510 
Excellent 22% 40% 
Good 70% 50% 
Fair 11% 9% 
Not good - 1% 
Bad - - 
P<0.05 
Chapter IV 
52 
Electrocardiography 
(Table 5). The QRS-duration increased from 96 to 108 milliseconds in 11 years time, 
but still is relatively short. Right bundle branch block was present in 22%. We found 
no difference between transpulmonary and transventricular approach (with right 
ventricular incision) regarding the incidence of a right bundle branch block during 
follow-up. The increase in QRS-width was more for the patients who underwent a 
reoperation: 25 msec (range 12-56) for the patients with and 11 msec (range –10-38) 
for the patients without reoperation between 1990 and 2001. No patient showed 
decrease of the QRS-complex after successful surgery. The QRS complex in 2001 
was wider for the patients with right ventricular dilatation on echocardiography: 120 
msec (range 92-178) versus patients without dilatation: 97 msec (80-130). And also 
the increase in QRS-width was more: 16 msec for the patients with dilatation and 7 
msec for the patients without dilatation. 
 
Table 5 Standard 12-lead ECG long term after surgery for PS 
 16yrs  27yrs p-value
Number of patients 45 38
Rhythm (%) 
Sinus 39 (87) 35 (92) 0.3
Nodal 3 (7) 0
Atrial 3 (7) 1 (3)
Pacemaker 0 2 (5)
Aflutter - -
PR interval (msec) 150 +21 150 +24 0.15
QRS duration (msec) 90 +16 100 +22 <0.0001
RBBB (%) 9 22 <0.01
QTc segment (msec) 387 +23 392 +25 0.6
QRS axis (degree) 80 +20 63 +17 0.08
P-wave duration (msec) 85 +11 90 +13 0.01
P-wave height (cm) 0.30 +0.06 0.20 +0.09 0.9
P-wave axis (degree) 60 +18 56 +24 0.1
LVH (%) 0 0 1.0
 
 
Twenty-four hour ambulatory monitoring 
None of the patients had atrial flutter or fibrillation in 1990 or 2001 on 24-hour 
ambulatory monitoring. Signs of sinus node disease were found at last follow-up in 1 
patient. No ventricular pauses longer than 3 seconds occurred. Ventricular 
tachycardia of more than 10 complexes were not found, 2% showed ventricular 
tachycardia of 3-10 complexes.  
 
Echocardiography 
(Table 6) The maximal flow velocity over the pulmonary valve did not change 
significantly in 10 years time (1.6 m/s in 1990 to 1.7 m/s in 2001). Pulmonary 
regurgitation was present at last follow-up in most patients (89%). Over the last 11 
years 2 patients showed progression from moderate to severe pulmonary 
regurgitation. We found no correlation between the presence of pulmonary 
insufficiency and the age at surgery, or right ventricular incision during surgery. 
However, we did find a correlation with the use of a transannular patch. In 5 patients 
the right ventricular dimension increased between 1990 and 2001, in 2 of these also 
an increase in pulmonary regurgitation was found, in the other 3 pulmonary 
regurgitation was moderate to severe and remained unchanged. Only 2 of the 6 
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patients who underwent pulmonary homograft implantation showed regression of 
right ventricular dilatation. Paradoxical septal motion was found in 8 patients at last 
follow-up; 7 of these 8 had severe pulmonary regurgitation. Half of the patients (51%) 
showed moderate to severe tricuspid insufficiency at last follow-up. One patient 
showed a mild stenosis on the left pulmonary artery (gradient 19 mmHg). 
 
Table 6 Echocardiographic results in 2001, 22-33 years after surgery for PS 
 1990 2001 p-value 
Number of patients 45 38  
LA dimension (mm) 32 +6 37+5 0.4 
LVED dimension (mm)  44 +4 46 +5 0.7 
  
LA dilatation (%) 2 (4) 2 (5) 0.8 
LV dilatation (%) 0 0 1.0 
RA dilatation (%) 24 (53) 24 (63)  
RV dilatation (%) 23 (51) 20 (53)  
  
LVH (%) 0 0 1.0 
RVH (%) 5 (11) 7 (18)  
  
Median FractShort.LV (%) 35 33 0.6 
  
Good RV syst function (%) 43 (96) 36 (95) 0.8 
Good LV syst function (%) 44 (98) 36 (95) 0.4 
  
Valve insuff (%)  
PI        no 7 (16) 4 (11) 0.1 
mild 17 (38) 29 (53)  
moderate 7 (16) 6 (16)  
           severe 14 (31) 8 (21)  
  
TI        no 11 (24) 8 (21) 0.2 
Mild 14 (31) 10 (26)  
Moderate 17 (38) 19 (50)  
                      Severe 3 (7) 1 (3)  
Vmax TI 2.4 + 0.3 2.6 +0.3 0.4 
  
Vmax PS (m/sec) 1.6 +0.3 1.7 +0.3  
 
 
Maximal exercise 
The median exercise capacity was 101% in 1990 and 90% of the predicted values in 
2001. Almost all patients showed some decrease in exercise capacity between 1990 
and 2001. The median maximal heart rate was in both studies 91% of expected. No 
arrhythmias occurred. We found no relation between exercise capacity and velocity 
over the pulmonary valve before surgery, duration of aortic cross clamp time, 
presence or absence of a right bundle branch block on the ECG, or young age (<1 
year) at operation. However, the patients with right ventricular dilatation and severe 
pulmonary insufficiency significantly showed lower exercise capacity (p=0.04). In 2 of 
the 6 patients who underwent reoperation because of severe pulmonary regurgitation 
the exercise capacity improved, in the other 4 it decreased. 
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Discussion 
 
This series comprises a cohort of consecutive patients operated at young age at a 
single institution with longitudinal follow-up of 22-33 years. This study shows that the 
most important sequel after operation for pulmonary stenosis is residual pulmonary 
regurgitation.  
 
Mortality 
Late mortality is low in our study. Others report similar excellent long-term survival.3,8 
Less favourable outcome is found only in patients operated at older age.3 An 
explanation for this may be the longer period of right ventricular pressure overload 
with subsequent right ventricular failure. 
 
Reintervention 
Although mortality was low, 15% of the patients needed a reintervention. Hayes et al 
found a low (4%) need for reoperation during their study, but their study period was 
10 years only.4 In our study also only 3% of the patients needed a reintervention in 
the first 10 years after surgery and this was for residual pulmonary stenosis. All the 
other reinterventions were performed 15 years or longer after the first operation, and 
mainly because of severe pulmonary insufficiency. The need for reoperation was not 
correlated with the preoperative severity of pulmonary stenosis, but rather with the 
amount of pulmonary insufficiency, which occurred after surgery. This is similar to the 
time clinical course in patients with tetralogy of Fallot in whom pulmonary 
regurgitation leads to clinical problems only after long time. Only now are we 
beginning to realise that the long-term consequences of pulmonary regurgitation 
become manifest 15 to 30 years after surgery. This is probably related to the 
longstanding volume overload of pulmonary regurgitation, leading to right ventricular 
dysfunction over time. At first, compensatory mechanisms based on right ventricular 
dilatation and paradoxical septal movement develop and only after a longer period 
high end-diastolic pressures, secondary tricuspid insufficiency and right-sided heart 
failure appear. Also other factors such as aging with cell destruction and apoptosis 
may be responsible for this right sided heart failure. By analyzing the 
echocardiograhic results of 1990, we found that the patients with need for 
reoperations during the following decade, had not only significantly more severe 
pulmonary regurgitation, but also more often right atrial and right ventricular 
dilatation, paradoxical septal motion and severe tricupid regurgitation. Pulmonary 
insufficiency occurred especially in the patients who underwent valvuloplasty with 
use of a transannular patch. The transannular patch technique is a well known risk 
factor for the development of pulmonary regurgitation in Fallot patients and now 
proofs to be a risk factor in isolated pulmonary valve stenosis patients as well.9 This 
implies that patients after surgical repair of pulmonary stenosis with a transannular 
patch should be followed carefully, since they are at substantial risk of severe 
pulmonary regurgitation needing a second, and maybe third operation. A surgical 
alternative for the use of a transannular patch is the insertion of a pulmonary 
allograft, and when a patch is still the best alternative for a patient, a long small patch 
should be inserted to prevent the development of severe pulmonary regurgitation.   
  Information on equally long-term outcome after balloon valvuloplasty is not yet 
available, but studies with shorter follow-up intervals, show at least as good results 
as after surgical treatment.10,11 Therefore, at the moment, balloon valvuloplasty is the 
treatment of choice for patients with isolated pulmonary stenosis. Our surgical data 
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should provide a standard for comparing the long-term outcome with that of 
percutaneous balloon valvuloplasty.  
 
Residual lesions 
Residual pulmonary stenosis at follow-up was mild in all patients. Obviously, this was 
achieved at the cost of pulmonary insufficiency, which was observed in almost all 
patients at follow-up. In the patients who underwent a reoperation with pulmonary 
valve replacement because of residual pulmonary insufficiency, right ventricular 
dimensions diminished in only 2, and remained unchanged in 4 of the 6 patients. 
Maybe, this should be an argument in favor of earlier valve replacement in order to 
prevent irreversible right ventricular dilatation. Pulmonary valve replacement late after 
right ventricular outflow tract obstruction can be performed with low risk and provides 
clinical improvement in symptomatic patients, but pulmonary homografts have a 
limited life-span.12,13 This same discussion of when to operate residual pulmonary 
insufficiency is currently being held for Fallot patients and is still not answered with 
full satisfaction.  
 
Arrhythmias 
Clinical significant arrhythmias occurred only in patients with severe pulmonary 
insufficiency in need of reoperation and, very important, they all disappeared after 
surgery. As in Fallot patients, the supraventricular arrhythmia seems to be the result 
of elevated right ventricular filling pressures with subsequent right atrial overload.14 
The prevalence of supraventricular arrhytmia may be a marker for the timing of 
reoperation.  
 
Clinical condition 
At last follow-up NYHA class, subjective well-being and exercise performance was 
lower than expected as described by others.15,16 We suggest that pulmonary 
insufficiency may account for the impairment of clinical condition.16 Indeed exercise 
capacity was related to dilation of the right ventricle with severe pulmonary 
insufficiency. Serial evaluation with stress testing seems a valuable tool to define the 
moment of reintervention in patients with pulmonary insufficiency after surgical 
pulmonary valve repair. In Fallot-patients right ventricular function seems to improve 
after late pulmonary valve replacement for residual insufficiency.19,20 In the 6 patients 
in our study, who underwent late reoperation for pulmonary regurgitation, we 
observed an increase in QRS-duration, instead of decrease and also exercise 
capacity increased in only 2 of the 6 patients, suggesting that probably 4 of these 6 
patients were reoperated to late. Earlier reintervention may be warranted in patients 
with severe pulmonary regurgitation and right ventricular dilatation. 
 
Study limitations 
For administrative reasons, only 51/90 patients were invited to participate in the 
study. However, because 45/51 (88%) gave their consent, the population studied is 
not a select group.  
 
 
Conclusion 
 
Different surgical management techniques for pulmonary stenosis all lead to a good 
and long-lasting relief of elevated right ventricular pressure, but this is achieved at 
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the cost of pulmonary insufficiency in virtually all patients. Patients operated upon 
with a transannular patch are at increased risk for reoperation. Especially right atrial 
and ventricular dilatation and paradoxical septal motion are predictive for pulmonary 
regurgitation with need of reoperation. Supraventricular arrhythmias disappeared 
after reoperation. Pulmonary insufficiency may account for some impairment of 
clinical condition in these patients. 
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Abstract 
 
Background 
Great concern exists about the abilities of the anatomic right ventricle to sustain the 
systemic circulation in patients with transposition of the great arteries who underwent 
a Mustard procedure. A prospective study was performed to examine long term 
survival, clinical outcome and right ventricular function 25 years after surgery. 
 
Methods 
Ninety-one consecutive patients underwent a Mustard procedure between 1973 and 
1980. After 14 and again after 25 years (range 22-29) patients were studied with 
ECG, echocardiography, exercise testing and Holter-monitoring. 
 
Results 
The cumulative survival and event-free survival were 77% and 36% after 25 years. 
Re-operations were necessary in 46%. No impressive loss of sinus rhythm was 
found. While all patients had good right ventricular function 14 years after repair, 61% 
of the patients showed moderate to severe dysfunction after 25 years, when studied 
by echocardiography. Furthermore, the QRS-complex widened and the exercise 
capacity decreased.  
 
Conclusion 
The anatomic right ventricle appears unable to sustain the systemic circulation at 
long-term follow up and clinical condition of patients late after Mustard repair is 
declining. We may expect more deaths or need for heart transplantation in the next 
decade.  
 
 
Introduction 
 
The atrial switch procedure dramatically improved the survival of children born with 
complete transposition of the great arteries. For the long-term outcome major 
concerns are: the fate of the right ventricle supporting the systemic circulation, 
arrhythmias and, accordingly, long-term survival of these patients.1-5 Systemic right 
ventricular dysfunction and loss of sinus rhythm have been reported at long-term 
follow-up, but it is unclear whether these problems were found in a selection of 
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“worse cases” or whether systemic right ventricular failure and loss of sinus rhythm 
are inevitable in all patients.3,5-8 We performed a systematic follow-up study of a 
single centre cohort of 91 consecutive patients, who underwent a Mustard procedure 
in the seventies. In 1990 this cohort was investigated. The outcome then showed 
good right ventricular function in most patients, and the majority of patients were in 
sinus rhythm (69%). In 2001, 11 years after the first study, and 22-29 years after the 
Mustard operation, this same cohort was studied again to assess survival, clinical 
course, arrhythmia's and systemic ventricular function and to compare the data with 
the study of 1990. 
 
 
Methods 
 
Patients 
All 91 consecutive patients, who underwent a Mustard repair for transposition of the 
great arteries at the Thoraxcenter between 1973 and 1980 and who were younger 
than 15 years at the time of surgery, form the basis of this report. Before the Mustard 
operation improved atrial mixing was achieved in 15 of the 91 patients (16%) by a 
Blalock-Hanlon atrioseptostomy and in 65 of the 91 (71%) by a Rashkind balloon 
atrioseptostomy. Operations were performed with mild hypothermia and complete 
cardiopulmonary bypass in 18 patients (all between 1973 and 1976) and with deep 
hypothermia and circulatory arrest in 64 patients. In 9 patients the cooling technique 
was not described in detail. Cold cardioplegia was used in 38 patients (42%) after 
1976. In 36 patients additional surgery for ventricular septal defect (VSD) closure 
and/or pulmonary valve stenosis (PS) was performed. These 36 patients are further 
referred to as “complex Mustard”.  
 
Follow-up 
Survival status was established in all 91 patients. In order to assess cardiac function, 
a first systematic follow-up study was performed in 1990. At that time 18 patients had 
died and 5 had moved abroad. Fifty-eight of the remaining 68 patients (79% of the 
survivors, 85% of those eligible for follow-up) agreed to participate in the first follow-
up study. These 58 patients were invited for a second follow-up in 2001. Between 
1990 and 2001 2 additional patients died, 1 patient underwent cardiac 
transplantation, and one patient refused to participate, so 54 participated in the 
second follow-up study in 2001. Patients who did not participate in this study were 
contacted by telephone. The evaluation, both in 1990 and in 2001, consisted of a 
detailed history, physical examination, a standard electrocardiogram (ECG), 24-hour 
ambulatory ECG, exercise test, and echocardiogram. The institutional Medical Ethical 
Review Board approved the study. All patients gave their consent. 
 
Electrocardiography 
Standard twelve lead surface electrocardiograms were analysed for rhythm, P wave 
axis, height and duration of the P wave (measured in lead II), PR interval and QRS 
duration. A QRS duration > 120 msec was defined to be a complete bundle branch 
block. A single observer made all ECG measurements.  
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Twenty-four hour ambulatory ECG 
A three-channel recorder was used. Sinus node dysfunction was assessed using the 
modified Kugler criteria and was judged present in the case of nodal escape rhythm, 
sinusarrest > 3 sec or severe sinusbradycardia (<30 beats/min at night or <40 
beats/min during daytime).9 
 
Echocardiography 
Transthoracic two-dimensional echocardiography and echo-Doppler studies were 
performed using a Hewlett-Packard Sonos 5500 echocardiograph. The same 
echocardiographer performed a systematic echo assessment in 1990 and in 2001. 
Baffle obstruction was diagnosed if there was evidence of obstruction in both the two-
dimensional image and in the Doppler flow pattern: low flow velocity (< 0,5 m/s) in 
superior or inferior caval vein and acceleration to >1.0 m/s in the baffle with the 
typical flat non-pulsating curve profile. Obstruction to pulmonary venous drainage 
was diagnosed if the peak velocity at the junction of the pulmonary venous atrium 
and right atrium exceeded 1.5 m/sec.  
A systematic approach to judge right ventricular dimension and function was 
performed separately by two experienced cardiologists blinded for the other data. 
Interobserver variability was analysed, and a kappa value of >0.7 was considered 
excellent. Dimensions were judged as normal, mildly, moderately or severely dilated.   
  Right ventricular systolic function was graded as normal, mildly, moderately or 
severely impaired. Acoustic quantification is an automatic border detection technique 
that has been used for the quantitative assessment of ventricular volume and 
performance and was used to assess right ventricular ejection fraction in the patients 
where it was technically feasible. An ejection fraction of > 50% was defined normal. 
All echocardiographic studies of 1990 were re-evaluated. The degree of tricuspid 
regurgitation (minimal, moderate, or severe) was estimated with color-Doppler by the 
width and length of the regurgitant jet and the Doppler flow pattern in the pulmonary 
veins. Pulmonary hypertension was defined by an early diastolic pulmonary 
regurgitation flow velocity of > 2.5 m/s or, in the absence of left ventricular outflow 
tract obstruction, a mitral regurgitation flow velocity of > 3.0 m/sec.  
 
Maximal exercise capacity 
Maximal exercise capacity was assessed by bicycle ergometry with stepwise 
increments of 20 Watts workload per minute. Exercise capacity was compared to that 
in normal individuals corrected for age, sex, and body height. Exercise capacity < 
85% of the predicted normal value was considered to be abnormal.  
 
Major events 
Major events were defined as death, cardiac transplantation, re-operation, 
pacemaker implantation, or hospital admission for arrhythmia, endocarditis or heart 
failure. 
 
Data analysis 
Data are presented as mean and standard deviation, unless indicated otherwise. The 
Chi-square and Fisher’s exact test were used for the comparison of discrete 
variables. The Student t-test was used to compare continuous variables. All tests 
used were two-tailed. The Mc Nemar test of symmetry was used to compare the 14- 
and 25 years outcome. Cumulative survival curves were constructed using the 
Kaplan-Meier method. Among patient subgroups the logrank test was used to 
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compare survival curves. The level of significance was chosen at p < 0.05. 
Multivariable Cox-regression analysis was performed for survival, event-free survival 
and for right ventricular dysfunction. The variables tested were birth weight, type of 
palliation, ‘complex’ Mustard procedure, age at operation, year of operation, use of 
deep hypothermia, use of cold cardioplegia, aortic crossclamp time, right ventricular 
incision, peri-operative complications, residual lesions, and rhythm at first outpatient 
visit after operation. Continuous variables were not categorised in the model. The 
proportional hazards assumptions were tested by constructing interaction terms 
between the variables and time to each end-point. Cox regression analyses showed 
no statistically significant interactions with time (each p>0.05). The model selection is 
based on the stepwise principle, where the limit to enter and to remove a variable 
was both 0.05. 
 
 
Results 
 
The median age at Mustard operation was 2 years (range 0 – 11 years). Further 
baseline characteristics and surgical details have been previously reported.1,6 
Information on survival is complete for the total cohort of 91 patients. 
 
Survival 
The cumulative survival after the Mustard repair was 80% after 14 and 77% after 25 
years (Figure 1). Twenty patients died of whom 5 in the peri-operative period. Of the 
15 late deaths (>30 days post-operative), 3 had right ventricular failure and 
pulmonary edema diagnosed directly after the Mustard procedure, 3 others had atrial 
flutter/fibrillation, 7 suffered from sudden death 1-15 years after surgery, and 2 
patients died 23 and 26 years after surgery due to progressive right ventricular pump 
failure. 
Crossbars present the 95% confidence intervals. 
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One patient had heart transplantation successfully performed 26 years after her 
Mustard repair because of failure of the systemic right ventricle. We found no 
differences in survival between patients with simple versus complex Mustard 
operation (Figure 2).  
 
 
Major events 
Cumulative event-free survival after 29 years was 36% (Figure 1). Since the initial 
Mustard procedure, re-operations were performed in 25 patients (46%) (Table 1). 
One additional patient had successful balloon angioplasty of a baffle obstruction. The 
median interval between the Mustard repair and re-operation was 11 years (range 2-
29 years). No patients died during re-operation.  
 
Table 1 Reoperations 
 number time since initial repair (+ range) 
in years  
baffle stenosis  17 13 (2-23) 
arterial switch 2 9 (8-9) 
residual VSD 2 9 (2-16) 
aortic coarctation 1 8 
patent arterial duct 1 2 
subpulmonary stenosis  1 6 
tricuspid and mitral valve 1 11 
 
 
Of the patients seen at last follow-up, five patients (9%) were admitted to the hospital 
for heart failure. Pacemaker implantation was performed in 16 patients (28%), of 
whom 4 in the period between 14-25 years follow-up, all 4 because of sinus node 
disease. Between 14-25 years follow-up 3 patients (5%) were admitted for electrical 
cardioversion for supraventricular tachycardia and 2 for endocarditis. A total of 42 
patients (61%) had at least one hospital admission (for heart failure, endocarditis, 
arrhythmia, or re-operation) during the total follow-up period. 
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Clinical evaluation 
The median age at evaluation was 16 years in 1990 and 27 years (range 22 - 38 
years) in 2001, with a median follow-up of respectively 14 and 25 years (22 - 29 
years) after surgery. The clinical condition worsened between 1990 and 2001. After 
25 years follow-up 24% of the patients was in NYHA class I (Figure 3). Fifteen 
patients (29%) were taking one or more drugs: oral anticoagulants in 2, betablockers 
in 2, digoxin in 3, antiarrhythmics in 4 and ACE-inhibitors in 10 patients. ACE-
inhibitors were given because of evident heart failure in 2 patients and for right 
ventricular dysfunction in 8 patients. Of the 15 female patients, 4 had successful 
pregnancies.  
The mean oxygen saturation was 97% (range 80%-100%). Signs of heart 
failure (edema, liver enlargement, and elevated central venous pressure) were found 
at last follow-up in 1 patient. 
 
 
Electrocardiography 
The ECG findings are presented in Table 2. The percentage of patients having sinus 
rhythm on the 12-lead electrocardiogram diminished from 69% in 1990 to 63% in 
2001. The PR-interval and duration of the P-wave increased, but these changes were 
not statistically significant. The increase in QRS duration from 94 to 110 ms was 
highly significant (p<0.0001) (Figure 4) as was the change in QRS-axis. The QTc 
duration did not change. 
At last follow-up one patient had first degree AV-block and in 9 patients bundle 
branch block was present.  
 
Twenty-four hour ambulatory monitoring 
At last follow-up, none of the patients had atrial flutter or fibrillation (see Table 2). 
Junctional escape rhythm was seen in 23%. Signs of sinus node disease increased 
significantly between 14 and 25 years follow-up, but no ventricular pauses longer 
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than 3 seconds occurred. Ventricular tachycardia of more than 10 complexes were 
not observed, 8% showed ventricular tachycardia of 3-10 complexes.  
 
Table 2 Standard 12-lead ECG and 24 hour Holter electrocardiogram 
 14 years  25 years p-value 
     58 54  
12-lead ECG    
Rhythm   0.8 
Sinus 40 (69%) 34 (63%)  
Nodal 7 (12%) 7 (13%)  
Atrial 6 (10%) 5 (9%)  
Pacemaker 4 (7%) 8 (15%)  
Aflutter   1 (2%) -  
PR interval (msec) 157 165 0.09 
QRS duration +SD, (msec 95 +11 110 +17 <0.0001 
QTc segment +SD,(msec) 395 +32 396 +40 0.7 
P-wave duration +SD 86 +13 91 +15 0.06 
P-wave height +SD 0.25 +0.14 0.25 +0.14 0.9 
P-wave axis +SD 58 +23 59 +26 0.8 
24-hour Holter    
Sinus node disease 37% 43% <0.001 
Paroxysmal A fib/flutter 4% 0 0.2 
VT >10 beats  0 0 - 
VT 3-10 beats 7% 8% 0.7 
 
 
Echocardiography 
Right (systemic) ventricular dimension was dilated in 72% of the patients, which was 
58% ten years earlier. The function of this systemic ventricle changed markedly 
(Figure 5). While right (systemic) ventricular function was normal in 69% after 14 
years follow-up, ten years later only 6% of the patients had normal ventricular 
function (p<0.0001). The ventricular function changed from good to mild in 33%, 
moderate in 37% and severe dysfunction in 24%. The interobserver variability was 
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excellent with 90% agreement and a kappa value of 0.86. In 10 patients it was 
possible to measure the ejection fraction with acoustic quantification, which ranged 
from 19% to 53% with a mean of 38%. Tricuspid regurgitation was severe in only 2% 
in 1990, while in 2001 this was the case in 20% of the patients. Tricuspid 
regurgitation was not more frequent in patients with a “complex-Mustard” procedure. 
Pulmonary hypertension was found in 3% in 1990 and in 18% in 2001. Twenty-three 
patients had thirty residual lesions: baffle obstruction in 17, baffle leakage in 2, a 
residual VSD in 3 and pulmonary valve stenosis in 8 patients. 
 
Exercise tolerance 
Fifty patients exercised to maximal effort (1 patient was excluded because of spastic 
hemiplegia, 1 had psychomotor retardation and 2 patients refused). The maximal 
exercise capacity in these patients is shown in Figure 6 and was 72% (range 38 -
105) of the predicted normal values in 2001, compared to 84% in 1990 (p<0.0001). 
Thirty-eight patients (76%) had an exercise capacity bellow 85% of the predicted 
value. The maximal heart rate was 170 beats/minute (82% of expected) in 1990 and 
165 beats/minute (84% of expected) in 2001. During the test 5 patients (10%) 
developed arrhythmias: 3 patients had an increase of ventricular extrasystoles and 2 
patients developed paroxysmal supraventricular tachycardia. No ventricular 
tachycardia occurred. 
 
Risk factors for late death major events and systemic ventricular dysfunction 
Multivariable Cox-regression revealed one independent predictor for death, which 
was the period of surgery: patients operated between 1973 and 1976 showed a 
worse survival than those operated between 1977 and 1980 (Table 3). For the end 
point “moderate to severe dysfunction of the right ventricle at last follow-up”, 2 
independent predictors were found: atrial flutter at the first outpatient visit after the 
Mustard repair, and additional repair of VSD and/or PS (‘‘complex-Mustard’’). 
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Table 3 Multivariable Cox regression 
End point: death   
Independent predictors HR 95%CI 
-Surgery performed before 1977 3.1 1.1-9.5 
End point: moderate to severe right ventricular dysfunction 
  
Independent predictors HR 95%CI 
-Atrial flutter at first follow-up after Mustard repair 3.0 1.1-8.9 
-Complex Mustard procedure (VSD and/or PS) 1.9 1.1-4.0 
 
 
Discussion  
 
This series is unique in that it comprises a cohort of consecutive patients operated at 
a single institution with longitudinal follow-up of 22-29 years or until death. Our study 
shows some late attrition and substantial morbidity long-term after the Mustard 
operation. Most important a clear deterioration in systemic right ventricular function 
and clinical condition is seen in virtually all patients, between 14 and 25 (22-29) years 
after Mustard repair for transposition of the great arteries.  
 
Survival 
The cumulative survival was 80% after 14 and 77% after 25 years. We found a small 
continuing attrition rate as the population ages further. In contrast with others, we did 
not find a difference in survival rate between patients with simple or complex 
Mustard.10,11 In the literature, the most frequent cause of late mortality after the 
Mustard procedure is sudden death, presumed arrhythmic.2,10-12 In the present study 
the major cause of death changed from sudden or arrhythmic in the first 14 years 
after surgery, to progressive heart failure in the period from 14 to 25 years after 
surgery. 
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Morbidity 
Morbidity was substantial in our Mustard-population with an event-free survival 25 
years after surgery of only 36%. Re-interventions were performed in nearly half of the 
patients. Of the patients seen at last follow-up 28% needed a permanent pacemaker 
and 29% were using cardiac medication. 
 
Assessment of right ventricular function 
Although echocardiographic analysis of systemic right ventricular function has its 
limitations, we chose to use this technique again in 2001, to allow comparison with 
the 1990 study. With MRI, 28% of the patients would have been excluded because of 
a permanent pacemaker and we would not have been able to compare the data with 
the study of 1990.  
We found an excellent interobserver variability on visual estimation of right 
ventricular function. 
 
Systemic right ventricular function 
We observed a striking deterioration of systemic right ventricular function in the 
decade from 14 to 25 years follow-up. While all patients had good function or only 
mild dysfunction 14 years after repair, after a median follow-up of 25 years, moderate 
to server dysfunction developed in 61% of the patients, 33% developed mild 
dysfunction and in only 6% the function remained good. This time course suggests 
that, although the right ventricle can sustain the systemic circulation for about 2 
decades, development of right ventricular failure will be inevitable in the long run. 
Another expression of systemic ventricular failure is the increase in the incidence of 
pulmonary hypertension from 3% to 18% and the increase of severe tricuspid 
regurgitation from 2 to 20%. 
We found a rightward shift of the QRS-axis and marked widening of the QRS-
complex. The increase in QRS-duration may be another indicator of deterioration of 
right ventricular function in these patients.13 Patients exercise capacity showed a 
decrease from 84% of the predicted value in 1990 to 72% in 2001 (p<0.0001). No 
significant change in maximal heart rate at exercise was found. The cause of the 
impaired exercise capacity is still a matter of debate and can be due to impaired 
systemic ventricular dysfunction or chronotropic incompetence or the fixed 
atrioventricular filling rate due to the baffle situation. Chronotropic incompetence was 
not found in our study. Although still 77% of the patients are in clinically fairly good 
condition (NYHA I or II) after 22-29 years, we saw a deterioration in functional class 
in 10 years time. Thus, the physical condition of the post-Mustard patients is 
declining. Echocardiographic data, electrocardiographic measurements, exercise 
capacity and functional class all show signs of deterioration between 14 and 25 years 
after surgery. These consistent findings were observed in nearly all patients.  
  Ventricular dysfunction is recognised as a risk factor for heart failure and death 
in patients with a systemic right ventricle.3 If this deterioration progresses at a similar 
pace, it is likely that many of these patients, now aged 20-38 years, will develop heart 
failure, will die or need heart transplantation in the next decade. In patients with 
congenitally corrected transposition, with also the right ventricle supporting the 
systemic circulation, a survival rate of only 20% at age 60 is found and maybe we will 
find this same dreadful figure for the Mustard patients as well.14 Until now the 
expectation was that the Mustard patients would have a better life expectancy, but 
the line of developing systemic ventricular dysfunction shows otherwise. The median 
follow-up in our study (25 years) is the longest reported in the literature and we are 
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now beginning to see that the outcome of the Mustard patients in fact is comparable 
with the outcome of patients with congenitally corrected transposition.2,5,8,15-18 
Whether or not medication will improve this outcome, needs to be investigated.   
  Because abnormal ventricular filling may be due in part to flow limitations by 
the atrial baffle, the use of ACE inhibitors may be counterproductive and no positive 
results are found until now.19 The late arterial switch operation has not shown good 
results in adults so far and therefore is not an attractive option either.20,21 Whether 
resynchronisation therapy with pacing modalities will be of value in these patients, as 
it seems to be in patients with systemic left ventricular dysfunction and wide QRS-
complexes, needs to be investigated.22 
 
Cause of systemic right ventricular dysfunction 
The cause of right (systemic) ventricular dysfunction remains uncertain. Impaired 
atrioventricular transport, secondary to the rigid baffle-construction may be a 
contributing factor.23-25 In our study, however, baffle obstruction occurring in 1990 
was not found to be a predictor of right ventricular dysfunction in 2001. We could 
identify some other risk factors for ventricular dysfunction, such as atrial flutter at first 
follow-up after operation and complex versus simple Mustard procedures. The atrial 
arrhythmias, shortly after the operation are probably an expression of the impaired 
hemodynamic situation as described by others.26 Millane found myocardial perfusion 
defects, and Singh found impaired myocardial flow reserve in the systemic right 
ventricle in survivors of the Mustard operation suggesting coronary blood supply to 
be the main problem.27,28 Lubiszewska confirmed these findings and found greater 
perfusion defects more frequently in older patients with longer follow-up, which is in 
line with our study of deterioration of ventricular function over time.29 The fact that 
almost all patients develop right systemic ventricular dysfunction supports the theory 
that right ventricular dysfunction is inherent to the Mustard situation itself, with the 
anatomical right ventricle functioning as systemic ventricle. 
 
Atrial arrhythmias 
Although early atrial arrhythmias were a predictor for late ventricular dysfunction in 
our study, arrhythmias occurring late after surgery could not be identified as a risk 
factor for right ventricular dysfunction or death as is described by others.2,18 We 
found no significant ongoing loss of sinus rhythm and the incidence of atrial fibrillation 
and flutter was low in the last ten years, with only 3 patients needing electrical 
cardioversion. Furthermore, no case of atrial flutter or fibrillation was found on 
electrocardiograms, 24-hour Holter monitoring or exercise testing. Sinus node 
disease was the most common arrhythmia but most patients received their 
pacemaker in the first years after surgery and only 4 patients needed pacemaker 
implantation in the last 10 years. 
 
Study limitations 
The number of patients in this study is limited, as in other studies on grown up 
congenital heart disease. However, we report follow up on a consecutive cohort of 
operated patients, without selection bias related to the severity of disease. 
It should also be appreciated that assessment of right ventricular function with 
echocardiography has its limitations. MRI may serve as an additional method for 
studying right ventricular function. However, in patients who have a pacemaker, 
magnetic resonance is not a suitable technique and MRI was not available in 1990. 
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In the present study, serial echocardiography was chosen, to compare data over 
time, and each patient was used as his own control.  
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Abstract 
 
Background 
Pulmonary regurgitation is the most common problem in adult patients after surgical 
correction of tetralogy of Fallot. In order to get a better understanding of how 
pulmonary regurgitation affects the right ventricle, a longitudinal, long-term follow-up 
study of patients with varying degrees of pulmonary regurgitation and right ventricular 
dilatation was conducted.  
 
Methods and Results 
Sixty-seven patients, who underwent surgical correction tetralogy of Fallot in 
childhood, underwent an extensive cardiological examination 15 ± 3 years after 
surgery. Three subgroups were defined, according to the degree of pulmonary 
regurgitation and right ventricular size. All events were recorded and the cardiological 
examination was repeated 26 ± 3 years after surgery. 
None of 22 patients with mild to moderate pulmonary regurgitation/ right ventricular 
dilatation, showed an increase in pulmonary regurgitation or right ventricular 
dilatation. In the group of patients with severe pulmonary regurgitation and a 
restrictive right ventricular physiology, the QRS-duration increased significantly. 
Eighteen out of 30 patients with severe pulmonary regurgitation and severe right 
ventricular dilatation underwent pulmonary valve replacement. Twelve patients 
improved, but in 6 patients right ventricular dilatation persisted and further 
prolongation of the QRS-duration was seen. 
 
Conclusion 
Mild pulmonary regurgitation is tolerated well. Patients with a restrictive right 
ventricular physiology show a significant prolongation of the QRS-duration. Of the 
patients with severe pulmonary regurgitation and severe right ventricular dilatation, 
60% needed valve replacement in the following 11 years. Of these, two-third 
improved and one-third of these patients had persistent right ventricular dilatation 
and further prolongation of the QRS-duration.  
 
 
Introduction 
 
Surgical correction of tetralogy of Fallot consists of closure of the ventricular septal 
defect and relief of the right ventricular outflow tract obstruction. The latter includes 
resection of hypertrophic infundibular muscle tissue and, when the pulmonary 
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annulus and main pulmonary artery are too narrow, a longitudinal incision from the 
right ventricular outflow tract, across the pulmonary annulus into the main pulmonary 
artery, which is closed with a transannular patch. There was a liberal use of 
transannular patches in the 1970’s and 1980’s, since the most important factor 
associated with ventricular arrhythmia’s and poor survival was identified to be 
elevated right ventricular pressure persisting after surgery.1,2,3 The unavoidable 
consequence of this approach was pulmonary regurgitation, which was usually 
tolerated remarkably well until adult age. However, once adult, these patients 
sometimes developed right sided heart failure.4 Pulmonary valve replacement is the 
treatment of choice, 5,6,7,8,9 but the optimal timing for this procedure is not clear.10,11If 
valve replacement is postponed too long and the right ventricular ejection fraction 
has deteriorated too much, right ventricular function will not recover anymore after 
valve replacement.12,13 Moreover, a dilated right ventricle, represented by a QRS 
duration of > 180 msecs, is known to be associated with an elevated risk for 
ventricular arrhythmia and sudden death.14,15,16,17,18,19 Accordingly, it has been 
advocated that a patient with severe pulmonary regurgitation should be operated 
before the right ventricle is damaged too much. Since artificial valves are no option 
for pulmonary valve replacement, due to many thrombotic complications20, a 
bioprosthesis should be implanted, in spite of its limited longevity. The risks, 
associated with the unavoidable repetitive valve replacements, are the most 
important arguments against early pulmonary valve replacement.  
In the Thoraxcentre, until recently, a restrictive approach was used: only 
patients who developed clinical signs that were attributed to right ventricular failure, 
were referred for pulmonary valve replacement. Whether or not the operated patients 
benefited from this late pulmonary valve replacement and whether or not patients 
with pulmonary regurgitation who were not operated upon deteriorated in the 
subsequent years, was evaluated in this follow-up study.  
 
 
Methods 
 
Patients 
All 142 patients with tetralogy of Fallot (56 female and 86 male), who underwent 
intra-cardiac surgical repair in our institution between 1968 and 1980 and who were 
younger than 15 years of age at the time of the operation, were included in this study. 
Sixty-seven patients, 63 % of all patients eligible for follow-up, had an extensive 
cardiological evaluation both in 199021  and in 2001, respectively 15  ± 3 years and 
26 ± 3 years after surgery. The mean age in 2001 was 30 ± 5 years. There were no 
significant differences between those who participated in the follow-up study and 
those who did not, in terms of these baseline characteristics21. The study was 
approved by the local Ethical Review Board. 
 
Types of measurements 
In 2001 and in 1990 all participants underwent the same set of investigations: 
interview for the medical history, physical examination, 12-lead ECG, 24-hour 
ambulatory ECG, echocardiographic examination and bicycle exercise test. All 
patients underwent an extensive psychological examination, which is reported 
separately.22,23. 
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Definition of subgroups of the study population 
In order to evaluate the effect of long-standing pulmonary regurgitation on the right 
ventricle, the patients were divided in 3 subgroups, according to the severity of 
pulmonary regurgitation and size of the right ventricle, on the basis of the 
echocardiographic assessment in 1990. The groups consisted of patients with mild to 
moderate pulmonary regurgitation and no, or mild to moderate, right ventricular 
dilatation (n=22), patients with severe pulmonary regurgitation and mild to moderate 
right ventricular dilatation (n=15) and patients with severe pulmonary regurgitation 
and severe right ventricular dilatation (n=30). The latter group is further divided in 2 
subgroups: a group that underwent pulmonary valve replacement and a group that 
did not.  
 
Echocardiographic measurements and definitions 
Right ventricular dilatation was assessed by means of M-mode in the parasternal 
short and long-axis view and by visual estimate in the apical 4-chamber view. 
Moderate enlargement was defined as a larger than normal right ventricle, but 
maximally as wide as the left ventricle. The enlargement was judged as severe if the 
right ventricle was larger than the left ventricle in the 4-chamber view. Pulmonary 
regurgitation was classified as: 1). absent to light, 2). moderate or 3). severe. The 
right ventricle was assumed to have a restrictive physiology when end-diastolic 
antegrade flow was demonstrated with pulsed Doppler in the pulmonary artery, 
coinciding with the atrial contraction.  
 
ECG measurements 
The maximum width of the QRS complex in the 12-lead electrocardiograms was 
assessed by one cardiologist (J.R-H), who was blinded for the echocardiographic 
results. The QRS duration was measured as the time from the first deflection from 
the zero-line to the point where the final part of the QRS-complex again meets the 
zero-line, in the lead with the maximal QRS duration. 
 
Exercise test 
Maximal exercise capacity was assessed by means of bicycle ergometry with 
stepwise increments of 20 Watts per minute until exhaustion. The outcome was 
presented as relative to the predicted value for age, sex, and body length. 
 
Statistical analysis 
Survival was calculated and presented by means of a Kaplan-Meier survival table. 
Time-related data are presented as mean values with standard deviation, unless the 
distribution was very skewed. In that case they are presented as median value and 
range. A Chi-square test was used for comparison of dichotomized variables, the 
Student-t test for comparison of two sets of continuous variables with a normal 
distribution. A p-value < 0.05 was considered to be statistically significant. If a 
difference is tested and not significant, it is marked as n.s.  
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Results 
 
Survival and re-operation 
 
Perioperative mortality was 16% (23 patients). Six patients were untraceable. Data 
on survival and event-free survival was obtained from the remaining 113 patients.  
The baseline conditions are presented in Table 1. The overall survival and the event-
free survival are presented in Figure 1. The mean interval between surgical 
correction and re-operation for relief of right ventricular outflow tract obstruction or 
closure of residual ventricular septal defect was 3.6 ± 6.8 years. The mean interval 
between surgical correction and pulmonary valve replacement was 18.6 ± 5.4 years. 
The mean follow-up since pulmonary valve replacement was 6.4 ± 4.4 years.  
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Table 1 Baseline characteristics, prior palliation, type of repair and re-operations 
Number of patients 142 
Male  86 (61%) 
Female 56 (39%) 
Prior palliative shunt 50 (35%) 
Age at operation in years (median; range) 4.6 (range 0.1 – 13.0) 
Use of cold cardioplegia 47 (33%) 
Type of repair RVOT obstruction:  
Transannular patch 87 (61%) 
Infundibulectomy 40 (28%) 
RVOT patch 4 ( 3%) 
Aorta monocusp 9 ( 6%) 
Hancock bioprosthesis 2 ( 1%) 
Re-operations < 1990 19 (13%) 
Type of re-do surgery  
Closure residual VSD 8 (5%) 
Relief RVOTO 7 (5%) 
RVOT obstruction + VSD closure 1 (1%) 
PVR for severe pulmonary regurgitation 3 (2%) 
Re-operations > 1990  15 (10%) 
Type of re-do surgery  
PVR for pulmonary regurgitation 15 (10%) 
RVOT = right ventricular outflow tract. VSD =ventricular septal defect. PVR = pulmonary valve 
replacement. 
There were no significant differences in baseline characteristics between the group of patients that 
participated in the study and the group of patients that did not. The study population was therefore 
considered as a non-selected, representative part of the total group of operated patients 
 
 
Subgroup analysis 
In Table 2 the most important outcomes and the differences between the subgroups 
are shown. 
 
1. Patients with mild/moderate pulmonary regurgitation and mild/moderate 
right ventricular dilatation at 15 years follow-up 
None of the 22 patients had had progressive right ventricular dilatation or progressive 
pulmonary regurgitation in the additional 11 years of follow-up. The velocity of the 
tricuspid regurgitation had been 2.6 ± 0.6 m/secs after 15 years and was 2.7 ± 0.6 
m/secs after 26 years. The change in QRS-duration is shown in Figure 2a. None of 
the patients had clinically significant arrhythmia’s or were taking anti-arrhythmic 
drugs. 
 
2. Patients with severe pulmonary regurgitation and mild/moderate right 
ventricular enlargement at 15 years of follow-up 
Two out of these 15 patients had progressive right ventricular dilatation and were 
judged to have a severely dilated right ventricle in 2001. In the 13 other patients, the 
echocardiographic evaluation of right ventricular size and degree of pulmonary 
regurgitation did not change over the years. A restrictive physiology of the right 
ventricle was seen in all these 13 patients, but not in the 2 patients with progressive 
right ventricular dilatation. The increase of QRS duration of the 15 patients is shown 
in Figure 2b. None of the patients had clinically significant arrhythmia or was taking 
anti-arrhythmic drugs. 
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3. Patients with severe pulmonary regurgitation and severe right ventricular 
dilatation after 15 years of follow-up 
Of the 30 patients with a history of severe pulmonary regurgitation and severe right 
ventricular dilatation, 18 underwent pulmonary valve replacement and 12 did not. 
None of the 12 patients without pulmonary valve replacement had developed signs of 
venous congestion and none reported complaints of deterioration of their clinical 
condition. The echocardiographic assessment of the right ventricular size and 
pulmonary regurgitation did not change over the years. Yet, the QRS duration 
increased significantly; Figure 2c. Two patients developed supraventricular 
tachycardia and were taking anti-arrhythmic drugs. 
None of the patients who underwent pulmonary valve replacement died and the signs 
of venous congestion disappeared in all patients. Echocardiographic evaluation 
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revealed a decrease in ventricular size in 12 patients, of whom 5 had an entirely 
normalized right ventricular size. A severe right ventricular dilatation persisted in 6 
patients. In all patients the QRS duration increased until the pulmonary valve 
replacement. The QRS duration decreased after the operation in 14 patients and 
increased further in 4 patients (Figure 2d). Seven patients had had symptomatic 
arrhythmia’s: one patient developed ventricular tachycardias, 4 patients had atrial 
fibrillation and 2 patients had a complete atrioventricular block, for which pacemaker 
insertion was necessary. Three other patients needed pacemaker implantation for 
sinus node dysfunction and atrial fibrillation. 
Figure 2d In the patients who had a decrease of right ventricular size after pulmonary valve 
replacement, the QRS duration increased from 125 ± 22 msec in 1990 to 150 ± 20 msecs before 
pulmonary valve replacement and returned to 135 ± 21 msec in 2001. In the patients with persistent 
right ventricular dilatation, the QRS duration was 135 ± 25 msec in 1990, which increased to 190 ± 35 
msecs before pulmonary valve replacement and which increased further to 196 ± 30 msec in 2001 
 
Bicycle exercise test 
The differences between the subgroups of the results of the exercise tests are shown 
in Table 2. Only patients who had a persistent right ventricular dilatation after 
pulmonary valve replacement had a significantly worse result in 2001 than in 1990. 
 
Table 2 Surgical data and a summary of events and follow-up data from 15 to 26 years of follow-up 
after surgical data 
QRS prolongation between 1990 and 2001 in patients with 
severe pulmonary regurgitation and severe RV dilatation
0
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1990 2001
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QRS duration 1990: 128 ± 35 msec
QRS duration 2001: 155 ± 30 msec
ǻQRS 28 ± 23 msec
Figure 2c
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Figure 2d
QRS duration in patients with PVR in 1990, just 
before PVR and in 2001
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 Mild to moderate PR  
No/mild /  
moderate RV dil 
Severe PR 
Moderate  
RV dil 
Severe PR  
Severe RV dil 
   No PVR With PVR 
No of pts 22 15 12 18 
Surgical data     
Age at operation 
(in yrs) 
 
5.1 +2.9 
 
3.9 +2.5 
 
4.3 +2.7 
 
4.5 +3.2 
Prior palliation  
(no of pts) 
 
4 (18%) 
 
5 (33%) 
 
3 (25%) 
 
9 (50%) 
Transannular patch  
(no of pts) 
 
2 (9%) 
 
10 (66%) 
 
10 (83%) 
 
14 (78%) 
Cold cardioplagia  
(no of pts) 
 
7 (32%) 
 
6 (40%) 
 
7 (58%) 
 
9 (50%) 
     
Events 15-26 yrs of follow-up    
PVR 
(no of pts) 
0 0 0 15 
Arrhythmia’s 
(no. Of pts.) 
0 0 2 7 
VT 0 0 0 1 
SVT 0 0 2 4 
ICD 0 0 0 1 
PM 0 0 0 5 
     
Echo data after 26 yrs    
Progression RV dil  
(no of pts) Ƈ 
 
0 
 
2 
 
0 
 
0 
Progression PRƇ 0 0 0 0 
Diminished RV dilƇ 0 0 0 12 
     
ECG data     
QRS-duration  
after 15 yrs (in msecs) 
 
107 +26 
 
120 + 20 
 
127 + 35 
 
134 + 29 
QRS-duration  
after 26 yrs (in msecs) 
 
119 + 25 
 
139 + 26 
 
155 + 30 
196 + 30*/ 
135 +21** 
     
Exercise test     
After 15 yrs 
(% of predicted) 
 
88 +25% 
 
80 + 18% 
 
69 + 27% 
 
71 + 17% 
After 26 yrs  
(% of predicted) 
 
89 + 15% 
 
82 + 14% 
 
80 + 11% 
61 +12%*/ 
80 +22%** 
Ƈcompared with echo data after 15 yrs of follow-up 
* persistant RV dilatation after PVR 
** normal or slightly dilated RV 
PR = pulmonary regurgitation, RV = right ventricle, PVR = pulmonary valve replacement, VT = 
ventricular tachycardia, SVT supraventricular tachycardia, ICD= intra cardiac defibrillator, PM = 
pacemaker, TR = tricuspid regurgitation 
 
 
Discussion 
 
This study shows that mild to moderate pulmonary regurgitation has no tendency to 
increase in a period from 15 to 26 years of follow-up after surgical correction and that 
the right ventricle of these patients do not increase in size. This subgroup of patients, 
has by far the best long-term results of this study.24,25 Since the patients of this group 
are operated upon with an approach very similar to modern insights - almost entirely 
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without the use of a transannular patch and with a very low percentage of previous 
palliative procedures - this seems to promise good long-term perspectives of the 
infants operated upon nowadays.26 
A recognized positive effect of a restrictive right ventricular physiology is that it 
prevents severe right ventricular dilatation. This is also found in this study: none of 
these patients had echocardiographic evidence of further dilatation of the right 
ventricle. Also the exercise capacity remained stable. However, unlike other 
reports,27 the exercise capacity was substantially depressed. The decreased exercise 
capacity is probably explained by the very nature of restriction: the inability to 
increase end-diastolic volume, which would be necessary for the increase in stroke 
volume, required during exercise. 28 In contrast to the unchanged echocardiographic 
data and exercise test, we saw a substantial prolongation of the QRS-duration, 
suggesting deterioration of right ventricular function.29,30 Therefore, a regular 
outpatient control, with special emphasis on right ventricular function, is necessary 
for patients with a restrictive right ventricular physiology. 
As a result of a restrictive policy towards pulmonary valve replacement that 
was used in Rotterdam, the timing of pulmonary valve replacement was relatively 
late, when compared to more recent insights. Therrien et al showed that pulmonary 
valve replacement in patients, in whom the right ventricular ejection fraction was less 
than 40%, did not result in improvement of right ventricular function afterwards12. 
However, in the patients who underwent pulmonary valve replacement in this study, 
the right ventricle had deteriorated to such a degree, that there were clinical signs of 
right ventricular failure and still, 12 out of 18 patients showed a remarkable 
improvement afterwards. This improvement was seen clinically  (the venous 
congestion disappeared), echocardiographically (reduction of right ventricular size), 
on the 12-lead ECG (QRS duration decreased substantially) and with the bicycle 
exercise test. The latter is in line with an earlier report.31  
On the other hand, in the remaining 6 patients, right ventricular dilatation 
persisted after pulmonary valve replacement. These patients would probably have 
benefited from earlier valve replacement. Neither clinical symptoms, nor ECG-data, 
nor echocardiographic data after 15 years of follow-up could predict whether or not 
the right ventricle would improve afterwards. Therefore, these data support the 
concept of earlier pulmonary valve replacement in all patients with severe pulmonary 
regurgitation and severe right ventricular dilatation, in order to reduce the risk of 
irreversible right ventricular damage. However, it also shows that pulmonary valve 
replacement should still be considered in patients who already have a substantially 
depressed right ventricular function, since there is a good chance for improvement.  
The most striking outcome in the group of 12 patients with severe pulmonary 
regurgitation and severe right ventricular dilatation was the impressive increase in 
QRS-duration. Analysis of our own data, together with the accumulated evidence in 
literature, lead to a change in our treatment policy: these patients were referred for 
pulmonary valve replacement, although they were entirely asymptomatic. 
The overall survival up to 30 years of the initial hospital survivors is only 
slightly lower than that of the normal population. The high early mortality of 16% 
reflects the surgical risk that was the rule in the 1970’s.32,33 The event-free survival 
after 26 years is poor: less than 50%. In the early years after the surgical correction 
the aim of a re-operation was closure of a residual ventricular septal defect or relief of 
residual right ventricular outflow tract obstruction. In the last 10 years the only type of 
re-intervention was pulmonary valve replacement, indicating that pulmonary 
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regurgitation in combination with depressed right ventricular function had become the 
dominant problem. 
The prevalence of supraventricular arrhythmia’s in this study is significantly 
higher than that of ventricular arrhythmia’s, 20,34,35,36 both only occurring in patients 
with severe pulmonary regurgitation and severe right ventricular dilatation; this 
supports the notion that arrhythmia’s are not the result of the congenital heart defect 
and surgery per sé, but of a poor hemodynamic situation on top of it.37  
 
Limitations of the study 
The small number of patients and the fact that right ventricular function was not 
assessed directly, are the two most important limitations of the study. MRI, the tool 
for assessment of global right ventricular function nowadays and for non-invasive 
flow-measurements, was not available in 1990 and poorly accessible in our institution 
in 2001.  
 
 
Conclusion 
 
Two-third of the patients in this study with severe pulmonary regurgitation and severe 
right ventricular dilatation, who developed signs of right sided heart failure, benefited 
from pulmonary valve replacement, with recovery of right ventricular function 
afterwards. However, in one-third of these patients, severe right ventricular dilatation 
persisted after valve replacement. These patients might have benefited from earlier 
pulmonary valve replacement. A more aggressive approach, as advocated in the 
recent years, seems justified in all patients with severe pulmonary regurgitation and 
severe right ventricular dilatation, in order to reduce the risk that a patient is operated 
upon too late. The finding, that the patients with only mild to moderate pulmonary 
regurgitation had a so much better outcome than the patients with severe pulmonary 
regurgitation, gives strong support to the current surgical policy to avoid severe 
pulmonary regurgitation at the initial surgical correction.  
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Abstract 
 
Background 
The long-term success of intracardiac repair of tetralogy of Fallot is hampered by the 
occurrence of arrhythmias. Numerous studies have stressed the potential role of 
ventricular arrhythmias. However, the importance of other arrhythmias in the 
morbidity of these patients appears to be underestimated. Furthermore, most follow-
up studies have been limited to children or adolescents, whereas many patients have 
reached adulthood after earlier repair of tetralogy of Fallot. The aim of the present 
study was to determine the incidence of atrial fibrillation, atrial flutter, and other 
supraventricular arrhythmias in adult patients after intracardiac repair for tetralogy of 
Fallot and their correlation with surgical and clinical findings. 
 
Methods and Results 
The study group consisted of 53 consecutive patients referred to the Thoraxcenter 
adult congenital heart disease clinic. They underwent repair at a mean age of 9.1 
years (range, 0.7 to 55 years). The median age at the time of study was 23.2 years 
(range, 15 to 57 years; mean age, 26.6 years), with a mean duration of follow-up of 
17.5 years (range, 1.4 to 32 years) after surgery. Records were reviewed extensively 
for evidence of arrhythmias. The follow-up study included routine 12-lead ECG, 24-
hour continuous ambulatory monitoring, and echocardiography, and 46 patients 
underwent exercise testing. Sinus node dysfunction was recorded in 19 patients 
(36%), of whom 4 required a permanent pacemaker. Atrial fibrillation or flutter was 
found in 12 patients, and other supraventricular tachycardias were found in 6. The 
former were more frequently at older age at follow-up. Antiarrhythmic therapy and 
cardioversion were typically directed at control of atrial (and not ventricular) 
tachyarrhythmias. Ten patients (19%) showed nonsustained ventricular tachycardia; 
they were older at initial surgery and older at follow-up and had more intracardiac 
repairs and longer cardiopulmonary bypass times.  
 
Conclusions 
Despite an emphasis on ventricular ectopy in past series, the main sources of 
morbidity in adult patients after surgical correction of tetralogy of Fallot emanated 
from atrial arrhythmias, which were present in one third of the patients.  
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Introduction 
 
The long-term success of primary intracardiac repair for tetralogy of Fallot is 
hampered by the occurrence of arrhythmias and late sudden death due to 
arrhythmias.1 - 4 Numerous studies have stressed the potential role of ventricular 
arrhythmias in these events.2, 4 - 17 However, atrial arrhythmias are rarely mentioned, 
and their role in the morbidity of these patients appears to be underestimated. Only 
recently has attention been paid to atrial flutter as a culprit arrhythmia.3,18 
Furthermore, most follow-up studies have been limited to children or adolescents, 
whereas many patients have reached adulthood after earlier repair of tetralogy of 
Fallot.  
In the present report, we present a study of 53 adult patients with repaired tetralogy 
of Fallot who were seen at the Thoraxcenter Clinic for Adult Congenital Heart 
Disease to assess the clinical significance of both atrial and ventricular arrhythmias 
and to establish their relation to surgical and other clinical findings.  
 
 
Methods 
 
Patients 
Fifty-three patients were studied who had surgically repaired tetralogy of Fallot and 
presented consecutively at the Clinic for Adult Congenital Heart Disease of the 
Thoraxcenter between July 1990 and April 1993. The evaluation of the patients 
included a detailed history and clinical examination; review of hospital and clinical 
records for evidence of arrhythmias on 24-hour ambulatory ECG (Holter) monitoring, 
monitor strips, and routine ECG; and exercise testing and echocardiography.  
 
Clinical Evaluation 
Patients were assessed clinically for functional status according to the New York 
Heart Association classification. Medication and symptoms were systematically 
recorded with an emphasis on episodes of palpitations, dizziness, syncope, and 
cerebral embolism. Special attention was given to signs of right-sided heart failure, 
pulmonary and tricuspid regurgitation, residual pulmonary stenosis, and residual 
shunts during physical examination.  
 
Rhythm Registration 
All available hospital and clinic records were reviewed for evidence of arrhythmias. 
The presence of an arrhythmia on any one recording (monitor strip, routine ECG, or 
Holter recording) was sufficient to code a patient for that rhythm disturbance, 
excluding arrhythmias related to cardiac catheterization or the perioperative period.  
Fifty-three patients had multiple routine 12-lead ECGs, and 52 patients 
underwent 24-hour continuous ambulatory ECG (Holter) monitoring with a mean of 
1.4 tracings (range, 1 to 4 tracings) per patient. One pacemaker-dependent patient in 
sinus rhythm with complete heart block declined Holter monitoring. Modified chest 
leads V3 and V5 were recorded with Oxford MR 14 recorders. The tapes were 
analyzed by trained technicians using Cardiodata PRODIGY or an Oxford MEDILOG 
MP-14 analyzer. Representative tracings were reviewed by one of the authors with 
special attention paid to P-wave morphology. The diagnosis of ventricular 
tachycardia (three or more consecutive ventricular premature beats) was made 
carefully to avoid misinterpretation of supraventricular as ventricular tachycardia in
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 view of the high prevalence of complete right bundle-branch block. Sinus 
bradycardia was diagnosed as a sinus rate of <50 beats per minute during waking 
hours. Any combination of at least two of sinus bradycardia, abrupt sinus pauses (>1 
second in the absence of respiratory variation), and escape beats was coded as 
sinus node dysfunction. Supraventricular tachycardia consisted of an abrupt salvo of 
three or more consecutive atrial premature beats at a rate of >100 beats per minute. 
Atrial fibrillation, atrial flutter, and ectopic atrial rhythm were diagnosed using 
conventional criteria.  
  Ventricular arrhythmias were categorized in four groups by using modified 
Lown criteria19: (1) no ventricular arrhythmias or premature ventricular beats of <30 
per hour, (2) multiform premature ventricular complexes or couplets of <30 per hour, 
(3) >30 premature ventricular beats per hour, or (4) ventricular tachycardia (defined 
as three or more consecutive ventricular beats with a mean rate of >100 beats per 
minute). Invasive electrophysiological studies were not performed.  
 
Echocardiography 
Two-dimensional echocardiography with color Doppler and velocity profiles and M-
mode recordings were performed in all patients with a Toshiba SSH 140 A with 3.75- 
and 2.5-MHz transducers or a Vingmed CFM 750 with a 3.25-MHz transducer. 
Images were obtained from conventional precordial, subcostal, and suprasternal 
views. Two-dimensional guided M-mode measurements were made of the left atrial 
(normal, <45 mm) and left ventricular (normal, <60 mm) end-diastolic dimensions. 
Right atrial enlargement was identified on four-chamber views if the right atrium was 
larger than the left. Left ventricular function was assessed qualitatively as normal or 
abnormal (eg, hypokinesis, akinesis) on two-dimensional images. Color Doppler was 
used to localize residual shunts (accepted only if confirmed by velocity 
measurements) and to quantify valvular regurgitation. Regurgitation was determined 
from multiple views. Tricuspid insufficiency was graded as severe if the insufficiency 
jet reached the posterior wall of the right atrium. Pulmonic insufficiency was judged 
as severe if back flow extended from the bifurcation of the pulmonary arteries with a 
long broad jet beyond the pulmonic valve far into the right ventricular outflow tract. 
The maximum velocity of regurgitation was determined by continuous-wave Doppler 
interrogation to assess the maximum instantaneous systolic right ventricular and 
diastolic pulmonary artery pressure gradient using the modified Bernoulli equation.  
 
Exercise ECG 
Symptom-limited exercise on a bicycle ergometer was performed in 46 patients. 
Exercise tests were not performed in 7 patients. One patient was hemiparetic and 6 
others declined, of whom 1 was pacemaker dependent. Workload was increased 
stepwise by 20 W/min, and the test was terminated when the subject approached 
exhaustion or a sustained arrhythmia occurred. Performance was compared with 
standardized data based on age, sex, and height.20 Rhythm was monitored 
continuously throughout the test and recovery period. The tracings were reviewed by 
the authors.  
 
Statistical Analysis  
Continuous variables presented as mean ±SD or median (range) were analyzed 
using two-tailed Student's t test. Univariate analysis for categorical variables was 
performed using the X2 test or Fisher's exact test. Differences were considered 
significant if the null hypothesis could be rejected at the .05 probability level.  
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Results 
 
The study group of 53 patients underwent complete repair of tetralogy of Fallot at a 
mean age of 9.1 ± 9.0 years (range, 0.7 to 55 years). The median age at the time of 
study was 23.3 years (range, 15 to 57 years; mean, 26.6 years). Mean duration of 
follow-up was 17.5 years (range, 1.4 to 32 years). Twenty-eight patients (53%) were 
women.  
 
Surgery  
Before the definitive surgical correction, 27 patients received an aortopulmonary 
shunt (Blalock-Taussig in 16, Waterson in 10, and Potts in 1). During the total 
correction, 47 of the 53 patients had caval cannulation, right atriotomy was performed 
in 36, and infundibulectomy was done in 51. Pericardial patches for enlargement of 
the right ventricular outflow tract (transannular) were used in 43 patients, and Dacron 
patches for closure of the ventricular septal defect were used in all. Five patients 
received a pulmonary valve bioprosthesis (allograft). A patent foramen ovale was 
closed in 13. Mean cardiopulmonary bypass time for the first repair was 134 ± 45 
minutes. Seventeen patients (30%) required two or more intracardiac operations: 10 
closures of a residual ventricular septal defect, 10 implantations of a pulmonary valve 
bioprosthesis (allograft), and one tricuspid valve replacement.  
 
Clinical Evaluation and Follow-up  
At follow-up, 31 of 53 patients (58%) were in New York Heart Association functional 
class I, 19 (36%) were in class II, and 3 (6%) were in class III (Table 1). Palpitations 
were felt by 17 patients (32%), and 10 patients (19%) had syncope or near-syncope. 
Cerebral embolism (not including perioperative events) occurred in 4 patients (7%). 
On physical examination, a diastolic murmur of pulmonary insufficiency was present 
in 49 of the 53 patients (92%). None of the 53 patients had edema, and only 4 had 
elevation of jugular venous pressure. 
Eight patients were judged cyanotic, but cyanosis was never severe, and no 
patient had clubbing. In 4 patients, measured arterial saturations were 96%, 94%, 
89%, and 88%. The 2 hypoxemic patients (and 1 without hypoxemia) had residual 
ventricular septal defects and elevated right ventricular diastolic pressures. The other 
5 patients showed no echocardiographic evidence of shunting.  
Diuretic use in 9 patients (17%) probably accounted for the low incidence of 
elevated venous pressure and the absence of edema. Digoxin was administered to 
10 patients (19%), and antiarrhythmic agents (propafenone, sotalol, amiodarone) 
were given to 13 (24%) (9 patients with atrial fibrillation or flutter and 4 with 
ventricular tachycardia). Three patients received long-term anticoagulation (warfarin).  
Cardioversion was used in 6 patients: four times for sustained symptomatic 
supraventricular tachycardia, once for atrial fibrillation, and once for atrial flutter. It 
was never required for ventricular arrhythmias.  
Two patients died during the study period. The first patient had syncopal 
episodes and ventricular tachycardias on ambulatory monitoring. Because of severe 
pulmonary regurgitation and peripheral pulmonary stenosis with high right ventricular 
pressure (72/7 mm Hg), a pulmonary homograft was implanted together with patch 
enlargement of the right pulmonary artery. This patient died suddenly at home, 2 
weeks after this second operation. The second patient had severe pulmonary 
regurgitation and a high right ventricular pressure (103/7 mm Hg) after her first repair, 
but she was considered inoperable because of left pulmonary atresia after a left-side 
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Blalock-Taussig shunt. She was taking amiodarone and procainamide for frequent 
attacks of atrial flutter and supraventricular tachycardia and died suddenly. Both 
patients had demonstrated premature ventricular complexes on their routine ECG.  
Six of the 27 women delivered 10 live infants without complications.  
 
Table 1 Surgical and clinical parameters and their correlation with arrhythmias  
 All Patients No AT SVT AF/AFl No VA Mult/Coup >30 PVCs VT 
No. of patients 53 35 6 12 6 17 20 10 
Age at first repair, y 9 9 5 12 9 7 7 173 
Follow-up time, y 17 17 20 18 16 17 18 17 
Age at follow-up, y 27 25 25 313 25 24 25 343 
Prior shunt, n 27 16 4 8 3 9 8 8 
>1 Repair, n 17 9 2 6 1 4 5 73 
Mean CPB time, min 134 138 125 128 106 126 126 1833 
NYHA class I, n 31 23 2 6 5 11 11 4 
NYHA class II, n 19 10 4 5 1 6 8 4 
NYHA class III, n 3 2 0 1 0 0 1 2 
Palpitations, n 17 7 2 83 0 5 6 63 
Near-syncope, n 101 4 0 64 0 3 2 53 
Cerebral embolism, n 4 2 1 1 0 2 1 1 
Cardioversion, n 6 0 4 2 . . . . . . . . . . . .2 
Digoxin, n 10 2 3 53 1 4 3 2 
Diuretics, n 9 3 0 64 1 1 2 51 
Antiarrhythmics, n 13 2 2 93 0 2 6 5 
Anticoagulants, n 5 2 0 3 1 1 1 2 
No AT indicates no atrial tachyarrhythmias; SVT, supraventricular tachycardia; AF/AFl, atrial fibrillation 
and/or atrial flutter; No VA, no ventricular arrhythmia or <30 PVCs/h; Mult/Coup, multiform ventricular 
extrasystoles or couplets <30/h; >30 PVCs, >30 premature ventricular compexes per hour; VT, 
ventricular tachycardia; CPB, cardiopulmonary bypass; and NYHA, New York Heart Association 
1
 Three patients had syncope, and seven patients had near-syncope 
2
 Although patients who underwent cardioversion often had ventricular arrhythmias, such therapy was 
in all cases directed to atrial tachyarrhythmias 
3
 P<.05 
4
 P<.01 compared with frequency in remaining patients without this arrhythmia 
 
 
Arrhythmias  
Monitor strips during hospitalization showed atrial fibrillation or flutter in 7 patients. 
Routine 12-lead ECG showed chronic atrial fibrillation or flutter in 3 patients, and 2 
patients were in ectopic rhythm. Six patients were pacemaker dependent (2 because 
of surgically induced complete heart block and 4 because of sinus node dysfunction). 
Six patients showed premature ventricular complexes on their routine ECG. On 
Holter monitoring, 6 patients (11%) showed atrial fibrillation or flutter, and 47 (89%) 
showed ventricular arrhythmias. Exercise testing demonstrated ventricular ectopy in 
22 patients (48%), of which four were episodes of nonsustained ventricular 
tachycardia.  
On a review of monitor strips, routine ECGs, and Holter recordings, some 
degree of sinus node dysfunction was recorded in 19 patients (36%). In 4, it was 
severe enough to require a permanent pacemaker. Atrial tachyarrhythmia was 
present in 18 patients (34%), consisting of sustained supraventricular tachycardia in 
6 (11%), of whom 4 required DC cardioversion, and atrial fibrillation or flutter was 
present in 12 patients (23%).  
Ventricular arrhythmias were found in 47 (89%). No ventricular arrhythmias or 
<30 premature ventricular complexes per hour were found in 6 patients (11%); 17 
Chapter VII 
96 
patients (32%) demonstrated multiform ventricular extrasystoles or couplets; 20 
patients (38%) had >30 premature ventricular complexes per hour; and 10 patients 
(19%) had ventricular tachycardia.  
The follow-up time was not significantly different between the patients with and 
those without arrhythmias (Table 1). Compared with patients without arrhythmias, 
patients with atrial fibrillation or flutter (P=.04) or ventricular tachycardia (P=.017) 
were older. Age at total repair was higher for patients with ventricular tachycardia 
(P=.013). There was no association with a previous shunt operation. Longer 
cardiopulmonary bypass time (P=.0016) and multiple repairs (P=.02) appeared to be 
associated with ventricular tachycardia.  
In most categories of atrial or ventricular arrhythmias, New York Heart 
Association class I predominated. As expected, palpitations and near-syncope were 
noted in the patients with atrial fibrillation or flutter and in patients with ventricular 
tachycardia. The occurrence of cerebral embolism was unrelated to the presence of 
arrhythmia. All six episodes of cardioversion were required for atrial tachycardia; 
there was no need for cardioversion to terminate ventricular arrhythmias as sustained 
ventricular tachycardia was never documented.  
 
Echocardiography  
Echocardiographic results are shown in Table 2. There was almost uniform presence 
of right atrial enlargement (52 of 53; 98%). There were 4 patients with left atrial 
enlargement, and 3 of these showed atrial fibrillation or flutter as well as ventricular 
tachycardia. Three patients had a left ventricular abnormality (enlargement or 
contraction abnormality), and 2 of the 3 had atrial fibrillation or flutter (P=.05). One 
patient with a segmental contraction abnormality had a transection of a coronary 
artery branch at the time of initial repair due to an abnormal course of the coronary 
artery across the right ventricular outflow tract.  
Small echocardiographically detectable ventricular septal defects were seen in 
25 patients and were significantly associated with atrial fibrillation or flutter (P=.03). 
Of the 4 patients with left atrial enlargement but without left ventricular abnormality or 
residual aortopulmonary shunt, all had ventricular septal defects. No correlation could 
be found between severe tricuspid or pulmonic insufficiency and atrial or ventricular 
rhythm disturbances. The mean tricuspid insufficiency jet velocity was 2.8 m/s, 
corresponding to a tricuspid pressure gradient of 31 mm Hg. There was no 
correlation of the right ventricular pressure with any arrhythmia. 
 
Table 2 Arrhythmias and echocardiographic data  
 All 
Patients
 
No AT
 
SVT
 
AF/AFl
 
No VA
 
Mult/Coup 
 
>30 PVCs
 
VT 
No. of patients 53 35 6 12 6 17 20 10 
Right atrium enlargement, n 52 34 6 12 5 17 20 20 
Right ventricular enlargement, n 50 32 6 12 5 17 19   9 
Left atrium enlargement, n  4   1 0    31 0  1  0    31
Left ventricular abnormality, n  3   1 0    21 0  1  0  2 
Ventricular septal defect, n 25 16 1    81 4  5 10  6 
Pulmonic insufficiency, n 39 27 5   7 3 16 13  7 
Tricuspid insufficiency, n 11   7 0  4 3  4  2  2 
Tricuspid insufficiency velocity, m/s     2.8     2.7    2.8     2.9    2.7     2.8     2.9     2.7
For abbreviations, Table 1 
1
 P<.05 compared with frequency in remaining patients without this arrhythmia 
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Exercise  
Peak performance was 29% to 112% of the predicted normal value (mean, 77%). 
Patients with tricuspid or pulmonic insufficiency reached peak levels of exercise that 
were similar to those of the other patients. Exercise capacity was significantly lower 
in the group with atrial fibrillation or flutter (65%; P=0.03).  
During exercise, 48% of the patients showed ventricular ectopy, of whom 4 
demonstrated unsustained ventricular tachycardia. No test was terminated because 
of sustained arrhythmia. No patients were found to have previously unsuspected 
ventricular arrhythmias.  
 
 
Discussion 
 
Despite an emphasis in past series on the importance of ventricular ectopy2, 4,5–17 and 
its high prevalence in the present study (89% of the patients), most complaints 
emanated from patients with atrial arrhythmias. 
 
Incidence of Arrhythmias  
The incidence of arrhythmias in adults with surgically repaired tetralogy of Fallot was 
higher than previously reported (Table 3). Atrial arrhythmias were found in 34% and 
ventricular arrhythmias were found in 89%, exceeding frequencies found in previous 
series that exclusively used ambulatory monitoring.2,4–14 The presence of 
supraventricular tachycardia in 11% of our patients parallels the experiences of 
Miyamura et al10 (19%) and Waien et al17 (14% to 24%) but is substantially higher 
than in most other series that used ambulatory monitoring.15-17 Atrial flutter and 
fibrillation in particular are remarkable by their absence in other tetralogy of Fallot 
follow-up studies. In five studies,8, 21–24 only 13 cases of atrial fibrillation or flutter were 
reported in 1140 patients. On the other hand, in a collaborative study of 380 patients 
with atrial flutter (age, 1 to 25 years), only 30 (8%) had tetralogy of Fallot (28 
repaired, 2 with shunts only); the denominator (ie, the total number of patients with 
tetralogy of Fallot from whom these 30 were drawn) was not given.18  
With respect to supraventricular tachycardia, surface ECGs do not permit 
separation of atrioventricular nodal reentry from accessory pathways or ectopic atrial 
foci. However, the clinical importance of this rapid supraventricular rhythm is 
manifested by the need to cardiovert 4 of 6 of these patients. Similarly, without 
invasive testing it is not possible to distinguish atrial flutter from atrial reentry around 
surgical scars. Nevertheless, the need for management of this tachyarrhythmia is 
equally urgent.  
The higher frequency of arrhythmias in the present study may be explained by 
the methods we used and by patient selection. We carefully sifted through all 
available material in search of rhythm disturbances as they appeared on monitor 
strips, routine ECG tracings, and Holter records. The accumulation of multiple Holter 
tracings in response to complaints increased the chances for detection of 
arrhythmias in the present study. Furthermore, because we included only adults, the 
study preferentially selected patients who were older at surgery or who had a longer 
follow-up interval after surgery and therefore were more likely to represent an earlier 
era of surgical repair.23 Only three other studies using ambulatory monitoring have 
been limited to adults.15,16,17 Finally, other studies traced patients who had previously 
undergone surgery at a single institution,22 who were selected from among 
volunteers,13,15,17 or who were chosen to participate.2  
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In contrast, the present study covers all repaired patients who presented at the 
sole geographic center for adult patients with congenital heart disease in the 
Rotterdam area. Referral may have been triggered by having reached the upper age 
for pediatric care, by unfamiliarity of the adult cardiologist or family physician with 
such patients, or by new symptoms. These indications for referral may account for a 
higher frequency of arrhythmias. The problems our patients present should not be 
seen as aberrations from the usual—perhaps more benign—outlook for all patients 
with successfully repaired tetralogy of Fallot. We stress that they are more likely to be 
representative of the postrepair tetralogy population referred to well-equipped adult 
cardiovascular centers.  
 
Table 3 Studies of adults with repaired tetralogy of Fallot  
Author Burns et al15 Zahka et al16 Waien et al17 The present study (Thoraxcenter)
Year 1984 1988 1992 1994 
Patient age, mean y 27 26 28 27 
Patient age, range, y 18 to 41 19 to 35 18 to 71 15 to 57 
Follow-up, y 14 18 14 17 
Holter monitoring, n 44 56 36 52 
Exercise test, n + - + + 
Atrial arrhythmia, n - 1 SVT 4 SVT 6 SVT, 
    12 AF/AFl 
Ventricular arrhythmia, % 64 79 56 94 
SVT indicates supraventricular tachycardia; AF/AFl, atrial fibrillation and/or atrial flutter; +, yes; and -, 
not done 
 
 
Atrial Arrhythmias  
The pathological significance of supraventricular tachycardia is hard to interpret. Brief 
salvos of supraventricular tachycardia have been found on ambulatory monitoring in 
as many as 22% of healthy individuals.26 Nevertheless, patients with residual cardiac 
abnormalities may not tolerate sustained tachycardia, and four of six episodes of 
cardioversion were required for this arrhythmia. Evidence that transient sinus node 
dysfunction was noteworthy is provided by the need for pacemakers in 4 such 
patients and persistent ectopic atrial rhythm in 2 other patients.  
Atrial flutter and fibrillation have not been found on routine ambulatory 
monitoring of healthy persons.25-28 On the contrary, they are a marker of poor 
hemodynamics.22 Atrial flutter and junctional rhythm have been reported in 18% and 
46%, respectively, during follow-up of patients with repaired ostium secundum atrial 
septal defect.29 After atrial baffle repair of transposition of the great arteries, atrial 
fibrillation and flutter occur frequently (25%) and continue to increase with duration of 
follow-up.30 Atriotomy and atrial sutures may play a role in the development of atrial 
arrhythmias in these patients and may also be of significance in tetralogy patients.  
In the present study, the age at follow-up was significantly higher in the 
patients with atrial fibrillation or flutter. In addition to age, the presence of left-side 
pathology in several of our patients appeared to be related to arrhythmias. Three of 4 
patients with left atrial enlargement by echocardiography had atrial arrhythmias. 
None had left ventricular abnormalities or mitral insufficiency. However, all had small 
residual ventricular septal defects that, in combination with their older age at the time 
of surgery, may have had some importance. A voluminous shunt (4.3:1) was found 
only once in a patient demonstrating atrial flutter or fibrillation who had no left-side 
chamber abnormalities. On the other hand, we found a significant correlation 
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between left ventricular abnormalities and the incidence of atrial arrhythmias, 
although this, to our knowledge, was never described in postoperative tetralogy of 
Fallot patients. The near-universal presence of right-side chamber enlargement 
prevented any correlation with arrhythmias. Neither pulmonic insufficiency nor 
tricuspid insufficiency was more frequent among patients with rhythm disturbances.  
Much of the morbidity in our patients was due to atrial arrhythmias: 66% of 
patients with fibrillation or flutter complained of palpitations, and 50% noted dizziness 
or near-syncope. Antiarrhythmic therapy and cardioversion were typically directed at 
control of symptomatic atrial—not ventricular—arrhythmias. The relative importance 
of atrial tachyarrhythmias is also indicated by the fact that even though approximately 
half of the 10 patients with ventricular tachycardia complained of palpitation or near-
syncope, all except 2 symptomatic patients also had atrial flutter or fibrillation. 
Conversely, among the 10 symptomatic patients with atrial tachyarrhythmias, 
ventricular tachycardia was present in only 2. Furthermore, patients with atrial 
arrhythmias demonstrated reduced exercise capacity.  
 
Ventricular Arrhythmias  
The correlation between patients with ventricular tachycardia and older age at first 
repair was described by others2,7,8,9,21 but is not universally supported.13,14 The age at 
follow-up was significantly greater for patients with ventricular tachycardia, whereas 
the follow-up intervals were similar. Thus, age at first repair and age at follow-up 
probably should not be considered independent variables. Longer cardiopulmonary 
bypass time and multiple repairs emerged as significant and have been reported 
previously.3,14,23 Damage to the myocardium may have already occurred when older 
patients were operated on, or the anatomy in these patients may have been more 
complex. Prior aortopulmonary shunt procedures were not more frequent among 
patients with ventricular arrhythmias (as noted previously7,14 ) despite reports of such 
association.22  
Of the 10 patients with ventricular tachycardia, 60% had palpitations, and 50% 
had near-syncope. However, when patients with concomitant atrial arrhythmias were 
removed, the frequency of these same symptoms no longer reached significance. 
Sustained ventricular tachycardia was never documented, and cardioversion was 
therefore never required for termination of ventricular arrhythmias.  
Although we anticipated a linkage between ventricular ectopy and severe 
pulmonary regurgitation with secondary marked dilatation of the right side of the 
heart, no such correlation could be confirmed. This confirms the recent report of Joffe 
et al.31 Reberger et al32 measured right ventricular volumes by nuclear magnetic 
resonance velocity mapping in patients after surgical correction of tetralogy of Fallot 
and found a virtually normal range of right ventricular ejection fractions in the majority 
of their patients with pulmonary regurgitation. However, in the present study, no 
direct measure of right ventricular function was made, so that, on the basis of the 
echocardiographic Doppler studies of the amount of pulmonary regurgitation alone, 
we could not differentiate between patients with and those without myocardial 
decompensation.  
All 3 patients with a left ventricular abnormality had ventricular arrhythmias; 2 
of the 3 had ventricular tachycardia, but these numbers were too small to achieve 
statistical significance.  
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Prognosis  
In contrast to previous reports suggesting the advantage of exercise over resting 
ECGs to assess clinical risk from arrhythmias,1,7 this approach yielded no clinically 
useful new information when compared with Holter testing.  
Despite the availability of ambulatory monitoring, the two deaths that occurred 
during this 3-year period were signaled by the presence of premature ventricular 
complexes on routine ECG. This finding was limited to only 4 other patients and, 
when complicated by right ventricular hypertension, should be taken seriously.  
 
 
Conclusions  
 
Adults with repaired tetralogy of Fallot presenting at centers caring for such patients 
may differ from those in published series: patients are older and are more likely to 
have complaints and to have had multiple operations, valvular prostheses, 
pacemakers, pregnancies, and cardiac medication.  
Although it might be assumed that pressure or volume overload of the right 
atrium and right ventricle would cause dilatation and predispose to arrhythmias, no 
such relation was demonstrated. Instead, an interesting but not fully understood 
association with left-side abnormalities and residual ventricular septal defect was 
found.  
Despite an emphasis in past series on the importance of ventricular ectopy 
and its high prevalence in the present series, the main sources of morbidity in these 
adult patients emanated from atrial arrhythmias: atrial fibrillation, atrial flutter, 
supraventricular tachycardia, and sinus node dysfunction. These were present at one 
time or another in one third of our patients. Antiarrhythmic therapy and cardioversion 
were typically directed at control of symptomatic or sustained atrial tachyarrhythmias. 
Pacemakers were needed twice as often for sinus bradycardia as for heart block.  
These observations should be useful to physicians who assume the late care 
of adults with repaired tetralogy. They broaden the focus of attention from ventricular 
ectopy and atrioventricular block to include atrial and sinoatrial dysrhythmias, 
paralleling the delayed emergence of these rhythm disturbances in patients with 
previous Mustard, Fontan, and atrial septal defect repairs.  
 
 
References 
 
1. Garson A Jr, Gillette PC, Gutgesell A, McNamara DG. Stress-induced ventricular arrhythmias after 
repair of tetralogy of Fallot. Am J Cardiol. 1980;46:1006-1012 
2. Garson A, Randall DC, Gillette PC, Smith RT, Moak JP, McVey P, McNamara DG. Prevention of 
sudden death after repair of tetralogy of Fallot: treatment of ventricular arrhythmias. J Am Coll 
Cardiol. 1985;6:221-227 
3. Garson A. Ventricular arrhythmias after repair of congenital heart disease: who needs treatment? 
Cardiol Young 1991;1:177-181 
4. Chander JS, Wolff GS, Garson A, Jr, Bell TJ, Beder SD, Bink-Boelkens M, Byrum CJ, Campbell 
RM, Deal BJ, Dick M 2d, Flinn CJ, Gaum WE, Gillette PC, Hordof AJ, Kugler JD, Porter CJ, Walsh 
EP. Ventricular arrhythmias in post-operative tetralogy of Fallot. Am J Cardiol 1990;65:655-661 
5. Rosing DR, Borer JS, Kent KM, Maron BJ, Seides SF, Morrow AG, Epstein SE. Long-term 
hemodynamic and electrocardiographic assessment following operative repair of tetralogy of 
Fallot. Circulation 1978;58(suppl I):I-209-I-217 
Artial arrhythmias after repair of tetralogy of Fallot 
101 
6. Deanfield JE, McKenna WJ, Hallidie-Smith KA. Detection of late arrhythmias and conduction 
disturbance after correction of tetralogy of Fallot. Br Heart J 1980;44:248-253 
7. Kavey REW, Blackman MS, Sondheimer HM. Incidence and severity of chronic ventricular 
dysrhythmias after repair of tetralogy of Fallot. Am Heart J 1982;103:342-350 
8. Deanfield JE, McKenna WJ, Presbitero P, England D, Graham GR, Hallidie-Smith KA. Ventricular 
arrhythmias in unrepaired and repaired tetralogy of Fallot. Br Heart J 1984;52:77-81 
9. Kobayashi J, Hirose H, Nakano S, Matsuda H, Shirakura R, Kawashima Y. Ambulatory 
electrocardiographic study of the frequency and cause of ventricular arrhythmia after correction of 
tetralogy of Fallot. Am J Cadiol 1984;54:1310-1313 
10. Miyamura H, Kanazawa N, Fukuda J, Eguchi S, Morikawa M, Aizawa Y, Matsukawa T. Long-term 
postoperative status of tetralogy of Fallot. Jpn Circ J 1986;50:855-858 
11. Fukushige J, Shimomura K, Harada T, Fukazawa M, Veda K, Tokunaga K. Incidence and severity 
of ventricular arrhythmia in patients after repair of tetralogy of Fallot. Jpn Heart J 1988;29:795-800  
12. Walsh EP, Rockenmacher S, Keane JF, Hougen TJ, Lock JE, Castaneda AR. Late results in 
patients with tetralogy of Fallot repaired during infancy. Circulation 1988;77:106-107 
13. Horneffer PJ, Zahka KG, Rowe SA, Manolio TA, Gott VL, Reitz BA, Gardner TJ. Long-term results 
of total repair of tetralogy of Fallot in childhood. Ann Surg 1990;50:179-183 
14. Vaksmann G, Fournier A, Davignon A, Durcharme G, Houyel L, Fouron JC. Frequency and 
prognosis of arrhythmias after operative `correction' of tetralogy of Fallot. Am J Cardiol 
1990;66:346-349 
15. Burns RJ, Liu PP, Druck MN, Seawright SJ, Williams WG, McLaughlin PR. Analysis of adults with 
and without complex ventricular arrhythmias after repair of tetralogy of Fallot. J Am Coll Cardiol 
1984;4:226-233 
16. Zahka KG, Horneffer PJ, Rowe SA, Neill CA, Manolio TA, Gardner TJ. Long-term valvular function 
after total repair of tetralogy of Fallot: relation to ventricular arrhythmias. Circulation 1988;78(suppl 
III):III-14-III-19 
17. Waien SA, Liu PP, Ross BL, Williams WG, Webb GD, McLaughlin PR. Serial follow-up of adults 
with repaired tetralogy of Fallot. J Am Coll Cardiol 1992;20:295-300 
18. Garson A, Bink-Boelkens M, Hesslein PS, Hordof AJ, Keane JF, Neches WH, Porter CJ. Atrial 
flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol 1985;6:871-878 
19. Lown B, Wolf M. Approaches to sudden death from coronary heart disease. Circulation 
1971;44:130-142 
20. Godfrey S. Exercise Testing in Children. London, UK: WB Saunders; 1974 
21. Katz NM, Blackstone EM, Kirklin JW, Pacifico AD, Bargeron LM. Late survival and symptoms after 
repair of tetralogy of Fallot. Circulation 1982;65:403-410 
22. Wessel HU, Bastanier CK, Paul MH, Berry TE, Cole RB, Muster AJ. Prognostic significance of 
arrhythmias in tetralogy of Fallot after intracardiac repair. Am J Cardiol 1980;46:843-848  
23. Fuster V, McGoon DC, Kennedy MA, Ritter DG, Kirklin JW. Long-term evaluation (12–22 years) of 
open heart surgery for tetralogy of Fallot. Am J Cardiol 1980;46:635-642 
24. Cullen S, Celermajer DS, Franklin RCG, Hallidie-Smith KA, Deanfield JE. Prognostic significance 
of ventricular arrhythmia after repair of tetralogy of Fallot: a 12 year prospective study. J Am Coll 
Cardiol 1994;5:1151-1155 
25. Bethge KP, Bethge D, Meiners G, Lichtlen PR. Incidence and prognostic significance of ventricular 
arrhythmias in individuals without detectable heart disease. Eur Heart J 1983;4:338-346 
26. Bjerregaard P. Premature beats in healthy subjects 40-79 years of age. Eur Heart J 1982;3:493-
503 
27. Brodsky M, Wu D, Denes P, Kanakis C, Rosen KM. Arrhythmias documented by 24-hour 
continuous electrocardiographic monitoring in 50 male students without apparent heart disease. 
Am J Cardiol 1977;39:390-396 
28. Clarke JM, Shelton JR, Hamer J, Taylor S, Venning GR. The rhythm of the normal heart. Lancet 
1976;2:508-512 
29. Bink-Boelkens M, Meuzelaar KJ, Eygelaar A. Arrhythmias after repair of secundum atrial septal 
defect: the influence of surgical modification. Am Heart J 1988;115:629-633 
30. Bink-Boelkens M, Velvis H, van der Heide JJH, Eygelaar A, Hardjowijono R. Dysrhythmias after 
atrial surgery in children. Am Heart J 1983;106:125-130 
31. Joffe H, Georgakopoulos D, Celermajer DS, Sullivan ID, Deanfield JE. Late ventricular arrhythmia 
is rare after early repair of tetralogy of Fallot. J Am Coll Cardiol 1994;5:1146-1150 
Chapter VII 
102 
32. Rebergen SA, Chin JG, Ottenkamp J, van der Wall EE, de Roos A. Pulmonary regurgitation in the 
late postoperative follow-up of tetralogy of Fallot: volumetric quantitation by nuclear magnetic 
resonance velocity mapping. Circulation 1993;88:2257-2266 
 
&
KD
SW
HU

  
 
 105 
Coronary anomaly imaging by multislice computed 
tomography in corrected tetralogy of Fallot  
 
 
K Nieman, J W Roos-Hesselink, P J de Feyter  
 
 
Heart, 2003;89:663-664 
 
 
A 47 year old man with corrected tetralogy of Fallot was admitted with clinical heart 
failure. After prior left sided Blalock anastomosis at the age of 4 years, complete 
correction was performed at 9 years of age. Before pulmonary homograft insertion at 
40, a fistula between the right coronary artery (RCA) and right ventricular outflow 
tract (RVOT) was detected. The procedure, which involved incision of the RVOT, was 
complicated by laceration of a small arterial branch, requiring end-to-end 
anastomosis.  
 
Cardiac catheterisation confirmed the previously described fistula; however, selective 
intubation of an anomalous left sided coronary artery ostium failed.  
 
At a pacemaker controlled rate of 60 beats/min, ECG gated multislice spiral 
computed tomography (MSCT) angiography (Somatom VolumeZoom, Siemens, 
Germany) was performed, during a 42 second breath hold. The volume rendered 
MSCT angiogram reveals an anomalous coronary artery that originates between the 
left and non-coronary sinus of Valsalva and trifurcates into a marginal, septal, and 
circumflex branch (upper panel).  
 
A large calibre vessel, with branches to the right ventricle (RV), originates from an 
otherwise normal RCA, and terminates at the RVOT (lower panel, A and B), 
confirmed from inside the RVOT by virtual angioscopy (lower panel, C). A small, 
previously lacerated arterial branch runs across the RVOT to the anterior 
interventricular groove (B). The absence of a substantial anterior interventricular 
branch, and the location of the fistula at the RVOT, suggest that the fistula may have 
been formed after laceration of an anomalous LAD during surgical correction of 
tetralogy of Fallot, causing akinesia of the anterior wall.  
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Is a bicuspid aortic valve a risk factor for adverse outcome 
after an autograft procedure?  
 
 
AJ.J.C. Bogers, A.P. Kappetein, J.W. Roos-Hesselink, J.J.M. Takkenberg 
 
 
Annals of Thoracic Surgery, in press 
 
 
Abstract 
 
Background 
Recently bicuspid aortic valve disease is posed to be a possible risk factor for 
dilatation of the pulmonary autograft. 
 
Methods 
Analysis of all 123 patients in our prospective cohort with their native aortic valve in 
situ at the autograft procedure. 
 
Results 
The bicuspid aortic valve group (n=81) had more males (p=0.05), prior cardiac 
surgery (p=0.02), prior aortic valve balloondilatation (p=0.01), aortic stenosis (p=0.03) 
and less deterioration of left ventricular function (p=0.02) than the tricuspid group 
(n=42).  
Hospital mortality occurred in 3 patients (bicuspid 2, tricuspid 1). The follow up was 
99% complete (median 5.3 years, sd 3.5, range 0.1-13.4) with a total of 674 patient 
years. During follow-up 4 patients died (bicuspid 2, tricuspid 2). Overall survival was 
95% (95%CI 89-98%) at 5 and 10 years.  
Seven patients required reoperation for autograft failure, all structural. Freedom from 
autograft reintervention was 97% (95%CI 92-100%) at 5 years and 89% (95%CI 79-
98%) at 10 years. There were no differences in outcome between the groups. 
Four patients required reoperation for allograft failure, all structural.  Freedom from 
allograft reoperation was 99% (95%CI 97-100%) at 5 years and 91% (95%CI 82-
100%) at 10 years. There was no difference between the groups.   
 
Conclusions 
An autograft procedure in patients with a bicuspid aortic valve is justified. Bicuspid 
aortic valve disease is not a contraindication for an autograft procedure. Patients with 
a bicuspid aortic valve will meet the limitations of the autograft procedure in the same 
frequency as the overall autograft population. 
 
 
Introduction 
 
Recently the issue was brought up, whether or not a bicuspid aortic valve is a risk 
factor for adverse outcome after an autograft procedure.1-5 The presence of a 
bicuspid aortic valve is associated with aortic dilatation, aneurysm formation and 
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aortic dissection due to focal abnormalities within the aortic media. Although the 
aortic and pulmonary arterial wall do differ histologically in the normal situation,9,10 
the pulmonary artery has the same embryological origin as the aorta and undergoes 
similar degenerative changes. Knowing that the aortic wall is abnormal in patients 
with a bicuspid aortic valve,5-8 the causative mechanism for autograft failure was 
suggested to be an abnormality of the pulmonary arterial as well.4,5 It is not yet clear, 
however, whether these differences in patients with a bicuspid aortic valve effectively 
predispose to clinical autograft failure.5 This would create a significant problem 
because in most autograft series, patients with a bicuspid aortic valve mount up to 
60-70 % of the patient population.1,3,11 
From the clinical point of view we would expect such a predisposition to cause 
problems either at the proximal anastomosis, at the autograft itself or at the distal 
anastomosis. To assess the outcome after an autograft procedure possible allograft 
problems should be studied as well. In this regard we analysed in our series of 
autograft procedures whether or not a bicuspid aortic valve results in a higher rate of 
autograft failure. 
 
Materials and Methods 
The present analysis was conducted in accordance with the regulations of the 
institutional medical ethical committee, the patients consented to being included in 
our registry. Between September 1988 and June 2002 134 patients underwent an 
autograft procedure at our institution. Eleven patients had a previous aortic valve 
replacement and were excluded from this study, because a history of aortic valve 
replacement might influence dilatation of the aortic annulus and root.  
The remaining 123 patients with their native aortic valve in situ at the autograft 
procedure were included in the present analysis. Characteristics of patients and 
operations are presented in Tables 1 and 2. Most of these patients are included in 
previous reports on different aspects of the autograft procedure.11-13 
Left ventricular function was assessed by angiography or echocardiography 
and graded semiquantitatively as good or mildly, moderately or severely impaired. 
Aortic valve morphology was determined using the operative reports. A tricuspid 
aortic valve, defined as having three separate functional leaflets, was found in 42 
patients. A bileaflet aortic valve was defined as having two separate functional 
leaflets. One of these may contain a more or less developed fusion area or raphe. A 
unicuspid aortic valve was defined as having one commissure and a single functional 
leaflet. Because of the low numbers of unicuspid valves and because the distinction 
between unicuspid and bicuspid could not always be made accurately, these two 
valve types are analysed together and further referred to as the bicuspid group, 
containing 81 patients.  
Preoperatively the aortic annulus was dilated in 2 patients (bicuspid 1, 
tricuspid 1), the aortic sinuses were dilated in 9 patients (bicuspid 4, tricuspid 5) and 
the ascending aorta was dilated in 4 patients (bicuspid 3, tricuspid 1). 
Concerning the operative technique, the proximal anastomosis of the autograft 
onto the aortic annulus was done by continuous suturing technique in 98 patients 
(bicuspid 68, tricuspid 30) and by interrupted sutures in 25 patients (bicuspid 13, 
tricuspid 12). In all patients the pulmonary valve was replaced by a pulmonary 
allograft.  
Valve-related events were scored as defined by previously published guidelines.14 
The 11 patients that were excluded because of previous aortic valve 
replacement, did not differ in outcome from our study cohort (no mortality, 1 autograft 
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reoperation for structural valve disease at 5.8 years postoperatively, 1 
balloondilatation for stenosis of the pulmonary allograft at 0.7 years postoperatively 
and 1 replacement of the pulmonary allograft at 2.1 years postoperatively) 
During follow up patients underwent standardized serial echocardiography at 6 
months, 1 year and yearly thereafter to determine autograft and allograft function 
over time. 
All analyses were done using SPSS 10.0 for Windows (SPSS, Chicago, Ill.). 
Means were compared using the unpaired T-test. The Chi-square test or Fisher’s 
Exact test were used to compare categorical variables. All tests were 2-sided, with an 
α-level of 0.05. Cumulative survival and freedom from reintervention or valve-related 
events were analyzed using the Kaplan-Meier method. The survival of a patient 
started at the time of the autograft procedure and ended at death (event) or last 
follow up (censoring). The analysis of autograft and allograft survival started at the 
time of autograft procedure and ended at reintervention (event) or last follow up or 
patient death (censoring). The log-rank test was used to compare survival between 
groups. 
 
 
Results 
 
Patients with a bicuspid aortic valve more often had a history of cardiac surgery 
(27/81 vs. tricuspid 7/42, p=0.01) as well as prior balloon dilatation of the aortic valve 
(20/81 vs. tricuspid 3/42, p=0.02)  
By definition of our study cohort the etiology of the aortic valve disease is different in 
the two study groups, Table 1.  
The groups differed in the diagnosis posing the indication for surgery. Aortic 
stenosis, either valvular or subvalvular, and either alone or in combination with aortic 
regurgitation, was significantly more often the indication for surgery in the bicuspid 
valve group (65/81 vs. tricuspid 22/42, p=0.002)  
At admission for operation, the mean overall weight and length were 58 kg (sd 
24, range 4-111) and 156 cm (sd 35, range 48-200) respectively. All patients were in 
sinus rhythm. In 108 patients, data on left ventricular function from echocardiographic 
or angiographic studies were available. In this subset of patients the left ventricular 
function was less often deteriorated in the bicuspid valve group (8/70 vs. tricuspid 
12/38, p=0.04), Table 1. In our study group 51 patients were in New York Heart 
Association class I, 45 in class II, 19 in class III, 5 in class IV and in 3 the class was 
unknown, there was no difference between the bicuspid and tricuspid valve groups. 
The autograft procedure in our center is routinely carried out with the root 
replacement technique. This yielded 117 root replacement procedures, no 
subcoronary procedures and only 6 inlay procedures. The inlay procedures were less 
often carried out in the bicuspid valve group (1/81 vs. tricuspid 5/37, p=0.02). 
Concomitant procedures were done in 22 patients, without a difference between the 
groups. No circulatory arrest was applied 
Three patients died in hospital. In the bicuspid valve group one patient died of 
postoperative sepsis and mediastinitis and one due to a myocardial infarction after 
intraoperative damage to a coronary artery. In the tricuspid valve group a Marfan 
patient with a root aneurysm in preoperative cardiogenic shock died postoperatively 
due to cardiac failure. 
One patient (bicuspid native aortic valve) needed a permanent pacemaker for 
postoperative total atrioventricular block. No perioperative transient ischemic attacks 
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or strokes of any kind were registered. In the early postoperative period, 16 patients 
(13%) needed mediastinal reexploration for persisting blood loss.  
 
Table 1 Preoperative characteristics  
 Total 
N=123 
Bicuspid 
N= 81 
Tricuspid 
N=42 
P 
Mean age (years (SD; range)) 23 (13;0.3-53) 21 (13;0.3-52) 25 (14;1-53) 0.07# 
Male/female ratio 77/46 46/35 31/11 0.08* 
Prior cardiac surgery1  34 27 7 0.01* 
Prior balloon dilatation 23 20 3 0.018* 
Diagnosis 
Aortic valve regurgitation (AR) 
Aortic valve stenosis (AS) 
AR + AS 
Subvalvular AS + AS or ASAR 
 
36 
32 
44 
11 
 
16 
28 
29 
8 
 
20 
4 
15 
3 
0.002* 
 
Etiology 
Bicuspid valve 
Other congenital 
Degenerative 
Rheumatic 
Endocarditis (recently cured) 
Other  
 
76 
23 
2 
9 
4 
9 
 
76 
5 
0 
0 
0 
0 
 
0 
18 
2 
9 
4 
9 
<0.001* 
Length (cm, (SD; range)) 156(35;48-
200) 
152(38;48-
189 
163(27;68-
200) 
0.08# 
Weight (kg; (SD, range)) 58(24;4-111) 55(26;4-111) 62(21;15-105) 0.08# 
Sinus rhythm 123 81 42  
Creatinin (µmol/L, N=112)(SD, 
range) 
66(23;12-157) 63(23;12-121 72(24;22-157 0.04# 
Qualitative LVF (N=108) 
Good 
Mild/moderate impairment 
Severe impairment 
 
88 
19 
1 
 
62 
7 
1 
 
26 
12 
0 
0.04* 
NYHA class (N=120) 
I 
II 
III 
IV/V 
 
51 
45 
19 
5 
 
35 
27 
13 
3 
 
16 
18 
6 
2 
0.75* 
SD: standard deviation. NYHA: New York Heart Association. LVF: left ventricular function. 
*Fisher’s exact test or Chi-square test. # Independent samples test 
1Prior cardiac surgery concerned in all patients the left ventricular outflow tract: aortic valvotomy in 26 
(with closure of ventricular septal defect in 2, enucleation of discrete subaortic stenosis in 1 and aortic 
root plasty in 1), aortic valve reconstruction in 4 (with closure of ventricular septal defect in 1 and 
enucleation of discrete subaortic stenosis in 2), enucleation of discrete subaortic stenosis in 3 (with 
aortic root plasty in 1), myectomy in 1 
 
 
Follow up was 99% complete. The mean follow-up was 5.5 years (median 5.3, 
sd 3.5 years, range 0.1-13.4 years) with a total follow-up of 674 patient years. During 
follow-up another 4 patients died, two patients in each group. Postoperatively one 
patient, discharged in good health but readmitted after 4 weeks for noncardiac 
infection, died of sepsis after 7 weeks. One patient died due to recurrent rheumatic 
fever after 6 months, one after 1.8 years due to cardiac failure and one patient died 
4.9 years postoperatively due to cardiac failure after replacement of the autograft 
with a mechanical prosthesis 4 months earlier.  
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Table 2 Operative details 
 Total 
N=123 
Bicuspid 
N= 81 
Tricuspid 
N=42 
 
Type of operation 
Root replacement 
Subcoronary implantation 
Inlay/miniroot 
 
117 
0 
6 
 
80 
0 
1 
 
37 
0 
5 
 
0.02* 
Concomitant procedures1 
None 
Yes 
 
102 
22 
 
67 
15 
 
35 
7 
0.97* 
Mean aortic cross-clamp time 
(SD, range) 
139(32;90-238) 136(29;90-225) 146(37;91-238) 0.1# 
Mean perfusion time  
(SD, range) 
199(70;114-68) 199(77;114-
685) 
200(55;125-
366) 
0.95# 
Hospital death 3 2 1 1.0* 
SD: standard deviation 
*Fisher’s exact test or Chi-square test. # Independent samples test 
1Concomitant procedures were septal extension in 3, myectomy in 3, enucleation of discrete subaortic 
stenosis in 5, reduction plasty of the ascending aorta in 4, graft replacement of the ascending aorta in 
2, coronary surgery in 4 and mitral reconstruction in 1 
 
 
Overall survival at 5 and 10 years was 94% (95%CI 89-98%). Figure 1. 
Endocarditis was diagnosed in 2 patients, in one patient of the autograft after 3.4 
years and in one patient of the allograft after 8.8 years. Both were treated medically. 
 
Figure 1 Cumulative survival after autograft procedure for native aortic valve disease 
 
 
Seven patients required operative reintervention of the autograft, all for structural 
valve failure. Clinically this consisted in progressive root dilatation with regurgitation 
of the autograft valve. Macroscopically no signs of degeneration were observed, in 
particular no stenosis or calcification. Histology of 2 explanted autografts revealed an 
abrupt focal interruption of the elastin skeleton of the media.15 In 4 of these patients a 
mechanical bileaflet aortic valve prosthesis was implanted in the autograft root, 2 
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patients underwent a prosthetic root replacement and in one patient an allograft root 
replacement was done. There were no postoperative catheter interventions on the 
autograft. 
Freedom from autograft reintervention was 97% (95%CI 92-100%) at 5 years 
and 89% (95%CI 80-98%) at 10 years. There were no differences between the 2 
groups, Figure 2. 
 
Figure 2 Freedom from autograft reintervention for bicuspid or tricuspid aortic valve disease 
 
 
 
In the 116 surviving patients 493 echocardiographic studies were performed after 
discharge. Table 3 displays the echocardiographic findings of all 109 patients 
(excluding death and those patients who were reoperated) at last follow up. Of this 
last echocardiographic follow up, adequate information was available for 106 
autografts and 105 allografts.  
In 107 patients (including those who were reoperated or who died during follow up) 
more than one echocardiographic study with information on autograft regurgitation 
was available. Figure 3 displays for each patient the linear regression line that 
reflects the progression of echocardiographic aortic valve regurgitation over time. 
The bold line represents the overall progression of echocardiographic regurgitation of 
the whole autograft group over time, which can also be described by the equation: 
y=0.84+0.114*t 
Four patients required reoperation for allograft failure, all structural. There were no 
postoperative catheter interventions on the allograft. Freedom from allograft 
reintervention was 99% (95%CI 97-100%) at 5 years and 91% (95%CI 82-100%) at 
10 years. Figure 4. There was no difference between the bicuspid valve and tricuspid 
valve group.  
Last echocardiographic follow up was available for 100 autografts and 99 pulmonary 
allografts, Table 3. A right ventricular outflow tract gradient of 30 mmHg or more was 
found in 15 patients.  
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Figure 3 Progression of echocardiographic autograft regurgitation over time 
For each patient the linear regression line that reflects the progression of echocardiographic aortic 
valve regurgitation over time is presented. The bold line represents the overall progression of 
echocardiographic regurgitation of the whole autograft group over time, which can also be described 
as yt= 0.84+0.114*t (yt= regurgitation at time t) 
 
Figure 4 Freedom from allograft reintervention after autograft procedure for native aortic valve disease 
 
Table 3 Echocardiographic findings at last follow up 
(N=109, excluding death and reoperation) 
 Aortic regurgitation Pulmonary regurgitation 
Grade 0-1 63 81 
Grade 2 32 19 
Grade 3 9 3 
Grade 4 2 2 
Missing 3 4 
No gradients were found on the autograft. A right ventricular outflowtract gradient of over 30 mmHg 
was found in 15 patients, of these 7 were over 50 mmHg 
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Discussion 
 
It is well known that the aortic and pulmonary arterial wall differ histologically5,7,9 and 
that the pulmonary arterial wall changes dynamically during life.10 In patients with a 
bicuspid aortic valve the aortic wall is abnormal, with thinner elastic lamellae and a 
greater distance between the elastic lamellae.6 The pulmonary arterial wall may show 
abnormalities in association with bicuspid aortic valve as well.4,5 However, there is no 
conclusive evidence so far that the pulmonary arterial wall in patients with a bicuspid 
aortic valve additionally predisposes to autograft failure.  
Clinical analysis has resulted in a limited number of reports on this subject, in 
part based on selected patients1,2,4 and in part based on other observations than 
consecutive cohort series.3 Nevertheless the advice was put forward to provide 
additional support for the autograft, in particular at the proximal anastomosis and at 
the sinotubular junction of the autograft during surgery.1,2,5 
In our present consecutive series of patients, those with a bicuspid aortic valve 
showed some baseline differences, compared to the patients with a tricuspid aortic 
valve. For instance, they had more prior surgery on the aortic valve, they had more 
prior balloon dilatations on the aortic valve, had a lower male to female ratio, had 
more often aortic stenosis as preoperative diagnosis and had less often an impaired 
left ventricular function. Almost exclusively the root replacement technique was 
applied. However, we found no differences in postoperative events between patients 
with bicuspid and tricuspid aortic valves. Both survival and reoperation rates were 
satisfactory. Our series does not confirm that a bicuspid aortic valve is a risk factor 
for failure after an autograft procedure. Consequently, a bicuspid aortic valve is also 
not an argument for additional surgical measures providing external support of the 
autograft in this selection of patients. However, the incidence of autograft 
regurgitation is certainly a clinical problem, already well known from the series of 
Ross16 and is, at least in part, related to autograft root dilatation.17 Serial 
echocardiography in our series suggests that autograft regurgitation over time is 
progressive (0.114 grade per year).  
In order to provide additional support for the autograft we pay attention to 
insert the autograft as close as possible onto the aortic annulus.13,17 Further follow up 
studies should provide further information on the results of this technique in 
comparison with different methods of autograft support.1,5 The recently described 
methodology of meta-analysis and microsimulation to assess durability of valve 
substitutes is very useful in this regard.12,18 
We conclude that the application of an autograft procedure in patients with a 
bicuspid aortic valve is justified, that bicuspid aortic valve disease is not a 
contraindication for an autograft procedure and that patients with a bicuspid aortic 
valve will meet the limitations of the autograft procedure in the same frequency as 
the overall autograft population. 
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Abstract 
 
Objective 
The association of a bicuspid aortic valve with coarctation of the aorta is well 
recognized. Yet, not much is known about the incidence of clinical problems related 
to a bicuspid valve (aortic stenosis and regurgitation), and the incidence of ascending 
aorta and aortic arch pathology, in combination with coarctation repair. 
 
Patients 
Hundred-twenty-four adult patients after surgical correction of aortic coarctation were 
studied. The incidence of aortic valve, ascending aorta, and aortic arch pathology 
was determined using echocardiography and magnetic resonance imaging. The 
median age at coarctation repair was 9 years, and at last follow-up 28 years.  
 
Results 
Three patients died due to aorta pathology. Aortic valve disease was found in 63% of 
the patients, requiring an intervention in 22%, at a median of 13 years after 
coarctation repair. Ascending aorta dilatation was observed in 28% and aortic arch 
abnormalities in 23%, among whom kinking of the aortic arch was found in 12%. 
Antihypertensive medication was used in 24%. In the patients with hypertension the 
age at operation and age at follow-up were significantly higher (p=0.0011 and 
p<0.0001 respectively). 
 
Conclusion 
In addition to the well-known problems of hypertension and recoarctation, aortic valve 
and aortic arch pathology are commonly encountered in patients with previous 
coarctation repair. Aortic abnormalities may predispose to dilatation and dissection, 
thus necessitating careful life-long attention in all coarctation patients. 
 
 
Introduction 
 
Coarctation of the aorta accounts for 8% of congenital heart disease. In the past, 
coarctation was considered to be a simple “correctable lesion” and surgery, first 
performed in 1944, was believed to be curative. In keeping with this belief, 
normotensive patients were often discharged post-operatively without long-term 
follow-up. However, as increasing numbers of surgically corrected patients reached 
maturity, it has become clear that almost one third of patients become or remain 
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hypertensive, despite correction of their lesion, with an increased risk of accelerated 
atherosclerosis and end organ damage.1 Furthermore recoarctation occurs in 3-
35%.2, 3, 4 
The association of a bicuspid aortic valve with coarctation of the aorta is well 
recognized, but estimates of the coarctation patients having a bicuspid valve range 
from 25 to 85 %.2,5 The clinical significance of a bicuspid valve in coarctation patients 
is not well established.  
To address these issues, we performed a retrospective study of the patients 
after coarctation repair seen in our department for adult congenital heart disease with 
emphasis on both aortic valve and aortic arch pathology. 
The specific purpose of this study is a) to assess the prevalence of aortic 
stenosis or regurgitation in these patients, b) to assess how often dilation of the 
ascending aorta and pathology of the aortic arch occurs in patients with coarctation 
and c) to assess a possible correlation of aortic arch pathology with hypertension or 
recoarctation. 
 
 
Methods 
 
All patients seen in our department for adult congenital heart disease with surgically 
corrected coarctation were reviewed. They were included in the study if at least two 
follow-up echocardiographic studies were available, containing two-dimensional 
imaging of the aortic root in long-axis parasternal views and complete Doppler 
evaluation of the aortic valve. Echocardiograms were performed with the use of 
standard commercially available equipment. A MRI-scan of the thoracic aorta was 
performed.  
Aortic valve morphology was examined by echocardiography in the two 
dimensional parasternal long-axis and short-axis views. The presence in short-axis 
views of only two cusps in systole or diastole, or both identified a bicuspid aortic 
valve. The presence or absence of aortic regurgitation or stenosis was determined 
with use of Doppler and Color Doppler echocardiography. The severity of aortic 
regurgitation was graded as minor, moderate or severe. We report aortic stenosis 
present if the peak velocity over the aortic valve with continuous wave Doppler 
velocity was > 2 m/sec.  
The diameter of the ascending aorta was measured with echocardiography 
and MRI perpendicular to the long axis of the aorta with use of the leading edge 
technique at the level of the sinuses of Valsalva. Dilatation was defined as a diameter 
of 40 mm or more. 
Aortic arch morphology was examined with echocardiography and MRI. 
Abnormalities were categorized as arch hypoplasia, cervical aortic arch or kinking of 
the aortic arch.  
The diagnosis recoarctation was limited to patients who underwent a reintervention 
for recoarctation.  
Hypertension was considered present if medication for hypertension was prescribed. 
Data were analyzed by the Wilcoxon Test or the Fischer’s exact test as 
appropriate. Age and duration of follow-up are given as median values with the 
corresponding 25th and 75th percentiles, or ranges. 
A probability value of p< 0.05 was considered significant. 
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Results 
 
Of the 149 adult patients who undergone surgery for coarctation and follow up at our 
department, 25 had inadequate echocardiograms. The baseline characteristics did 
not differ between the patients with and without adequate echocardiograms. 
Hundred-twenty-four patients (71 males and 53 females) had adequate 
echocardiograms, and are included in this report. They had been operated on by 
several techniques: resection and end-to-end-anastomosis (91), subclavian flap  (14) 
and graft plasty (10). In nine patients the surgical technique was not described in 
detail. Associated intracardiac anomalies were recorded at the time of surgery in 67 
patients (54%) (Table 1). The median age at coarctation repair was 9 years (range 4-
16 years). The time from surgery until last follow-up was 18 years (range 13-25 
years). The median age at last follow-up was 28 years (range 20-36 years). During 
follow-up in the department for adult congenital heart disease 3 cardiac deaths 
occurred: 1 from acute ascending aorta dissection 14 years after coarctation repair, 1 
during aortic arch surgery 20 years after coarctation repair, and the third patient from 
aortic valve endocarditis, with massive acute aortic regurgitation, 18 years after 
coarctation repair. 
 
Table 1 Associated heart in defects in 124 patients with aortic coarctation 
Associated defects Number 
Ventricular septal defect 18 (15%) 
Persistent arterial duct 16 (13%) 
Atrial septal defect 4   (3%) 
Abnormal mitral valve 4   (3%) 
Transposition of the great arteries 3   (2%) 
Dextrocardia 1   (1%) 
 
 
Aortic valve disease 
Forty-eight patients had a bicuspid aortic valve, 30 patients had a trileaflet valve and 
in 46 patients it was difficult to differentiate between a bicuspid and a trileaflet valve, 
thus a bicuspid valve was found in 62% (48 out of 78 patients). During follow up, 
aortic valve intervention was performed in 27 patients (22%), 16 for aortic stenosis, 8 
for regurgitation and 3 for combined stenosis and regurgitation. Surgery was 
performed in 25 patients, while two underwent balloon dilatation of a stenotic aortic 
valve. Figure 1 shows survival free of aortic valve intervention after coarctation repair. 
In the 97 patients without aortic valve intervention, 23 patients had aortic stenosis, 
and 28 had aortic regurgitation (mild in 18, moderate in 5 and severe in 5 patients). In 
total aortic valve disease was observed in 63% of our patients. Of the patients with a 
bicuspid valve this percentage was as high as 70%. Several factors have been 
suggested to be related with the development of aortic regurgitation particularly 
hypertension, recoarctation, dilatation of the ascending aorta and aortic arch 
pathology.6, 7 However, none of these factors were significantly correlated with aortic 
regurgitation in our series. 
 
Aorta pathology 
In 60 patients (48%) we found aorta pathology. Dilatation of the ascending aorta was 
found in 35 patients (28%). This was particularly prominent in patients with a bicuspid 
valve (Figure 2).  
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In 28 patients aortic arch pathology was established (23%). Of these, hypoplasia of 
the arch was found in 10 patients, 4 showed a cervical aortic arch, 8 had severe 
kinking of the aorta and 8 showed both kinking and a cervical arch. 
 
Figure 1 Survival free of aortic disease 
 
Figure 2 Dilatation of the ascending aorta in relation to the aortic valve morphology 
 
 
 
Recoarctation 
In 28 patients (23%) recoarctation occurred, treated with surgery in 10 and with 
balloon dilation in 18 patients after a median interval of 16 years since the initial 
repair. Figure 3 shows the age at first repair in relation with the need for second 
intervention. Patients operated at younger age more often needed a re-intervention 
for coarctation.  
To assess the effect of recoarctation repair on the severity of aortic 
regurgitation we reviewed  the 6 patients with moderate to severe aortic regurgitation, 
who underwent an intervention for recoarctation. Regurgitation remained unchanged 
in four patients, increased in one, and decreased in one patient. 
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Figure 3 Age at operation in relation to recoarctation 
 
 
 
Hypertension 
Of the 124 patients, 30 (24%) used medication for hypertension at the last outpatient 
visit. Characteristics of patients with and without hypertension are shown in Table 2. 
In the patients with hypertension the age at operation was significantly higher than in 
patients without hypertension: 13 versus 6 years (p= 0.0001). Also the age at follow-
up was higher in the patients with hypertension: 38 versus 24 years (p< 0.0001)  
 
 
 
Table 2 Differences between patients with and without hypertension 
 number of patients patients with hypertension p Value 
Number 124 30 (24%)  
    
Type of surgery (%)    
-end-to-end 91 19 (20%) 0.2220 
-other 33 10 (31%)  
Recoarctation repair (%)    
-yes 28 10 (36%) 0.1350 
-no 96 20 (21%)  
Kinking aortic arch (%)    
-yes 16 6 (38%) 0.2163 
-no 108 24 (22%)  
Cervical aortic arch (%)    
-yes 12 3 (25%) 1.0000 
-no 112 27 (24%)  
Hypoplasia aortic arch (%)    
-yes 10 3 (30%) 0.7047 
-no 114 27 (24%)  
Dilatation ascending aorta (%)    
-yes 35 11 (31%) 0.2553 
-no 89 19 (21%)  
Aortic regurgitation (%)    
-yes 39 11 (28%) 0.636 
-no   85 20 (23%)  
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Discussion 
 
In this series of patients after coarctation repair disease of the aortic valve and /or 
aortic arch were observed frequently. 
Aortic valve disease was found in 63% of the patients 19 years after coarctation 
repair, of whom a third needed aortic valve intervention at a median of 13 years after 
coarctation repair. Thus, aortic valve problems is a frequent cause of morbidity and 
mortality of coarctation patients. The association of aortic valve disease and 
coarctation is mentioned in different reports.5,7,8 However, the incidence of aortic 
valve problems after coarctation repair found in our study, is surprisingly high, 
necessitating careful life-long follow-up of all coarctation patients. 
A bicuspid aortic valve was found in 62% of our coarctation patients, which is 
in line with other reports.2,5 However, the incidence of aortic valve pathology is higher 
than in studies of bicuspid aortic valves without coarctation, which emphasizes the 
additional role of the coarctation in the development of the aortic valve 
problems.9,10,11,12 It is likely that hypertension is a cause of the increased incidence of 
aortic valve problems. Furthermore, the remaining gradient over the coarctation 
region causing more stress on the aortic valve and aortic wall, resulting in aortic 
valve disease.  
Nevertheless, we could not demonstrate any influence of repairing the recoarctation 
on the degree of aortic regurgitation. 
Dilation of the ascending aorta was found in 28% of the patients. One study 
has shown a high incidence of ascending aorta dissection in patients with coarctation 
and bicuspid aortic valve, probably due to dilation of the ascending aorta in 
combination with persistent hypertension while others suggest that disease of the 
aortic valve and the aorta itself reflect an intrinsic abnormality of the media, possibly 
cystic medial necrosis. 6,10,13,14,15 We did not find a significant correlation between 
dilation of the ascending aorta and hypertension. However, we lost one patient due to 
dissection, who indeed had a bicuspid aortic valve and a dilated ascending aorta in 
combination with hypertension. Further study is necessary to determine what 
features or combination of features are most important risk factors for aortic 
dissection in these patients. Whether prophylactic surgery of the dilated ascending 
aorta is indicated in these patients can not be concluded from our data, but a more 
aggressive approach seems appropriate, especially if we take into account other 
reports of ascending aorta dissection and substantial late mortality in coarctation 
patients.10,12,16 
Aortic arch pathology, other then ascending aorta dilatation, was present in 23 
% of our patients. Not only arch hypoplasia, but also a cervical aortic arch and a 
striking number of patients with kinking of the aortic arch were found. These 
abnormalities of the arch may play an additional role in the development of 
hypertension and valve disease in these patients. Patients with kinking of the aortic 
arch more often were hypertensive than patients without kinking (38% versus 22%), 
although, due to the small numbers, we could not prove a significant difference 
(p=0.22). Kinking of the aortic arch has not been reported frequently, possibly 
because identification of this pathology was difficult, before the era of high quality 
echocardiography and magnetic resonance imaging. In nearly half of the patients we 
found some form of pathology of the ascending aorta or aortic arch, apart from the 
coarctation, suggesting that indeed this is in fact a disease of all parts of the thoracic 
aorta. 
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Hypertension 
In our study 24 % of the patients used medication for hypertension, comparable with 
other studies.17-19 We confirmed the clear relation of hypertension with age at 
operation and age at follow-up, but did not found a correlation between hypertension 
and the incidence of aortic regurgitation.20,21 
 
Study limitations 
The incidence of aortic valve and aortic arch pathology may be slightly overestimated 
due to patient selection, because a complete cohort of operated patients was not 
described. However we followed the majority of patients after their operation in our 
center. In comparison with other coarctation cohorts, our patients had fewer 
associated heart defects, which is compatible with less selection of more complex 
coarctation patients.22 It is more appropriate to assume that the high quality of 
diagnostic tools give better insight in the real incidence of this pathology. 
 
 
Conclusion 
 
In addition to the well-known problems of hypertension and recoarctation, aortic valve 
and aortic arch pathology are commonly encountered in patients with previous 
coarctation repair. Aortic abnormalities may predispose to dilatation and dissection, 
thus necessitating careful life-long attention in all coarctation patients. 
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Abstract 
 
The first successful Fontan operation was performed in 1971, and the first cohort of 
Fontan patients is reaching adulthood with unclear outcome of this palliative 
procedure. We studied the mortality, morbidity and also the quality of life of our adult 
Fontan patients.  
We examined all patients (n=36), who underwent a Fontan procedure and were seen 
in our adult outpatient clinic by using electrocardiography, exercise testing and 
echocardiography. Quality of life was assessed by the Short Form 36 questionnaire.  
The mean follow-up period was 15 years (range 0 – 23 years). Of the initial 36 
patients, 10 died (28%) at a mean of 10 years (range 0 – 21 years) after Fontan 
operation and one patient underwent cardiac transplantation. Reoperations were 
performed in 21 patients (58%) and the most common reason was revision of the 
Fontan connection. Sustained supraventricular tachycardia was observed in 20 
patients (56%) with an increased incidence of arrhythmias with longer follow-up. 
Thromboembolic events were detected in 9 patients (25%), 5 of whom had adequate 
anticoagulant levels at the time of event. The tromboembolic event was fatal for 3 
patients. A total of 195 hospital admissions (mean 3.8 ± 2.7 per patient (range 1 – 
13)) was recorded. Quality of life assessment showed physical functioning, mental 
health and general health perception to be significantly lower for Fontan patients than 
for the normal Dutch population.  
Thus, we found high mortality and very high morbidity in adult patients after the 
Fontan operation. In particular, reoperations, arrhythmias, and thromboembolic 
events compromise quality of life. 
 
 
Introduction 
 
Since Fontan and Baudet`s report of the first successful right-side cardiac bypass 
directing the entire systemic venous blood flow to the pulmonary arteries in a patient 
with tricuspid atresia, many modifications of this approach have been applied to all 
forms of functional univentricular heart disease. During the past 2 decades, several 
modifications of this operation and advances in management after surgery have 
improved surgical results.1,2 Unfortunately, late deterioration in functional capacity is 
described with longer duration of follow-up.3 As hospital mortality has decreased 
substantially, late mortality and especially, late morbidity are of great interest.4-6 The 
occurrence of late complications such as atrial arrhythmias, ventricular failure, 
Chapter XI 
132 
protein-losing enteropathy and thromboembolic events are increasingly recognised.7-
9
 No reports are available concerning quality of life in adult patients with a Fontan 
circulation. 
We evaluated the clinical course of adult Fontan patients, and assessed their quality 
of life.  
 
 
Methods 
 
Patients 
All adult patients who underwent a Fontan procedure and are regularly attended the 
outpatient clinic of the Thoraxcenter at the Erasmus Medical Center were included in 
this study. In 1978, the first Fontan operation was performed in our institute. We 
studied the long-term follow-up from Fontan operation until last follow-up or death. In 
2002, a cross-sectional study of surviving patients was undertaken. All medical and 
surgical records of the patients were reviewed for reoperations, arrhythmias, 
hospitalization and thromboembolic events. The cross-sectional evaluation consisted 
of physical examination, electrocardiography, exercise testing, and 
echocardiography. Quality of life was assessed with the Short Form 36 (SF-36) 
questionnaire. 
 
Arrhythmias 
The presence of an arrhythmia on any recording device was sufficient to code a 
patient for that rhythm disturbance, excluding arrhythmias related to cardiac 
catheterisation or the postoperative period. Supraventricular arrhythmia included any 
sustained episode of atrial flutter, atrial fibrillation or atrial tachycardia occurring at 
least 30 days after the Fontan operation.  
 
Exercise capacity 
Maximal exercise capacity was assessed by bicycle ergometry with stepwise 
increments of 10 Watts per minute for workload and compared with standardized 
data based on age, gender and height. 
 
Echocardiography 
Two-dimensional echocardiography with color Doppler, velocity profiles and M-mode 
recordings were performed. The Fontan connection was evaluated for obstruction in 
the conduit. Systemic ventricular function was judged by visual estimation of the 
echocardiographic images and graded as normal, mild, moderate or severe 
dysfunction. 
 
Quality of life 
A detailed health status questionnaire (SF-36) assessed physical functioning, general 
health, mental health, role limitations caused by physical health problems, energy 
and vitality, role limitations caused by emotional problems, social functioning, and 
bodily pain. For each of these health concepts, scores ranged from 0 to 100, with a 
higher score indicates a better health state.10,11 The SF-36 has acceptable internal 
consistency and test-retest reliability.12 
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Statistical analysis 
Data are presented as the mean value (SD) unless otherwise stated. The median 
value and range are presented if data were not normally distributed.  
 
 
Results  
 
Patients 
Thirty-six adult patients with a Fontan procedure, were seen in the outpatient clinic 
and included in the study. There were 18 men. Mean age at the time of Fontan 
operation was 12 years (range 2-34 years). Twenty-nine patients were operated in 
childhood and reached adulthood, and 7 patients underwent the Fontan operation at 
adult age. The primary cardiac malformation was tricuspid atresia in 21 patients 
(58%), double-inlet left ventricle in 9 patients (25%) and other complex congenital 
cardiac anomalies amenable to a modified Fontan operation in 6 patients (17%). 
Twenty-eight patients (78%) had >1 palliation procedures before the Fontan 
operation. The surgical technique used for the Fontan procedure was an 
anastomosis between right atrium and pulmonary artery in 20 patients (56%), an 
atrioventricular connection through a conduit to a rudimentary right ventricle in 12 
patients (33%), and a lateral tunnel variant of total cavopulmonary connection in 4 
patients (11%). 
 
Mortality 
Of the initial 36 patients, 10 died (28%) during follow-up and one patient underwent 
cardiac transplantation. One patient who underwent a Fontan operation in adulthood, 
died soon after surgery. Four patients died sudden 1, 8, 13 and 14 years after Fontan 
operation (Figure 1). Three patients died from pulmonary emboli and 2 from severe 
heart failure. The mean follow-up period of all patients after Fontan operation was 15 
years (range 0 – 23 years). Two patients were lost to follow-up 12 and 15 years after 
Fontan operation. 
 
Morbidity 
Event-free survival 10 years and 15 years after the Fontan operation was 
respectively 48% and 16% (Figure 2). Twenty-one patients (58%) needed >1 
reoperations. Thirty-nine cardiac reoperations were performed, consisting of 47 
procedures. The most common reoperations were a revision of the atrioventricular 
connection through a conduit to a rudimentary right ventricle conduit due to 
obstruction (n = 9), pacemaker insertion (n = 7) and conversion of the modified 
Fontan circulation to a total cavopulmonary connection (n = 9). Eight patients (22%) 
needed epicardial pacemaker implantation for sinus node dysfunction (n = 5), 
surgical related atrioventricular block (n = 2) and atrial flutter with coexisting sinus 
node dysfunction (n = 1).  
In 20 patients (56%) a sustained supraventricular tachycardia was present. All 
20 patients received antiarrhythmic therapy. The first episode of atrial tachycardia 
occurred at ± 5 years (0 -19 years) after Fontan operation. Figure 2 shows the 
incidence of arrhythmia during follow-up. Amiodarone given in 8 patients (47%), was 
the most effective drugs for reducing frequency and duration of the supraventricular 
tachycardia, with an interval of 1.4 years free of arrhythmias. Electrical cardioversion 
was performed in 14 patients. Two patients underwent catheter ablation of 
supraventricular arrhythmias, which was successful in 1 patient. All 4 patients with 
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primary total cavopulmonary connection developed severe atrial tachycardia and 2 
died due to arrhythmias.  
 
Figure 1 From Fontan operation until last follow-up or death 
Time development from age at Fontan operation until last follow-up or death. † is death and HTx is 
cardiac transplantation 
 
 
Figure 2 Incidence of arrhythmia during follow-up 
This figure shows the event-free survival for all cause mortality and morbidity, including reoperations, 
hospitalizations, arrhythmias and thromboembolic events. There is a separated curve for the incidence 
of arrhythmias after Fontan operation 
 
As presented in Table 1, mortality and morbidity due to reoperations (70%) 
and hospitalization occurred more frequently in patients with sustained atrial 
arrhythmias. In addition, ventricular dysfunction (60%) and severe atrioventricular 
regurgitation (25%) was more evident in patients with arrhytmias. After the onset of 
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the arrhythmia, a new thrombus in the right atrium was found in 2 patients and 
pulmonary embolism was suspected in 2 additional patients. The 4 late sudden 
deaths in this series were assumed to be arrhythmogenic. Two patients had 
documented ventricular tachycardia and 1 of these patients had severe heart failure 
while waiting for cardiac transplantation. Electrocardiograms at last contact in 23 
patients showed 14 (61%) with sinus rhythm, 7 patients with low atrial rhythm and 2 
with registered pacemaker activity. 
 
Table 1 Multivariables for patients with and without arrhythmias 
 No arrhythmias (n = 16) Arrhythmias (n = 20)  
Morphology   
Tricuspid atresia 10 (62%) 11 (55%) 
Double-inlet left ventricle   3 (19%)   6 (30%) 
Others   3 (19%)   3 (15%) 
Primary Fontan procedure (connection) 
Right atrium–pulmonary artery 10 (62%) 10 (50%) 
Right atrium-right ventricle   6 (38%)   6 (30%) 
Total cavopulmonary connection   0   4 (20%) 
Mean age Fontan operation 10 ± 9,5 14 ± 9,8 
Deaths   3 (19%)   7 (35%) 
Reoperations   7 (44%) 14 (70%) 
Number of hospitalization (mean)   3,4   7,1 
Ventricular function    
Good 11 (69%)   8 (40%) 
Moderate dysfunction   5 (31%)   9 (45%) 
Severe dysfunction   0   3 (15%) 
AV regurgitation   
None    8 (50%) 11 (55%) 
Grade I/II   7 (44%)   4 (20%) 
Grade III/IV   1 (6%)   5 (25%) 
 
 
Thromboembolic events were detected in 9 patients (25%) 5 of whom had adequate 
anticoagulants levels at the time of event. Abnormal coagulation factor, in particularly 
the procoagulation factor protein C was found in 6 patients (17%) and one patient 
was diagnosed with a deficiency Factor VII. Three (43%) of the 7 patients with 
abnormal coagulation factor had a thromboembolic event. Two patients had 
thrombotic obstruction of the Fontan conduit and needed reoperation. Four patients 
developed pulmonary emboli, 3 of whom died and 1 had a femoral artery thrombosis. 
Two patients had a cerebral accident with moderate to severe cerebral damage. 
Protein-losing enteropathy was not reported in our cohort. All patients needed at 
least 1 hospitalization after Fontan operation. A total of 195 hospital admissions 
(mean 3.8 ± 2.7 (range 1 to 13)) was recorded. Mean duration of the hospital stay 
was 9 days ± 11 (range 1 to 101 days). The most common reason for hospitalisation 
was an arrhythmia.  
New York Heart Association classification before the operation showed 32 of the 
patients (89%) in class III or VI. After the Fontan operation, classification indicated 
more patients in class II or III; however, with longer duration of follow-up, 
classification indicated most patients in class III (Figure 3).  
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Figure 3 NYHA classification pre- and post Fontan operation 
With longer duration of follow-up after Fontan operation functional class is declining 
 
In 2002, a cross-sectional study of the 23 surviving patients was undertaken. 
Exercise capacity was tested in 14 patients (58%). The total work performed was 
61%  ± 11% of the predicted exercise tolerance. Maximal heart rate during exercise 
was 145 ± 23 beats per minute. Systemic arterial blood pressures showed minimal 
increase during exercise, with a mean pressure increase of 26 ± 11 mmHg.  
Echocardiographic assessment showed 14 patients (61%) with good systemic 
ventricular function and 9 patients (38%) with moderate to severe dysfunction of the 
systemic ventricle. Dilatation of the systemic ventricle was present in 6 patients (25 
%). AV valve regurgitation was seen in 13 patients (57%), and was moderate to 
severe in 4. The right atrium for most patients was markedly dilated, with pronounced 
echogenicity of low blood flow.  
 
Medication 
Twenty-one patients (96%) were receiving anticoagulant therapy. Thirteen of the 23 
patients used other cardiac medication, with amiodarone and diuretics being the 
most common (Table 2). 
 
Table 2 Present medications of the 23 surviving patients after Fontan operation 
Medication  Number (%) 
Anticoagulants Coumarin 21 (91%) 
 Antiplatelet drugs   1 (4%) 
 None, on own request   1 (4%) 
Antiarrhythmic drugs  15 (65%) 
Diuretics    4 (17%) 
ACE inhibitors    2 (9%) 
 
 
Quality of life:  
The questionnaire was completed by 22 patients (96%). Due to language barrier, 1 
patient did not complete the questionnaire. The SF-36 dimensions of physical 
functioning, mental health, and general health perception were significantly lower for 
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patients with a Fontan circulation than for the normal Dutch population (Table 3). For 
social functioning, vitality and bodily pain, the patients did not differ from the general 
population. Fifteen patients (65%) were fully employed. Three unemployed because 
of their cardiac problems. None of our patients had children. 
 
Table 3 Quality of life based on the SF-36 results compared with population normative data 
N = 22 Fontan patients General population P-value 
1. Physical functioning 80.2 (14.5) 93.1 (11.8) < 0.0001 
2.Role – physical 61.9 (40.0) 86.4 (27.6) < 0.0001 
3.Role – emotional 79.4 (34) 85.4 (30.0) 0.4 
4. Social functioning 77.6 (26.7) 87.8 (19.1) 0.02 
5. Mental health 54.5 (22.6) 78.7 (15.2) < 0.0001 
6. Energy/vitality 68.8 (21.2) 70.7 (16.4) 0.6 
7. Pain 79.1 (23.8) 80.9 (19.4) 0.9 
8. General health perception 56.7 (21.6) 78.2 (17.3) < 0.0001 
 
 
Discussion  
 
This study showed a surprisingly high mortality in rate young adults and a high 
morbidity rate after the Fontan operation. Arrhythmias, reoperations and 
thromboembolic events often occurred and all patients had >1 hospital admission 
during follow-up. 
 
Mortality 
A possible risk factor for late mortality is surgery at older age.13,14 In our patients who 
underwent the Fontan operation at adult age, the mortality was as high as 57%. 
Three of our patients died suddenly late after Fontan operation, suggesting 
arrhythmia to play a major role. 
 
Morbidity 
Arrhythmias comprised the most common reason for hospital admission. 
Our data showed that the prevalence of atrial arrhythmias increased with 
longer interval after the Fontan operation. A correlation has been found between 
arrhythmias and reoperations. 15,16 In patients with arrhythmias, moderate to severe 
ventricular dysfunction was common (60%) and arrhythmias have been associated 
with right atrial thrombus. The high mortality and morbidity rates associated with 
arrhythmias make aggressive treatment necessary and it is urgent to convert these 
patients to sinus rhythm. The hemodynamic situation and the incidence of 
arrhythmias seem closely correlated, therefore, if new arrhythmias occur, a thorough 
evaluation of the total Fontan connection is clearly indicated because arrhythmias 
can be the first sign of hemodynamic deterioration. Amiodarone was found to be the 
most effective antiarrhythmic drug in our study. Electrophysiologically guided ablation 
of an arrhythmogenic substrate has become more successful in morphological 
abnormal hearts and must be considered when pharmacological therapy is 
insufficient and to avoid lifelong side effects of antiarrhythmic medication.  
Thromboembolic events after Fontan operation are a common and serious 
problem. In this study, the incidence of thromboembolic events during long-term 
follow-up was 25%, which is higher than in other recent studies reporting an 
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incidence of 10% to 20%. After a thromboembolic event we found a mortality rate of 
38%, which is higher than the 25% reported in the literature.8,17 Presumable, adult 
Fontan patients have more severe ventricular dysfunction and therefore cannot cope 
with the extra hemodynamic burden. Despite the documented frequency and clinical 
effect of thromboembolic complications, no consensus has been found in the 
literature regarding anticoagulant therapy, methods (ie, Coumadin vs anti-platelet 
agents), or duration of therapy. Coumadin is the most effective prophylactic therapy 
in preventing thromboembolism. Therefore, our regime is to put all patients on 
lifelong anticoagulant therapy (internation normalized ratio 2,0 to 3,5). Nevertheless, 
we found a high incidence of thromboembolic events, and more than 50% with 
adequate levels of anticoagulation. Even higher levels of anticoagulant therapy 
(internation normalized ratio 3,5 to 4,5) or additional antiplatelet drugs may be 
necessary in this population. 
Despite the abnormal hemodynamic situation, clinicians are frequently 
impressed by the ability of most patients to lead a nearly normal life. In our study, we 
found the fast majority to be in New York Heart Assosiation class I or II after 10 years 
of follow-up, but with time there is a progressive decline in functional status.3,6,18 
Maximal exercise in any patient after Fontan repair is subnormal or, at best, reaches 
the lower limit of normal. In our adult population, the maximal exercise tolerance was 
only 61% of the predicted value. In addition, the systemic arterial blood pressure did 
not increase during exercise. This is a known feature of the Fontan circulation, 
because it lacks the possibility to significantly accelerate blood flow during exercise.3 
The only mechanism to establish a greater output during exercise, is increasing the 
heart rate. We found an adequate increase of heart rate during exercise. 
 
Quality of life 
There have been several studies on the intellectual, social and emotional 
development of children and adolescents with congenital heart disease, but no study 
has been performed in adults after the Fontan operation.19-21 Our study showed a 
significantly lower score for physical functioning, mental health and general health 
perception compared to the normal Dutch population. Hospital mortality has been 
reduced and many Fontan patients reach adulthood but at the expense of repeated 
hospital admissions and surgical procedures. The psychological impact of these 
repeated procedures must be considered, and is very important in adolescence and 
young adulthood. Social isolation and mental health impairment may be the result of 
physical incapacity, restricted leisure time activities or parental overprotectiveness.22 
In addition, patients are usually aware of the potential reduction in their life 
expectancy and physical capabilities. To enhance the patient’s long-term quality of 
life, psychological aspects must be taken into account. An understanding by health 
professionals of the subjective experiences and dilemmas in these patients is 
necessary and improvement in care may be gained by offering professional 
psychological or emotional guidance. 
 
Study limitations 
Although long-term follow-up information was available for the large majority of 
patients, the incidence of transient arrhythmias and thromboembolic complications 
may not be complete, because we attended to only clinically relevant events. If so, 
the numbers of complications are underestimated, resulting in even higher morbidity-
rates. A profound bias with a retrospective study can occur, firstly when patients are 
accepted for Fontan operation and secondly by survival from the operation. 
Outcome in adult patients after the Fontan operation 
139 
Therefore, evaluation of this heterogeneous group for long-term consequences of a 
Fontan circulation has severe limitations. 
 
 
Conclusion 
 
We found a high mortality and impressive morbidity in adult patients after Fontan 
operation with recurrent hospitalizations, arrhythmia, reoperations and 
thromboembolic events. Adequate anticoagulant therapy is important in all adult 
patients. Since a longer life does not necessarily mean a better life, knowledge of the 
emotional response to health status problems is obliged and psychological aspects 
must be taken into account. The heterogeneity of the patients and their fragile 
hemodynamic situation demands individualized strategies for management and long-
term follow-up in specialized centers for adult congenital heart disease is strongly 
recommended. 
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Abstract 
 
Background 
Since knowledge about the psychosocial function of adult patients with congenital 
heart disease is limited, we compared biographical characteristics, and emotional 
and social functioning of these patients with that of the reference groups.  
 
Methods and results 
Patients with congenital heart disease (N=362, aged 20–46 years), belonging to five 
diagnostic groups, were subjected to extensive medical and psychological 
examination, 20–33 years after their first open heart surgery. All the patients were 
seen by the same psychologist, who examined their psychosocial functioning using a 
structured interview and questionnaires. The majority (78%)was living independently 
and showed favourable outcome regarding the marital status. Among 
married/cohabitant patients, 25–39-year-olds showed normal offspring rates. None of 
the 20–24-year-old patients had any children. The offspring rate dropped after the 
age of 40. The proportion of adult patients with a history of special education was 
high (27%). Accordingly, patients showed lower educational and occupational levels 
compared to reference groups. As regard to the emotional and social functioning 
(leisure-time activities), the sample showed favourable results.  
 
Conclusions 
Overall, this sample of patients with congenital heart disease seemed capable of 
leading normal lives and seemed motivated to make good use of their abilities.  
 
 
Introduction 
 
With the improvement of surgical techniques over the last decades, increasing 
survival rates of patients with congenital heart disease are resulting in a new and 
growing patient population: adults with operated congenital heart disease. Medical 
professionals not only encounter specific medical needs of these patients, but also 
deal with unique psychosocial characteristics of adults with congenital heart disease. 
So far, however, little is known about the specific psychosocial problems of these 
patients when they enter adulthood, or the extent to which they succeed in having a 
normal life. This might impede medical professionals in tailoring treatment to the 
specific needs of the adult patients with congenital heart disease, since these 
patients differ in many aspects from the well-known adult population with acquired 
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cardiac diseases. The purpose of this study was to provide a clear and solid view on 
the biographical characteristics and current emotional and social functioning of the 
adults with congenital heart disease.  
Both positive and negative outcomes have been documented regarding the 
educational and occupational functioning,1-6 living conditions, marital status and 
offspring 3,4,5,6 and emotional and social functioning.1,2,5,6 Deriving a complete picture 
of the adult patient with congenital heart disease from the existing studies is 
hampered by several factors, including small sample size, heterogeneous sample 
composition with regard to the type of congenital heart disease, different age 
ranges,low-response rate, non-standardised assessment procedures and variation in 
methods across various studies.  
This study is part of a multidisciplinary cohort study of the patients with 
congenital heart disease, 20–33 years after their first heart surgery. This work 
concerns the second follow-up of the cohort and offers the unique possibility to study 
its current psychosocial functioning with a larger sample size and age range in 
adulthood compared to the previous works. It has been suggested that patients rate 
the negative impact of the congenital heart disease on their functioning as more 
serious as they grow older.6 However, very little information is available about how 
these patients function later in adulthood.  
Therefore, the aims of the present study were: (1) to compare the biographical 
characteristics and emotional and social functioning of adults with operated 
congenital heart disease with that of reference groups; (2) to determine the 
relationship between cardiac diagnosis and the biographical characteristics and 
emotional and social functioning of the patients; and (3) to determine the effects of 
sex and age on biographical characteristics and on emotional and social functioning.  
 
 
Methods 
 
Inclusion criteria 
During the first follow-up of this study, which took place between 1989 and 1991, all 
consecutive patients who underwent their first open heart surgery for congenital heart 
disease between 1968 and 1980 in the Erasmus MC, and who were younger than 15 
years at the time of surgery, were eligible. This population is described in detail 
elsewhere.5 
The target population of the second follow-up (2000–2001) consisted of 498 
patients of the first follow-up. From the 498 patients, we excluded: 11 deceased 
patients (one with atrial septal defect, four with ventricular septal defect, two with 
tetralogy of Fallot, two with transposition of the great arteries and two with pulmonary 
stenosis), 26 untraceable patients and one patient who had undergone heart 
transplantation; 61 patients were also excluded because they belonged to a 
miscellaneous diagnostic group, consisting of a small number of patients with a 
variety of congenital heart defects.  
 
Patient sample 
Of the remaining 399 eligible patients, 37 refused to participate. The present patient 
sample consisted of the remaining 362 adult patients (mean age: 30.2 years, age 
range 20–46 years), of which 194 were males and 168 were females. For 
biographical characteristics, data were available for all the patients, but not on all the 
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topics. For emotional functioning, data were missing for 11 patients (eight were 
mentally retarded, one had a linguistic problem, two did not complete the 
questionnaire). For social functioning, data were missing for two persons (one was 
mentally retarded, one did not complete the questionnaire). The total number of 
patients answering each question(naire) are indicated in table 1, table 2, table 3, 
table 4 and table 5. The overall response rate, corrected for deceased patients and 
persons lost to follow-up, was 90.7%.  
The total number of patients belonging to different diagnostic groups was: atrial 
septal defect (ASD, N=93), ventricular septal defect (VSD, N=97), tetralogy of Fallot 
(ToF, N=77), transposition of the great arteries (TGA, N=55) and pulmonary stenosis 
(PS, N=40). The mean ages in these diagnostic groups were 32.8, 29.5, 30.2, 26.0 
and 31.3 years, respectively. Medical history and physical condition of these patients 
at the time of the first follow-up are described elsewhere.7,8,9,10 
For the biographical characteristics and social functioning, recent normative 
data were derived from the Netherlands Central Bureau of Statistics and, wherever 
available, were specified by age and sex.11 These recent reference data were derived 
from a variety of normative samples. Since these concerned very large samples, the 
representativeness for the average Dutch situation was warranted. Sample sizes of 
multiple and very large reference groups were not indicated in table 1, table 2, table 
3, table 4 and table 5 to prevent confusion. For emotional functioning, the reference 
group consisted of 5686 adults (mean age, 34.6 years; age range 15–65 years;2730 
males and 2956 females), derived from an extensive Dutch population study.12 
 
 
Instruments 
 
Biographical characteristics 
A structured interview was designed to assess biographical variables, such as living 
conditions, offspring, education and marital and occupational status. Special 
education included schools for learning-disabled, mentally handicapped and 
chronically ill children.  
 
Emotional functioning 
From the Dutch Personality Questionnaire (DPQ),12 derived from the California 
Psychological Inventory,13 three scales were used, namely hostility (19 items), self-
esteem (19 items) and neuroticism (21 items). Hostility measures the extent of 
criticism, distrust and intolerance towards other people. Self-esteem measures a 
positive attitude towards work, flexibility and being energetic and self-controlled. 
Neuroticism measures feelings of stress, depression, instability and insecurity. The 
response possibilities of the DPQ are: YES = 2, do not KNOW = 1, and NO = 0. A 
high score of self-esteem indicates a high self-esteem. On the other scales, the 
higher the scores, the poorer the social adjustment. The internal consistency, stability 
and validity of the DPQ can be considered favourable.12, 14 The psychometric 
qualities of the DPQ are describedelsewhere in more detail.5 
 
Social functioning 
Leisure-time activities were assessed with standardised items derived from the 
Netherlands Central Bureau of Statistics.15,16 
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Assessment procedure 
During their visit to the Erasmus Medical Centre, patients were interviewed and 
tested by a psychologist (EvR) and medically examined by a cardiologist. For 
patients with low intellectual functioning, the question(naire)s were verbally 
administered, if possible. Of the 362 patients, 28 patients preferred to complete the 
questionnaires at home. In these cases, the structured interview was done by 
telephone, except for five patients who refused to have such an interview.  
 
Statistical analyses 
For biographical characteristics, proportions of patients are presented in percentages 
and actual numbers. Levels of significance were calculated only when the patient 
sample was comparable to reference groups with regard to age and gender. In order 
to correct for multiple comparisons, only the differences in biographical 
characteristics with a level of significance lower than 0.01 were considered 
significant. As to the emotional and social functioning, for the both patient sample 
and for the reference groups, 95% confidence intervals (CI) were calculated, 
respectively, around the group means of the DPQ scales and the proportions on 
leisure-time activities. If the 95% CI of the patient sample did not overlap with those 
of the reference group, the differences between the group means or the participating 
proportions were considered significant. Comparisons between diagnostic categories 
were also performed based on 95% CI. Owing to small cell sizes, statistical 
differences between diagnostic categories could not always be proven. For the DPQ, 
Cohen’s Ds 17 were computed to assess the magnitude of differences in mean scores 
between the patient sample and the reference groups. According to Cohen's 
17criteria, a standardised difference of 0.20 can be considered as small, 0.50 as 
medium, and 0.90 as high.  
 
 
Results 
 
Biographical characteristics 
The main biographical characteristics are outlined in Table 1. The majority of the 
patient sample (78%) was living on their own (defined as living independently), while 
a total of 18% was not living independently, but with parents or another caretaker. 
When specified for age and sex categories, the living conditions of the patient sample 
showed high similarities with those of the reference group. The 25–29 year old 
females from the patient sample were living on their own, significantly more often 
compared to the reference group (p<0.01). Patients appeared to be living in (or under 
supervision of) institutions for mentally handicapped significantly more often than the 
reference group (4 vs. 1%; p<0.01), with no significant differences between 
diagnostic categories.  
With respect to the marital status of the patient sample, at least 72% was in 
some sort of relationship at the time of the interview. For persons living 
independently (N=279), no significant differences in marital status were found 
between the patient sample and the reference group.  
Regarding offspring, a total of 34% of the patient sample had one ore more 
child(ren). Among married persons or cohabitants (N=217), none of the 20–24 year 
old patients had any children, in contrast to 14% in the reference group. Within the 
age range of 25–39 years, no significant differences in offspring were found between 
the patient sample and the reference group. The proportion of patients with 
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congenital heart disease with offspring drops after the age of 40. Based on median 
split age groups, no significant differences between the diagnostic categories were 
found. Table 1 shows that 27% of the patient sample had followed some sort of 
special education in the past. Of these patients, 85% attended schools for learning-
disabled or mentally handicapped children and 15% for chronically ill children. The 
proportions of patients with a history of special education were significantly higher in 
the diagnostic categories tetralogy of Fallot (33% (22–44)) and transposition of the 
great arteries (40% (27–53)) than in the atrial septal defect group (13% (6–20)).  
The educational attainments of the patient sample were evaluated excluding 
those living in institutions for mentally handicapped. For the patient sample, the 
highest educational level completed was significantly more often a lower level 
incomparison to the reference group (47 vs. 39%,p<0.01). No significant differences 
in educational attainments were found between the diagnostic categories.  
Regarding the daily activities of the patient sample, at least 85% had a paid 
job (persons on long-term sick leave and working in labour institutions for mentally 
handicapped included), 7% received some sort of social security benefit and 8% 
were either attending school or doing full-time household work. Normative data on 
daily activities were not available. Although no significant differences between 
diagnostic categories were found, social security benefits were received most often in 
the diagnostic categories tetralogy of Fallot and transposition of the great arteries (12 
and 13%, respectively).  
The occupational status of the patient sample is further outlined in Table 2. 
The patient sample appeared to be significantly overrepresented in the lower level 
occupations, and underrepresented in the scientific occupations, compared to the 
reference group. No significant differences in occupational status were found 
between the diagnostic categories. As to the duration of employment, the patient 
sample did not differ from the reference group, nor were there any significant 
differences between diagnostic categories. In the decision to work part-time, the 
congenital heart disease played a role in 21% of the cases. Although no statistical 
differences between diagnostic groups were revealed, the congenital heart disease 
was mentioned as a reason to work part-time most often in the diagnostic categories, 
transposition of the great arteries, pulmonary stenosis and tetralogy of Fallot (40, 36 
and 29%, respectively). Besides specific cardiac problems, weariness was often 
mentioned as another reason. The estimation of the gross income in the patient 
sample exceeded that of the reference group to some extent. The congenital heart 
disease sick-leave percentage was higher than that of the reference group. This was 
not in accordance with their own perception, since the majority of the patient sample 
reported to have a lower sick leave than colleagues. Although no statistical 
differences were revealed, the sick-leave percentage was highest in the diagnostic 
categories, tetralogy of Fallot and transposition of the great arteries (10.7 and 10.1%, 
respectively). The congenital heart disease was mentioned as a reason for sick leave 
in 8% of the cases. Among the diagnostic categories, this was the case most often 
within the category, transposition of the great arteries (18%). The patients' estimation 
of career possibilities seemed favourable and equal for all the diagnostic categories. 
Table 3 provides an overview of the main, more objective, occupational variables for 
the five different diagnostic categories.  
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Table 1 Biographical characteristics of the patient sample 
 ASD 
(%) 
VSD 
(%) 
ToF  
(%) 
TGA 
 (%) 
PS  
(%) 
Total patient 
sample (%) 
 (N=93) (N=97) (N=77) (N=55) (N=40) (N=362) 
Living conditions (N=357)        
With parents   6 18 20 39 10 17 (62) 
On one’s one 92 77 75 57 82 78 (279) 
In institution for mentally 
handicapped 
  2   5   5   4   5   4 (15) 
Other   0   0   0   0   3 <1 (1) 
       
Marital status (N=357)       
No relationship 21 26 25 38 22 26 (93) 
Stable relationship   6 16 12 17   2 11 (39) 
Cohabitant 16 19 24 17 28 20 (71) 
Married 53 35 37 26 48 40 (143) 
Divorced   3   3   1   2   0   2 (8) 
Cohabitant or married after divorce   1   1   1   0   0   1 (3) 
       
Offspring (N=357)       
0 children 54 72 63 85 55 66 (234) 
1 child 12 12 13   9 18 12 (44) 
2 children 24 12 16   4 20 16 (56) 
>3 children 10   4   8   2   7   6 (23) 
       
Former course of education (N=358)       
Special education 13 28 33 40 23 27 (95) 
Regular education 87 72 67 60 77 73 (263) 
       
Educational attainment (N=334)       
Lower 47 43 52 48 43 47 (156) 
Average 31 36 32 31 43 34 (114) 
Higher 22 21 16 21 14 19 (64) 
       
Daily activities (N=362)       
Attending school   2   5   7   9   0   5 (18) 
Job 83 82 73 71 77 78 (282) 
Unemployed   0   0   3   7   0   2 (6) 
Disablement pensiona   1   0   3   4   0   1 (5) 
Volunteer, unpaid worka   2   3   1   2   0   2 (7) 
Long-term sick leave   2   1   0   2   2   1 (5) 
Household   6   1   3   0 10   3 (12) 
Labour institution for mentally 
handicapped  
  4   6   5   5   8   6 (20) 
Activity centre for mentally 
handicappeda 
  0   2   5   0   3   2 (7) 
Abbreviations: ASD, atrial septal defect; VSD, ventricular septal defect; ToF, tetralogy of Fallot; TGA, 
transposition of the great arteries; PS, pulmonary stenosis. Between the parentheses, the actual 
numbers of patients for which data were available are indicated 
aConsidered to receive social security benefiets 
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Table 2 Occupational status of persons with paid work in the patient sample and reference group 
(persons in labour institutions included)  
 Patient sample (N=302) Reference  
group 
P-value 
 % (N) M SD % M  
Occupational level (SBC 1992)a (N=236)b       
Elementary   5 (11)     6  NS 
Lower 34 (79)   22  <0.0001 
Average 39 (93)   41  NS 
Higher 18 (43)   22  NS 
Scientific   4 (10)     9  <0.001 
       
Duration of employment (N=295)       
Full-time (>36 h a week)       
Total 69 (205)   70  NS 
Male 91 (152)   89  NS 
Female 41   (53)   40  NS 
Part-time       
Total 31 (90)   30  NS 
Male   9 (15)   11  NS 
Female 59 (75)   60  NS 
Reason part-time employment       
Unrelated to heart disease 79 (71)      
Heart disease one of several reasons 11 (10)      
Heart disease the only reason 10   (9)      
       
Income (gross salary divided by 1000 Euros) 
(N=220) 
      
Total  25.9 18.7  21.0  
       
Sick leave (from previous year) (N=297)c       
Mean sick-leave percentagesd    7.9 31.3    5.5  
Sick leave according to patients       
Less than colleagues 57 (162)      
Equal to colleagues 30   (86)      
More than colleagues 13   (36)      
Reason sick leave       
Unrelated to heart disease 92 (169)      
Heart disease one of several reasons   4    (7)      
Heart disease the only reason   4    (7)      
       
Perception of career possibilities (N=285)       
Career possibilities according to patients       
Equal to colleagues 92 (262)      
Less than colleagues   8   (23)      
Between parentheses, the actual numbers of patients for which data were available are indicated. 
aStandaard Beroepen Codering 1992 (Standard Occupation Classification), Netherlands Central 
Bureau of Statistics, bOnly persons >25 years were included, persons living in institutions for mentally 
handicapped are excluded, cPersons on long-term sick leave are also included in this section (total 
N=307), dSick-leave percentage was used instead of number of days on sick leave, since the number 
of hours a person works a week (full-time/part-time) might vary considerably 
 
  
Emotional functioning 
On the DPQ, the patient sample obtained significantly more favourable results on 
hostility, self-esteem and neuroticism than the reference group (Table 4). The 
differences in mean scores could all be considered as medium, according to 
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Cohen's17 criteria, except for the effects, for females, on neuroticism, which could be 
considered as small.  
Of the 351 patients who completed the DPQ, 18 patients fulfilled their daily 
activities in either a labour institution or an activity centre for mentally handicapped 
and 25 patients completed it at home (one patient belonged to both of these groups). 
It was assumed that the DPQ reference group did not contain any mentally 
handicapped. Furthermore, possible bias from home-completed questionnaires 
should be excluded. Therefore, DPQ scores for the patient sample, after excluding 
those visiting labour institutions or activity centres for mentally handicapped and 
patients who completed the DPQ at home (DPQ-Excluded), were calculated. The 
results of the DPQ-Excluded group were only slightly different from those of the 
original 351 patient-respondents (Table 3). The DPQ-Excluded group also obtained 
significantly more favourable results on hostility, self-esteem and neuroticism than 
the reference group.7  
 
Table 3 Summary of main variables concerning occupational status for different cardiac diagnostic 
groups  
 ASD  VSD  ToF  TGA  PS  
 % M % M % M % M % M 
Occupational level (SBC 1992)a 
(N=236)b 
          
Elementary   5    6    2    0    7  
Lower 31  35  47  28  19  
Average 42  30  34  48  55  
Higher 18  22  13  19  19  
Scientific    4    7    4    5    0  
           
Duration of employment (N=295)           
Full-time (>36 h a week) 68  68  71  75  68  
Part-time 32  32  29  25  32  
           
Income (gross salary divided by  
1000 Euros) (N=220) 
          
  27.5  25.0  24.4  21.5  32.9 
Sick leave (from previous year) 
(N=297)c 
          
Mean sick-leave Percentaged    6.3    8.5  10.7  10.1    2.6 
Abbreviations: ASD, atrial septal defect; VSD, ventricular septal defect; ToF, tetralogy of Fallot; TGA, 
transposition of the great arteries; PS, pulmonary stenosis 
aStandaard Beroepen Codering 1992 (Standard Occupation Classification), Netherlands Central 
Bureau of Statistics 
bOnly persons >25 years were included, persons living in institutions for mentally handicapped are 
excluded 
cPersons on long-term sick leave are also included in this section (total N=307) 
dSick-leave percentage was used instead of number of days on sick leave, since the number of hours 
a person works a week (full-time/part-0time) might vary considerably 
 
 
Effects of diagnostic category, sex and age on emotional functioning of the patients 
were computed on the DPQ scales. No significant differences were found between 
the diagnostic categories. As for the sex effects, females scored significantly less 
favourable on self-esteem compared to males (females: MEAN = 29.9 (29.0–30.8); 
males: MEAN = 32.0 (31.3–32.7)). Furthermore, in accordance with the reference 
group, females reported significantly more complaints on neuroticism than males 
(females: MEAN = 10.3 (9.2–11.5); males: MEAN = 6.5 (5.6–7.4)). To assess age 
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effects, two categories (20–29 years and 30–46 years), based on the median split of 
the patient sample, were formed. No significant age effect was found.  
Since the number of male vs. female and younger vs. older patients differed across 
the diagnostic categories on all DPQ scales, sex and age effects were next tested 
when adjusted to diagnostic category. For each diagnostic category, 95% CI around 
the mean scores on the DPQ scales of male vs. female, and younger vs. older 
patients were compared. No significant sex or age effects were found.  
 
Social functioning 
Table 5 presents significant differences in participation in leisure-time activities 
between the patient sample and reference group for different age- and sex-based 
groups. For all of these differences, participation was higher in the patient sample 
than in the reference group. Higher participation in leisure-time activities was 
reported for outgoing activities like going to the movies, visiting clubs and discos and 
shopping, as well as for domestic activities like playing games and watching TV.  
When total sport participation (>1 h a week) between the diagnostic categories was 
compared, no significant differences were found. More intensive sport participation 
(>5 h a week), however, was found significantly more often in the diagnostic 
category, ventricular septal defect than in the transposition of the great arteries group 
(19%(11–27) and 4% (0–9), respectively). Apart from the brain-teasers, which were 
performed significantly more often by patients with ventricular septal defect and 
transposition of the great arteries than by the patients with tetralogy of Fallot and 
pulmonary stenosis, no further significant differences, between the diagnostic 
categories, in participation in leisure-time activities were found.  
 
Table 4 Mean scores, 95% CI, standard deviations and Cohen's D on the DPQa for patient sample    
   and reference group and DPQ-EX.b group  
 
DPQa Patient sample (N=351) Reference (N=5686) Cohen’s D 
 M (CI) SD M (CI) SD  
Hostility 14.9(14.1-15.6) 7.2 18.2(18.0-18.4 6.7 0.5 
Self-esteem 31.0(30.5-31.6) 5.3 28.0(27.9-28.1) 5.6 0.5 
Neuroticism      
Malec 6.5(5.6-7.4) 6.3 10.1(10.0-10.2) 7.5 0.5 
Femalec 10.3(9.2-11.5) 7.6 13.9(13.6-14.2) 8.3 0.4 
      
DPQ-EX (N=307)      
Hostility 15.0(14.2-15.8) 7.2   0.5 
Self-esteem 31.2(30.5-31.8) 5.4   0.6 
Neuriticism      
Maled 6.5(5.5-7.4) 6.4   0.5 
Femaled 10.2(8.9-11.4) 7.5   0.4 
aDutch Personality Questionnaire.12 
bDpQ-EX: Dutch Personality Questionnaire – results of patients after exclusion of mailed questionnaire 
data and patients attending either labour institutions or activity centres for mentally handicapped 
cMale: patients N=190, reference N=2730; female: patients N=161, reference N=2956 
dMale: patients N=167, female: patients N=140 
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Discussion 
 
Biographical, emotional and social features of the patient sample 
Overall, living conditions, marital status and offspring of the patient sample in the 
present study showed high similarity with the reference groups. Regarding living 
conditions, Ternestedt et al.6 also found similarities between patients with congenital 
heart disease and a normative sample. Kokkonen and Paavilainen3 and Utens et al,5 
however, did find differences: especially the young patients with congenital heart 
disease were living with their parents more often than reference groups. The higher 
mean age and larger age range in adulthood, in the present patient sample, 
compared to the relative young samples of the previous studies3,5 provide a possible 
explanation for these diverging findings. The previously found arrears in living 
conditions might be equalised later on in adulthood. As to marital status, the results 
of the present study confirm to those of Ternestedt et al,6 but are in contrast with the 
results of Kokkonen and Paavilainen3 and Gersony et al.4 The latter found patients 
with congenital heart disease to be married less often, or get married at a later age 
compared to the reference groups. It should,however, be mentioned that in the 
present study, marital status was scrutinised for a selection of the patient sample, 
namely those already living independently. Offspring was examined only for married 
persons or cohabitants. Furthermore, in this study, both sexes were included, instead 
of only females, which might explain the favourable outcome in offspring in contrast 
to the study of Gersony et al,4 who found elevated childlessness among congenital 
heart disease women. It should be noted that decreased rates of offspring for the 
youngest (20–24 years) and oldest (above 40 years) patients of the sample could not 
be proven significantly different because of empty and small cells.  
In the present study, the proportion of patients with a history of special 
education can be considered as high. For 15% of those the impact of the congenital 
heart disease on their school career (hospitalisation, restrictions) seemed to be the 
main reason for attendance of special education, since they had been in schools for 
chronically ill children. In the remaining 85%, some sort of learning disability or 
mental retardation seemed apparent, considering the type of special education they 
had attended. Additionally, within the patient sample, the highest educational level 
completed was more often a lower level compared to the reference group. Although it 
is well known that congenital heart disease patients encounter different barriers in 
their educational course during childhood, such as absence from school due to 
illness, treatment or recovery18,19 and learning-disabilities,19,20,21 the high number of 
adult patients with congenital heart disease with a history of special education never 
appeared so clearly as in this study. This high attendance of special education in the 
past might have resulted in lower educational attainments in adulthood: a finding, 
which is highly in contrast with the findings of Brandhagen et al.2 and Ternestedt et 
al.,6 who found an even higher educational level in the adults with congenital heart 
disease compared to the normative groups.  
In accordance with the educational attainments, this patient sample had lower 
level of occupations significantly more often than the reference group. The duration 
of employment of the patient sample, however, did not differ from the reference 
group. The gross income of the patient sample seemed somewhat higher than the 
reference group. However, it should be mentioned that most patients could only give 
a rough indication of their income and, owing to social desirability, they might have 
exaggerated their estimations. The sick-leave percentage of the patient sample was 
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higher than that of the reference group, although most patients estimated that their 
sick leave was less than colleagues. This might indicate possible denial. Accordingly, 
patients with congenital heart disease seemed to have a positive perception of 
theircareer possibilities. Overall, it can be stated that, despite a somewhat lower 
occupational level and higher sick leave, the present patient sample showed 
favourable results regarding the duration of employment, income and perception of 
career possibilities. Broadly speaking, this confirms the positive findings of previous 
studies1,3,4 with respect to employment.  
Regarding emotional functioning, Brandhagenet al.2 found an increased level 
of psychological stress in adults with congenital heart disease. Shampaine et al.1 
found both positive and negative emotional outcomes. Ternestedt et al.6 found more 
favourable emotional outcomes in patients with tetralogy of Fallot compared to 
patients with atrial septal defect. The present patient sample showed more 
favourable scores than the reference group on hostility, self-esteem and neuroticism. 
These findings are similar to those of Utens et al.5, who studied the same cohort with 
the same instrument regarding emotional functioning 10 years earlier. In this study,5 it 
was suggested that denial mechanisms and high achievement motivation possibly 
lead congenital heart disease patients to overrate their emotional states. Recently, 
perseverance has been put forward as a coping mechanism in congenital heart 
diseasepatients.6 
Social functioning of the patient sample can be considered favourable. If 
significant differences were found in participation in leisure-time activities, the 
congenital heart disease patients obtained more positive scores than the reference 
group. These overall favourable results on social functioning confirm earlier 
favourable findings.4,5 
 
Effect of cardiac diagnosis 
Regarding biographical characteristics, no significant differences between the 
diagnostic categories were found for living in institutions, having offspring, 
educational attainments, receiving social security benefits, occupational level and 
duration of employment. Regarding social functioning, participation in leisure-time 
activities was highly similar among the different diagnostic categories, except for 
intensive sport participation.  
Overall, it can be stated that individuals within the diagnostic categories transposition 
of the great arteries and tetralogy of Fallot showed some residual effects from the 
congenital heart defect as to participation in education, occupation and intensive 
sport, but further were able to live normal lives. This finding is supported by the fact 
that no significant differences in emotional functioning were found between the 
diagnostic categories.  
 
Effects of sex and age 
As to living conditions, the 25–29-year-old female patients were living on their own 
significantly more often than the reference group. Regarding the offspring, the 
patients seemed to raise families somewhat later, in their 20s, when compared with 
the reference group. Remarkably, there was a drop of patients with offspring after the 
age of 40. This is probably due to a cohort effect since for the eldest of the patient 
sample, the cardiac surgery was not yet available when they were born. Therefore, 
patients were more likely to be operated at an older age and treated with less 
advanced techniques compared to the youngest patients in this sample. Also, they 
were the first congenital heart disease patients to enter adulthood and experience 
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uncertainties regarding having offspring. The impact of the congenital heart disease 
on having offspring may, therefore, be greater for the older patients in the sample, 
compared to the younger ones.  
With respect to emotional functioning, female patients scored significantly less 
favourable on neuroticism (in accordance with the reference group) and self-esteem 
than male patients. This is consistent with previous findings,22 which showed that 
females with congenital heart disease report more somatic complaints than males 
with congenital heart disease.  
 
 
Limitations 
 
It should be noted that the present patient sample contains a selection of five 
frequent diagnostic categories and may, therefore, not be completely representative 
of all the congenital heart disease anomalies. The present patient sample concerns a 
generation of congenital heart disease patients who were treated with different 
techniques than the ones used at present. Since major advances took place in 
surgical techniques and psychosocial needs could have changed, the results of this 
study might not fully apply to young patients with congenital heart disease operated 
upon these days. Biographical characteristics and social functioning of the present 
study's sample might not be directly applicable to other countries and cultures, since 
life styles or aspects, for example, availability ofsocial security or educational 
systems, might differ considerably. Therefore, caution should be taken in 
generalising the psychosocial functioning of patients with congenital heart disease as 
described in this study.  
For biographical variables, normative data were not always available. Some 
biographical variables were only looked at under selected conditions (marital status 
of independently living persons and offspring of cohabitants or married persons). This 
might be attributed to the favourable results on these variables for the patient 
sample. Furthermore, some diagnostic categories had relatively small sample sizes, 
which implied larger 95% CI for these groups. This may have hampered finding 
differences between the diagnostic groups. Taking into account the large amount of 
comparisons that were made in this study, the amount of differences in psychosocial 
functioning between the patient sample and reference group can be considered 
limited. This strengthens the overall positive outcome for this sample of adult patients 
with congenital heart disease on biographical characteristics, and emotional and 
social functioning.  
 
Implications 
The present study shows that this sample of adult patients with congenital heart 
disease has residual problems regarding its educational and occupational status, 
which seems a reflection of disadvantaged positions in childhood as can 
beconcluded from the high attendance of special education in the past. However, 
patients seem to make good use of their abilities as can be concluded from their 
favourable outcomes on duration of employment and income, and their optimistic 
outlook on career possibilities. The diagnostic category transposition of the great 
arteries seems to be hampered by the congenital heart disease most often in their 
employment, since they mentioned it most often as a reason for part-time working or 
sick leave.  
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Taking in consideration further results on biographical characteristics, 
emotional and social functioning, these adult patients seem capable of leading 
normal lives. However, some precaution must be taken into account. Some of these 
positive outcomes, for example regarding sick leave, might be influenced by a 
tendency in these adult patients to give social desirable answers. Whether this 
should be explained by denial of restrictions or a coping strategy to keep an 
optimistic view on their possibilities is unclear. Future research should therefore aim 
at coping strategies in adult congenital heart disease patients, in order to get a better 
understanding of how they experience their abilities. Further, the longitudinal 
development of psychosocial functioning of these patients as well as the influence of 
medical variables (not yet systematically available) should also be the focus of future 
research.  
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Summary 
 
During pregnancy the cardiac output rises with 40-50%. In the first and second 
trimester mainly stroke volume increases, and in the third trimester especially the 
heart rate will increase. 
More women with congenital heart disease reach adulthood and desire to become 
pregnant. The hemodynamic changes during pregnancy are an additional burden for 
them. 
Predictors for occurrence of important cardiac problems during pregnancy are: 
previous cardiac events (heart failure, arrhythmias), lower functional class or 
cyanosis, obstruction in the left side of the heart or diminished systolic function of the 
systemic ventricle. 
Pregnancy is contraindicated in patients with pulmonary hypertension, in Marfan 
syndrome with an ascending aorta diameter of >50mm and in severe mitral or aortic 
stenosis.  
Foetal outcome is dependant on the hemodynamic situation of the mother and the 
medication she is taking. Ace-inhibitors and A-II antagonists are contraindicated 
during pregnancy. Oral anticoagulation therapy is potential harmful in the first 
trimester. 
The recurrence risk for children varies between 3 and 50%, depending on the nature 
of the congenital heart disease. 
 
 
Introduction 
 
In the Netherlands about 1500 children are born every year with congenital heart 
disease. During the last decades mortality has decreased substantially in these 
children and this has resulted in a new patient population: adults with congenital 
heart disease. In the Netherlands it has been estimated that about 25.000 adults with 
congenital heart disease are alive at the moment.1 Pregnancy raises 2 questions: 
concern if pregnancy might have a negative effect on the health of the female patient 
and the risk of congenital heart disease for the offspring. A team should guide these 
patients, consisting of a general practitioner, cardiologist, obstetrician and genetic 
counsellor. 
 
Physiological changes during pregnancy 
 
Almost every woman with congenital heart disease who would like to become 
pregnant realises that pregnancy means an extra burden for her heart. To provide 
proper counselling for these women the hemodynamic burden of pregnancy needs to 
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be analysed, and consequently this needs to be related to the different types of 
(corrected) congenital heart disease. The most important factor of this hemodynamic 
burden is the increase in maternal plasmavolume, which results in an increase in 
cardiac output of 40 to 50% during pregnancy.2 At first mainly stroke volume 
increases and heart rate rises in the second part of pregnancy (Figure1). During the 
first two trimesters of pregnancy blood pressure and arterial vascular resistance 
diminish due to the low resistance flow circulation in the uterus and placenta. 
Towards the end of pregnancy, blood pressure returns to pre-pregnancy-values. 
Pulmonic vascular resistance diminishes due to the increase in cardiac output with 
unchanged pulmonary pressure. Adaptation is not limited to the cardiovascular 
system. Respiratory volume rises to sustain the increase in oxygen that is needed, 
furthermore there is a higher thrombotic risk during pregnancy. In addition, during 
normal pregnancy more often supraventricular arrhythmias occur. 
 
Figure 1 Increase of stroke volume and rise of heart rate 
 
Graphical reproduction of increase in cardiac output (CO), stroke volume (SV) and heart rate (HR) 
during pregnancy. On the X axis the pregnancy duration in weeks, on the Y axis the increase in terms 
of percentage compared to the baseline before pregnancy 
 
 
The mother with congenital heart disease 
 
Women with congenital heart disease need timely information about the risks of 
pregnancy. It is primarily the task of the cardiologist to give this information. In the 
decision process it is important that the patient can discuss the different options with 
her general practitioner and/or obstetrician.3 Recently, the first prospective study was 
presented describing pregnancy in patients with heart disease.4 In Canada 599 
pregnancies in women with heart disease were described, about 80% of whom had 
congenital heart disease. In the study four predictors were identified for important 
cardiac problems during pregnancy (Table 1). Pulmonary oedema and symptomatic 
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arrhythmia's were the most common. Three women died, all three had more than 1 of 
the mentioned risk factors. Based on the predictors of this study the individual risk of 
pregnancy can be estimated. In general, functional class is found to be an important 
predictor: the risks of women in NYHA functional class I is very low, while women in 
functional class III or IV have a mortality risk of 7% or higher.5  
 
Table 1 Predictors for maternal cardiac events 
• Prior cardiac event (heart failure, TIA or CVA) or symptomatic arrhythmia 
• Prior cardiac event (heart failure, TIA or CVA) or symptomatic arrhythmia 
• NYHA functional class >II or cyanosis  
• Left heart obstruction (mitralstenosis; valve area <2cm2, aorticstenosis; valve area <1.5cm2 or left 
ventricular outflowtract obstruction >30mmHg, measured with Doppler) 
• Systemic ventricular dysfunction (ejection fraction <40%) 
   
Number of  
predictors  
Estimated risk of cardiac events 
in pregnancy  
 
  0 5%  
  1 25%  
>1 75%  
(Siu SC et.al., Circulation 2001; 104:515-21) 
 
In the following section different diagnosis groups will be discussed. 
Patients with volume overload of the systemic ventricle, for example aortic or 
mitral regurgitation do have a higher risk to develop clinical significant heart failure 
due to the increased circulating volume during pregnancy. However, because the 
diminished arterial vascular resistance during pregnancy, most patients do well. From 
the Canadian study we learned that in patients without symptoms and good systolic 
function of the systemic ventricle, the risk to develop cardiac problems during 
pregnancy is in the lowest category (5%) and the mortality risk is even much lower. 
Echocardiography will be the method of choice (ventricular function), in addition to 
history and functional class to predict the risks of pregnancy.  
Obstructions in the left side of the heart are a much greater risk. In patients 
with moderate stenosis of the aortic valve, the risk of cardiac problems during 
pregnancy is clearly increased, although mortality is low.6 This is due to the relatively 
fixed cardiac output in these patients while an increase in cardiac output is necessary 
during pregnancy. Restriction of physical activity is advisable. Patients with mitral 
stenosis do not bare the physiological increase of heart rate during pregnancy 
because of the reduced diastolic filling time of the left ventricle. This will lead to 
increase of dyspnoe. Beta blockade may be prescribed to decrease heart rate, 
guided by complaints and Doppler inflow pattern over the mitral valve.7 In patients 
with a severe aortic stenosis especially the peripartum changes in systemic vascular 
resistance are risky. Termination of pregnancy has the same risks and is therefore 
not indicated. If a patient with severe mitral stenosis or aortic stenosis is pregnant, 
balloon dilatation of the valve or even surgery needs to be considered. Cardiac 
surgery during pregnancy results in 20% foetal mortality risk. Of course it seems 
better to discuss with the patient pregnancy and the possibilities of treatment before 
pregnancy actually occurs.  
Impaired systemic ventricular function, is found in patients with left sided 
valvular disease and in patients who use their anatomic right ventricle as systemic 
ventricle: congenital correction of the great arteries and transposition of the great 
arteries treated with a Mustard or Senning procedure. In the case of diminished 
systemic ventricular function the risk of cardiac problems increases. If the patient 
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also had previous periods of heart failure or is in functional class III or IV, the risk 
increases to 75% and as a consequence pregnancy should be discouraged.2 If 
patients are in functional class I or II they tend to tolerate pregnancy quite well. 
Deterioration of right (systemic) ventricular function has been described in 10% of the 
patients and is sometimes irreversible.8  
  Patients with an uncorrected atrial septal defect usually tolerate pregnancy 
very well, but because of the risk of paradoxical emboly, instructions to prevent 
thrombosis should be given. 
In patients with uncorrected cyanotic heart disease the risk of problems 
increase if the oxygen saturation at rest is below 90%. Deterioration of cyanosis, 
decline in exercise capacity, heart failure and arrhythmias are seen in a third of these 
patients. 
In patients with uncorrected tetralogy of Fallot mortality for the mother is at 
least 4% and surgical correction is indicated before pregnancy. Surgical correction at 
adult age is possible with low risks. In corrected tetralogy of Fallot pregnancy usually 
caries low risks. In the case of severe pulmonic regurgitation resulting in clearly 
reduced exercise capacity or arrhythmia’s (supra ventricular tachyarrhythmia’s or 
ventricular tachyarrhythmia’s) replacement of the pulmonic valve needs to be 
considered before pregnancy.  
Pulmonary hypertension always caries a great risk and systolic pulmonary 
pressure greater than 66% of systolic systemic pressure, is an absolute contra 
indication for pregnancy.9,10 In particular high risk is found in patients with the so-
called “Eisenmenger syndrome” (right to left shunt due to high pulmonary vascular 
resistance for example in the case of a large VSD). In the literature mortality figures 
as high as 30 to 50% are found. In these patients a fall in peripheral vascular 
resistance with no change in pulmonary vascular resistance will lead to an increase 
in the right to left shunt, resulting in severe cyanosis.  
In patients with Marfan syndrome, pregnancy is a period of elevated risk to 
suffer from an aortic dissection, in particular during the third trimester and directly 
postpartum. If the diameter of the ascending aorta exceeds 50 mm, pregnancy 
should be discouraged. In the case of a aortic diameter of less than 40 mm the risk of 
dissection and other serious cardiac pathology is 1%, a diameter between 40 and 50 
mm increases the risk to 10%.11,12,13 The risk is even higher in Marfan patients with a 
family history of aortic dissection. Beta blockade treatment is indicated, also during 
pregnancy. 
Women with congenital heart disease sometimes also carry a higher risk of 
obstretic complications. For example the risk of hypertension during pregnancy is 
increased in patients with coarctation repair and the risk of peri partum blood loss is 
increased in patients who need anticoagulant therapy.  
 
 
Foetal risks 
 
Foetal risks can be divided into three categories. 
1. the inheritance risk of the congenital heart disease 
2. risks as a consequence of maternal hemodynamics 
3. risks as a consequence of maternal medication use 
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1. The inheritance risk varies from 2% to 50% and depends on the type of defect. 
This is discussed in detail in chapter 14. 
2. Risks as a consequence of maternal hemodynamics. 
In Table 2 risk factors for foetal problems are given. In the Canadian study the most 
frequent neonatal problems were premature birth (105 pregnancies) and low birth 
weight (22 pregnancies).5 In previous retrospective studies the functional class of the 
mother and cyanosis proofed to be predictors for foetal and neonatal mortality, which 
was confirmed by the Canadian study4,5,14,15. When the functional class of the mother 
is class I, foetal and neonatal mortality is almost zero, in the case of maternal 
functional class IV, mortality rate increases to 30 to 50%. Mild cyanosis with an 
oxygen saturation above 90% is found to have a percentage of 90% live births, while 
oxygen rates of lower than 85% have found to give a foetal survival chance of only 
12%.14  
 
Table 2 Predictors of neonatal events 
• NYHA class >II or cyanosis  
• Maternal left heart obstruction (mitralstenosis; valve area <2cm2, aorticstenosis; valve area 
<1.5cm2 or left ventricular outflowtract obstruction >30mmHg, measured with Doppler) 
• Smoking during pregnancy 
• Multiple gestations 
• Use of anticoagulants throughout pregnancy 
  
Number of  
risk factors 
Risk of neonatal  
problems 
 
0 2%  
1 or more 4%  
(Siu SC et.al., Circulation 2001; 104:515-21) 
 
 
Risks due to medication use of the mother 
The use of cardiac medication during pregnancy is not always preventable, and has 
a potential negative influence on the foetal development. On the other hand, 
hemodynamic instability in the mother is also a threat for the foetus. These aspects 
must be balanced, but often a decision will be made in favour of starting medication 
for the best well being of both mother and child.  
Coumadines may cause chondrodysplacia in a low percentage of children 
especially when used in the first trimester (especially between the 6th and 9th week). 
Replacement of coumadines by heparines already before conception has been 
propagated but is unnecessary and undesirable for the mother. However, if 
pregnancy has been proven, it is important to instruct the patient to change as soon 
as possible from coumadines to heparines to minimise foetal risks. It is rational to 
choose fractionated heparine, which gives a better anticoagulation for the mother, 
and there is less chance of tromboembolic complications. Although, no clear 
scientific evidence is available during pregnancy in patients with artificial valves, 
fractionated heparine (low molecular weight heparine) seems safe.16,17 In the near 
future new drugs become available like Ximelagatran and long-acting, 
subcutaneously administered, factor Xa-antagonists. In the case of manifest heart 
failure, treatment with digoxin, furosemide or thiazide medication is relatively safe.  
In the case of treatment with diuretics one should realise the risk of 
hypoperfusion of the placenta and increased foetal diuresis. Besides medication also 
bed rest and restricted fluid intake should be advised.  
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Many complaints and symptoms found in normal pregnant women imitate complaints 
and symptoms seen in the case of heart failure. Left sided heart failure is diagnosed 
only when basal crepitations remain present after deep breaths; right sided heart 
failure is present only when the central venous pressure is increased. ACE-inhibitors 
are absolutely contra indicated during pregnancy: lung hypoplasia and bone 
hypoplasia have been found when using this medication during the second and third 
trimester of pregnancy. Furthermore, growth retardation and foetal oliguria, 
oligohydramnion and persisting arterial duct are found due to the use of these ACE-
inhibitors. Also A-II antagonists are contra indicated. 
Supraventricular and ventricular arrhythmia's are best treated with beta-
blocking agents, although a low risk of diminished placenta perfusion with growth 
retardation of the foetus and bradycardia and hypoglcemia in the infant is described. 
Verapamil carries the risk of foetal AV-block, but may be administered in emergency 
cases. Antiarrhythmic agents of class Ic are not well studied in pregnancy. 
Amiodarone should not be the first choice, because of the negative effect of the 
foetal thyreoid.18,19,20 
Non-cardiac medication may also be contraindicated in patients with heart 
disease. For example, betamimetics, with or without corticosteroids may cause heart 
failure in patients with diminished ventricular function or left-sided valve disease.  
 
 
The peri-partum period 
 
In most women who are in functional class I and who experienced no complications 
during pregnancy, no additional peri-partum actions are necessary. However, stress 
reduction is desirable. For example this is necessary in patients with heart failure and 
those at risk for heart failure, women with life-threatening ventricular arrhythmias, 
severe mitral- or aortic stenosis or with Marfan’s syndrome with a dilated aorta. It is 
advisable to develop a strategy for peri-partum management in which the 
gynaecologist, anaesthesist and cardiologist are involved. This strategy should be 
written down and available at any time. In these women a left-lateral position during 
labour is advisable to reduce hemodynamic changes, (less inferior caval vein 
compression). Epidural anesthesia may be given to reduce the cardiac burden by 
pain relief and primary vacuum extraction may be performed to prevent labour during 
contraction. On the other hand one should realise that epidural anesthesia is 
contraindicated in patients with severe aortic or mitral stenosis in whom hypotension 
will form a potential threat.21 This is also true for women with “Eisenmenger 
syndrome”. 
Evidently, rhythm monitoring is indicated during labour in patients with important 
arrhythmia's and iv drug administration should be possible.   
Intra-arterial blood pressure guidance is indicated in patients with severe left sided 
valve disease or Marfan’s syndrome.  
Caesarean section is only indicated for obstetric reasons. An exception may 
be Marfan patients with an ascending aorta dilatation in whom aorta dissection or 
rupture may occur during the last weeks or during delivery, although this is still under 
debate. The guidelines advise endocarditis prophylaxis peripartum only when 
complications occur. However, based on recent literature, routine use of endocarditis 
prophylaxis is advisable in high-risk patients.22  
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During the first days post partum, a physiologic volume overload occurs, which 
may lead to heart failure in patients with severe valve disease or systemic ventricular 
dysfunction. In these women clinical observation for the first 72 hours post partum is 
mandatory. 
 
Conclusion 
 
Pregnancy is well possible in many, but not all patients with congenital heart disease. 
Careful counselling is important and should be performed in time. Collaboration 
between cardiologist, obstetrician, anaesthesist, genetic counsellor and general 
practitioner is indicated.  
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Introduction 
 
Congenital heart defects (CHD) are the most common developmental anomalies and 
are the leading non-infectious cause of mortality in new-borns. It has been estimated 
that 4 to 10 live born infants per 1000 have a cardiac malformation (0,4-1,0%), 40% 
of which are diagnosed in the first year of life. 1,2 The European Registration of 
Congenital Anomalies (EUROCAT) reported a prevalence of 58.9/10.000 live births 
in the northern part of the Netherlands (0,6%). Hoffman estimated that the true 
prevalence of CHD may be as high as 53 per 1000 pregnancies (5,3%), including: 
a 20% occurrence of heart defects in spontaneous abortion; 
a 10% occurrence in stillbirth; and 
a 1% occurrence in live birth.3 
In spite of tremendous advances in diagnosis and treatment of congenital 
heart disease, the underlying causes of the majority of CHD are only partly 
understood. Prior epidemiological studies suggested that Mendelian disorders 
constituted a very small percentage of CHD and that multiple factors were 
responsible for the majority of cases.4 Yet, recent studies have shown that CHD 
caused by single gene or single locus defects is more common that had been 
expected.5 Furthermore, it has become apparent that a higher percentage of heart 
defects occur in the context of familial disease than previously recognised.6 
Because many children with corrected congenital heart defect now reach 
adulthood and childbearing age, the birth prevalence of congenital heart defects, 
particularly of the more severe defects, may increase in subsequent years. 
 
Classification of causes: 
 
1. Chromosome disorders 
At the moment, chromosome disorders are known as the underling cause in eight to 
ten percent of the new-born babies with congenital heart disease; at adult age this 
percentage is lower because many children with chromosomal defects die at  young 
age. Examples of patients with a numeric chromosomal defect who reach the adult 
age are patients with Down’s syndrome (complete atrio-ventricular septal defect), 
Klinefelter syndrome and Turner syndrome (coarctation). 
 
2. Mendelian disorders 
Mendelian inheritance (single gene disorders) may be autosomal dominant, 
autosomal recessive or X-linked. Noonan syndrome, Marfan syndrome and Alagille 
syndrome are examples of autosomal dominant disorders. Also some isolated 
cardiac disorders are single gene disorders, such as  atrio-ventricular septal defects. 
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Recent molecular genetic studies suggest that the genetic basis of congenital heart 
disease has been underestimated.7,8  
 
3. Multifactorial inheritance 
The majority of congenital heart defects (80-85%) can not be explained by 
chromosomal or single gene disorders at the moment. In these patients it is assumed 
that multifactorial causes play a role. Multifactorial inheritance is a model that 
assumes that a disease is caused by the interaction of several genetic and 
environmental factors (such as maternal diabetes, maternal infections, alcohol, drugs 
and smoking). 
 
 
Genetic mechanisms hampering classification 
 
Several genetic mechanisms contribute to the difficulties in recognising the genetic 
causes of congenital heart disease:  
 
1. Genetic heterogeneity 
Tetralogy of Fallot (ToF) is a common type of congenital heart disease. Although the 
anatomic features are clear, at least 5 different genetic causes of ToF have been 
identified: approximately 16% of patients with ToF have a deletion of chromosome 
22q11, nearly 7% have trisomy 21 (Down syndrome), and a smaller number of ToF 
patients has mutations in NKX2.5 or JAG.1 (Alagille syndrome).9,10 So a genetic 
cause has been identified in nearly one third of ToF patients; additional genetic 
causes remain to be identified.  
 
2. Reduced penetrance refers to a situation where an individual who appears 
normal carries a disease causing gene mutation in a dominant gene. This is 
observed in familial anomalous pulmonary venous connection, familial 
atrioventricular septal defect and other familial congenital heart disease.5 
 
3. Variable expression refers to the situation that individuals with the same genetic 
defect show variable phenotypes. The variety of observed malformations caused by 
mutations in NKX2.5 and the fact that the gene is expressed throughout the heart, 
suggests that this gene may affect a number of pathways in cardiac development.  
A well known example of variable expression is in microdeletion 22q11.2. The 
features of this microdeletion syndrome may vary from subtle abnormalities like mild 
velopharyngeal insufficiency being the only feature, to the serious DiGeorge 
syndrome, with congenital heart defect, mental retardation, hypocalcemia and severe 
immunodeficiency. Cardiovascular abnormalities seen in patients with 22q11.2 
deletion are often abnormalities in the outflow tract, like truncus arteriosius, 
interruption of the aortic arch, pulmonary atresia, ventricular septal defect and 
tetralogy of Fallot.  
 
4. Genomic imprinting 
For many congenital heart defects the risk for offspring to get the same disorder is 
higher if the mother than if the father has a heart defect.5 Probably this is caused by a 
phenomenon called genomic imprinting. Genomic imprinting means that a certain 
part of the genome is modified in the germ cells with an “imprint” that turns certain 
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genes on or off, dependent on the gender of the person. This imprint is reversible in 
the next generation.  
 
Recurrence risks and prenatal diagnosis 
 
Recurrence risks for offspring of patients with a congenital heart defect depend on 
the cause of the defect. (Table1) 
 
Table 1 
Specific lesion Recurrence rate Associated syndromes 
Atrial septal defect 3-5% 
familial ASD with long PR higher 
Holt Oram-upper limb deformity 
autosomal dominant 
Ventricular septal defects 2-5% 
occasionally familial 
Down’s syndrome 
Atrio-ventricular septal defect 
(complete) 
10-14% in affected mother Down’s syndrome in > 50%  
Pulmonary stenosis 3-5%  Noonan, congenital rubella, 
Williams, Alagille 
Tetralogy of Fallot 3-5%  
22q11 deletion with 50% 
recurrence risk in 16%  
Deletion of chromosome 22q11 
(16%) 
Aortic valve stenosis 12-20% in affected mother  
Bicuspid valve may be familial 
Recurrence rate may be higher in 
syndromes 
Subaortic stenosis Familial cases described Shone’s syndrome (left heart 
abnormalities) 
Coarctation May be familial 
Association with bicuspid aortic 
valve  
22q11 deletion 
Patent arterial duct No information Congenital rubella 
Ebstein’s anomaly 6% in affected mother 
familial occurrence documented 
rare 
Marfan’s syndrome 50%  
autosomal dominant 
 
Complete transposition of the 
great arteries 
2% 
rare familial recurrence 
none 
Congenitally corrected 
transposition 
3-5% none 
 
 
Most patients with a chromosomal defect are not reproductive, although some 
women with Turner syndrome and men with Klinefelter syndrome do have the 
possibility of having children. The recurrence risks of these chromosomal defects 
depend on the precise diagnosis and exceeds the scope of this paper. 
The offspring of patients with mendelian or single gene disorders (autosomal 
dominant, autosomal recessive or X-linked recessive) have increased recurrence 
risks. For autosomal dominant traits the risk to be a mutation carrier for the offspring 
is 50%. Because of reduced penetrance and variable expression the true risk of a 
heart defect may be lower. For autosomal recessive disorders the offspring risk will 
be low if the carrier frequency is low. In X-linked disease the offspring risk may vary 
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as it depends on the gender of the parent and the level of expression in female 
carriers. 
In multifactorial inheritance the recurrence rate of heart defects in the offspring of an 
affected parent may vary between 1.5% and 14 % with higher rates if the affected 
parent is a female and if more family members are affected.4 Several studies have 
recently reported large families with congenital heart defects with high risks of 
recurrence.11-20 To estimate the recurrence risk for an individual couple it is essential 
to perform a thorough family investigation.  
Cardiac structural anomalies and functional problems in the fetus can be 
detected by prenatal echocardiography from 16 weeks of gestation or earlier. Many 
defects are already visible at that time, although not all defects will be detected.21 
Only in cases with a known chromosomal or mendelian (single gene) defect prenatal 
diagnosis by chorion villus biopsy or amniocentesis is an option.  
 
 
The future is nearby…. 
 
Dividing causes of congenital heart defects in chromosomal, mendelian (single gene) 
and multifactorial disease is a simplification. The possibility that phenotype variability 
of single gene  disorders is due to complex interactions between other genetic factors 
and/or environmental factors is a logical extension of the concept that simple 
Mendelian traits are, in fact, complex traits. On the other hand presumed complex 
traits may sometimes be due to a single gene disorder with low penetrance. 
Considerable interest has developed in identifying the modifying genetic and 
environmental factors. Identification of the factors that modify the phenotype of single 
gene disorders will enhance our appreciation of the clinical diversity of congenital 
heart defects.22-25 More genetic research is necessary for further identification of the 
genes. Many studies suggest a long list of (candidate) genes. Environmental factors 
such as maternal smoking, maternal exposition to drugs and supplements of folic 
acid and other nutritional factors are also subject of extensive research. 
 
 
In conclusion  
 
The interactions of genetic and environmental factors in patients with congenital 
heart defects are still a topic of research. Hopefully this will lead to a better 
understanding of the etiology of these defects and consequently to the availability of 
better information to patients about the risk of their offspring. In the end this may lead 
to prevention of a substantial part of these defects in the future. Further research in 
this field is necessary.  
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Summary and discussion 
 
 
Adult congenital heart disease is an intriguing new cardiovascular speciality. The 
advent of cardiac surgery and more recently catheter-based intervention has 
transformed the outlook for patients with congenital heart disease. Fifty percent or 
more of those currently alive and well, would have died before reaching adulthood 
had it not been for (surgical) intervention.1 Survival rates have improved dramatically 
and, dependant on the type of defect, 70 to 100% of the patients operated upon 
between 1968 and 1980 are still alive (Figure 1). However, in later live new problems 
arise in part of these patients. Accordingly, a major concern in the next decades will 
be the care of patients with congenital heart disease reaching adult life. In particular 
indications for and timing of reintervention are important.2,3  
 
Figure 1 Survival after congenital surgery 
Establishment of specialist centres to manage the complex grown-up heart disease 
population is a priority. These centres will provide the basis for research as well as 
for training into this new area of cardiology. Although most adult patients with 
congenital heart disease live a normal live, many have residua or sequelae requiring 
close observation or treatment. The spectrum of complexity increases in adult life, 
because rhythm disturbances, atherosclerosis and heart failure become apparent in 
addition to the already complex pathophysiology of the congenital defect. 
A major part of this thesis describes the outcome of patients operated in the 
era before 1980 with a mean of 25 years follow-up. In a way, we are studying a 
“moving target”, because since then, many changes have taken place in surgical 
techniques and catheter interventions for the treatment of specific abnormalities in 
these patients have been introduced. Thus, the long-term outcome of the patients 
undergoing surgery or catheter interventions nowadays will be different from that of 
25 years ago. Nevertheless, by prospectively studying long-term outcome of these 
patients, growing insight in the perspectives of the different patient-groups becomes 
available and will provide feedback to the (paediatric) cardiologists and cardiac 
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surgeons. For the patients, information on the long-term prognosis becomes 
available.  
 
Most congenital cardiac patients require life-long specialised cardiac care. 
Many of them need further surgery, percutaneous intervention, arrhythmia 
intervention or treatment for heart failure. Table 1 shows the morbidity in the different 
diagnosis groups as investigated in our longitudinal follow-up study 25 years after 
surgery. We focussed on 5 groups of patients. 
 
Table 1 
 Early mortality 
(<30days) 
Late CV-mortality 
(30d-25yrs) 
Reoperation Pacemaker Exercise 
capacity 
SV-
arrhythmia 
ASD 0% 0% 0% 5% 95% 8% 
VSD 11% 4% 6% 4% 91% 1% 
PS 2% 4% 15% 5% 90% 8% 
Mustard 5% 17% 46% 28% 72% 11% 
Fallot 16% 7% 28% 5% 83% 12% 
ASD = Atrial septal defect, VSD = Ventricular septal defect, PS = Pulmonary valve stenosis, Mustard = 
Transposition of the great arteries corrected with a Mustard repair, Fallot = Tetralogy of Fallot, Late 
CV-mortality = Cardiovascular mortality from 30 days until 21-33 years after operation, SV-arrhythmias 
= Supraventricular arrhythmia 
 
 
The outcome of patients with surgical repair of atrial septal defect during 
childhood is excellent.4 Over 21-33 years of follow-up there was no cardiovascular 
death and only 1 patient needed a reoperation. There are minor ongoing concerns 
regarding post-repair arrhythmias and right atrial dilatation, but these were not 
associated with significant morbidity and no episodes of heart failure, stroke, or 
pulmonary hypertension were observed. This outcome compares favourably with 
results of ASD patients at adult age, who often encounter supraventricular 
arrhythmias both without and after successful surgery at adult age. It is presumed 
that longstanding adverse haemodynamics with volume overload as well as atrial and 
perhaps pulmonary venous wall stretch lead to slow, inhomogeneous atrial activation 
and refractoriness which in turn causes reentry tachycardias.5 The issue of how 
defects should be closed is unresolved. Device closure in selected patients is a new 
safe and effective method of closing septal defects and is associated with reduced 
morbidity, shorter hospital stay and reduced costs, when compared to surgery.6 
However, at present there are no outcome studies with follow-up of much more than 
24 months and it is speculative, whether device closure will reduce the incidence of 
post-procedural rhythm disturbances. Early intervention, be that surgical or device 
closure, of all sizeable atrial septal defects is clearly indicated.5 One might conclude 
that patients with successfully closed ASD at young age do not need routine medical 
supervision other than dedicated to complaints. However, although the outcome is 
favourable after surgical ASD-closure, our study revealed that of the female patients 
only half of the expected number became pregnant compared to the normal Dutch 
population. The reason for this low number of pregnancies was not assessed, but 
psychological barriers in starting a family (for example due to fear for negative effects 
of pregnancy, and fear for heart disease in their children) may have played a role. 
This topic needs further attention. Perhaps, an appointment with the cardiologist at
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 the beginning of adulthood may help to give optimal information about the long-term 
prognosis of the disease, issues as family planning, career possibilities, and 
insurance matters might than be discussed. Although patients perform well on 
objective scales, attention for subjective health and quality of life is warranted.7  
 
Patients with ventricular septal defect closure at young age are often 
discharged from routine control, but an access mortality have been observed in a 
subgroup of these patients, especially those with high pulmonary resistance, in whom 
several cases of sudden death occurred (Figure 1).8 Reoperation was necessary in 
6% of the patients and some patients developed sinus node disease late after repair 
of VSD, requiring pacemaker implantation. Supraventricular rhythm disturbances 
were rare in this group. Thus, specialised cardiological care is warranted in patients 
after VSD closure perhaps at 5 year intervals. 
 
Follow-up of patients operated upon because of a relative “simple” lesion: 
valvular pulmonic stenosis, is not so “simple”. We found 7% late mortality and 15% 
reintervention in this group after 25 years. Pulmonary regurgitation was present in 
almost all patients after surgical repair. Especially the patients operated with the 
transannular patch technique frequently needed a reintervention. Supraventricular 
arrhythmias were associated with severe pulmonary regurgitation and these rhythm 
disturbances disappeared after reoperation.9 
  
The surgical management of patients with complete transposition of the 
great arteries has changed substantially. Nowadays the arterial switch operation is 
being used, but until the mid 1980’s most patients were operated upon using the 
atrial switch technique (Mustard or Senning procedure). Late follow up after the 
Mustard operation shows a 17% mortality rate and as high as a 46% rate of 
reintervention after 25 years.10 Our longitudinal study provides hard evidence for the 
inability of the anatomic right ventricle to sustain the systemic circulation for a 
prolonged period. Deterioration of ventricular function occurs over time, which was 
expected already on theoretical grounds. The clinical condition of our patients late 
after Mustard repair is declining and we may expect more deaths and need for heart 
transplantation in the next decade. Attention to baffle obstruction with a low threshold 
for treatment, surgical or by means of catheter intervention, may be a first step, but 
further research towards other treatment options (medication, biventricular pacing) is 
clearly warranted for these patients. Supraventricular arrhythmias are often found in 
this group of patients (11%). 
 
Late mortality after repaired tetralogy of Fallot is comparable with that of after 
surgery for pulmonary valve stenosis (7% in 25 years), although periprocedural 
mortality was higher. The need for reintervention is higher after correction of tetralogy 
of Fallot (Table 1). As in the patients with a pulmonic stenosis the Fallot patients 
operated with the transannular patch technique are particularly at risk for 
reintervention. Whether changes in surgical approach will prevent these problems in 
the future is speculative. The timing of reoperation for pulmonary regurgitation is still 
under debate, but our study showed that surgery should not be postponed too long.10 
Many of these adult patients lead unrestricted lives and seem asymptomatic at 
follow-up. Residual significant pulmonary regurgitation however, is common and 
gradually results in right ventricular dilatation and dysfunction with consequently 
diminished exercise capacity and rhythm disturbances.11,12 Although ventricular 
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arrhythmias are important, because they are a risk factor for sudden death in these 
patients, these do not occur very frequently.2 Supraventricular rhythm disturbances, 
on the other hand, play a major role in the morbidity of these patients.12 
 
The Fontan operation is used for patients with complex heart disease with 
only one functioning ventricle, for example patients with tricuspid atresia. In our adult 
Fontan patients we found a high mortality (28%) and also a very high morbidity, up to 
100% in 10 years after operation. Particularly reoperations, supraventricular 
arrhythmias, and thromboembolic events were common. Quality of life assessment 
showed physical functioning, mental health and general health perception to be 
significantly lower for Fontan patients compared to the normal Dutch population.13 
These patients comprise a small proportion of our adult congenital patient population, 
but they are responsible for the majority of major problems encountered in our daily 
practise. These patients need particularly intensive follow-up in a specialised centre 
for congenital heart disease. An aggressive approach towards rhythm disturbances, 
heart failure and cyanosis is necessary with an extensive diagnostic work-up, 
including (transoesophageal) echocardiography, magnetic resonance imaging and 
cardiac catheterization and angiography. 
 
Coarctation repair is associated with hypertension and recoarctation. Less 
well known is the high incidence of problems related to a bicuspid aortic valve, 
which was found in 63 % of our adult coarctation patients.14 Furthermore, aortic 
stenosis as well as aortic regurgitation occurred, requiring intervention in a third of 
these patients. Some form of ascending aorta pathology (aorta dilatation and aortic 
arch abnormalities) was found in half of the coarctation patients. A surprisingly high 
number of patients showed kinking of the aortic arch. The bicuspid aortic valve is 
correlated with ascending aortic wall abnormalities, due to media degeneration, 
comparable with the abnormalities found in Marfan’s syndrome. This may lead to 
ascending aorta dilatation with the risk of aortic dissection. It is not clear whether 
these media degenerative changes are also present in the pulmonary artery and thus 
whether the Ross-operation is a good choice for these patients. In our patients we 
did not find additional problems after the Ross-procedure in patients with a bicuspid 
aortic valve, but longer follow-up is certainly necessary.15 
 
Quality of life was studied in 350 patients with congenital heart disease. Most 
patients lead normal lives and are well capable of finding a job and building a career. 
In our study 85% of the patients had a paid job.16 However, the wish to have a child 
of their own, may cause insecurities, especially for young female patients.  
 
Pregnancy leads to an increase in cardiac output of 40%, and during 
pregnancy all females have a higher risk of rhythm disturbances and thrombo-
embolic events. Most grown-ups with congenital heart disease, who have a normal 
functional capacity can tolerate pregnancy, but pre-pregnancy counselling is 
mandatory, including a review of medication to avoid any drugs that may be 
deleterious to the foetus, like ACE inhibitors and A-II antagonists.17 The risks to the 
mother of morbidity and mortality and, when appropriate, the impact of pregnancy on 
long-term survival should be discussed. In addition, the risks to the foetus of 
inheriting congenital heart disease should be considered.18 
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Implications: An expert multidisciplinary team for adult congenital heart disease is 
necessary for this special patient group and should be associated with a strong 
paediatric cardiac group and cardiac surgical group. Expert skills should be available 
in diagnostic and interventional cardiac catheterisation, echocardiography, 
electrophysiology, cardiac imaging (3-dimensional echocardiography, magnetic 
resonance imaging) as well as management of high-risk pregnancies and 
reproductive counselling.19 Motivation, trained staff and adequate diagnostic and 
therapeutic techniques are the first requirements to deliver good clinical care. At the 
moment, motivation is present, but definitely more doctors and nurses should be 
trained to deal with this growing population and finally, healthcare resources should 
be allocated to provide better access to 3-D echocardiography, magnetic resonance 
imaging, electrophysiology and cardiac catheterisation (device closure and stenting). 
It is therefore appreciated that the Netherlands Society of Cardiology has recognised 
adult congenital heart disease as one of the six area’s of expertise or 
‘subspecialisation’ within cardiology.  
Many congenital patients can be followed in an appropriate general adult 
cardiac service. Yearly follow-up in the general hospital, in combination with visits 
once every 3-5 years in a specialist centre is well possible.  
However, we recommend that all patients should be seen for initial 
consultation at least once in a specialised adult cardiac centre to establish the 
diagnosis and need for follow-up care. Patients who should be seen frequently and 
perhaps exclusively in the specialist centre include those with the prospect of 
premature death, reintervention or complications of their condition and those, whose 
condition is unfamiliar to general cardiologists. Any patient who develops a new 
clinical problem related to their congenital heart defect should be referred for re-
evaluation in the specialist centre. Furthermore, consultation should be requested 
with the specialist unit prior to any intervention in adults with congenital heart 
disease.19 All surgical and percutaneous interventions in these patients should be 
performed by surgeons and interventional cardiologists, who are trained in this highly 
specialised area, in centres with experience in this field.  
Long-term follow-up of patients with congenital heart disease is “life-long 
follow up” and continuous research in this field is mandatory. This thesis is but a step 
in this proces. 
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Samenvatting 
 
Tot het begin van de zestiger jaren hadden kinderen die geboren werden met een 
aangeboren hartafwijking slechte vooruitzichten en vaak overleden deze kinderen op 
jonge leeftijd. Sinds de introductie van open hart chirurgie met behulp van de hart-
long machine (in Rotterdam in 1968) is het mogelijk deze patiëntjes te opereren en 
sindsdien bereikt ongeveer 85% van deze kinderen de volwassen leeftijd. Er onstaat 
hierdoor een groeiende groep volwassenen met een aangeboren hartafwijking. In 
Nederland zijn dat er ongeveer 25.000. Er is echter weinig bekend over de lange 
termijn prognose van deze mensen. Het is niet goed bekend of zij een normale 
levensverwachting hebben of toch vroeger dan gemiddeld overlijden. Vaak zijn er 
restafwijkingen waarvoor nieuwe operaties of andere ingrepen nodig zijn en er is een 
verhoogde kans op ritmestoornissen en hartfalen. Eerdere studies naar de lange 
termijn resultaten waren vaak gericht op de mensen met problemen, waardoor er een 
selectie kan zijn opgetreden van de ziekste patiënten. Het is dan ook de vraag of 
deze eerdere studies representatief zijn voor de hele groep van geopereerde 
mensen. Tenslotte is er weinig bekend over de kwaliteit van leven van deze mensen 
en of zij een leven leiden zoals hun leeftijdsgenoten op het gebied van sport, werk, 
relatie en kinderen. Om deze reden hebben we een systematisch na-onderzoek 
georganiseerd van patiënten die in ons ziekenhuis op jonge leeftijd zijn geopereerd 
aan aangeboren hartafwijkingen. 
 
In deze studie hebben we de hele groep patiënten bestudeerd die in Rotterdam op 
de kinderleeftijd een open hart operatie heeft ondergaan tussen 1968 en 1980. Er 
heeft geen selectie plaatsgevonden. De 5 grootste groepen patiënten met 
verschillende diagnoses zijn opgeroepen voor onderzoek. Het betreft de mensen met 
een gaatje in het tussenschot tussen de boezems van het hart (ASD), met een gaatje 
in het kamertussenschot (VSD), de mensen met een verkeerde aansluiting van de 
grote slagaders die geopereerd zijn met een zogenaamde Mustard operatie 
(Mustard), mensen met een vernauwing van de klep naar de longslagader 
(PS=pulmonaal stenose) en mensen met een tetralogie van Fallot, een combinatie 
van een gaatje in het kamertussenschot, een vernauwing van de longslagader en 
verplaatsing van de grote lichaamsslagader (TOF). Al deze mensen werden 
opgeroepen om mee te doen aan de studie. Het onderzoek bestond uit een bezoek 
aan de cardioloog, een ECG, een echo van het hart, een fietstest, een 24-uurs ritme 
registratie en een 2.5 uur durend psychologisch interview. Het onderzoek werd 
verricht in 1990 en opnieuw in 2001, om het verloop in de tijd te registreren. 
 
In hoofdstuk 2 tot en met 6 worden de resultaten van de 5 verschillende groepen 
beschreven. Alle patiënten zijn op jonge leeftijd geopereerd (<15 jaar) en zijn in 2001 
tussen de 20 en 50 jaar oud. (Tabel 1) 
 
De patiënten met een gaatje in het tussenschot tussen de boezems (ASD) doen het 
uitstekend. Zij hebben een normale levensverwachting, hebben geen nieuwe 
operaties of andere ingrepen gehad en hebben een normale inspanningscapaciteit. 
Uit andere studies is bekend dat mensen met een ASD dat niet, of pas op volwassen 
leeftijd gesloten is een grote kans hebben op ritmestoornissen. Uit ons onderzoek is 
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gebleken dat het belangrijk is deze gaatjes op jonge leeftijd te sluiten, omdat 
daarmee het optreden van ritmestoornissen grotendeels voorkomen kan worden. 
 
De patiënten met een gaatje in het tussenschot van de kamers (VSD) hadden 
rondom de operatie op jonge leeftijd een forse sterfte zien (20% in het eerste jaar). 
Dit is tegenwoordig gelukkig beduidend verbeterd. De ‘late’ overleving is goed, maar 
toch minder dan in de algemene bevolking. Vooral de mensen met een hoge druk in 
de longen blijken, zo blijkt uit dit onderzoek, een fors verhoogde kans op overlijden te 
hebben. Wij vonden weinig late restafwijkingen zoals kleplekkage, infectie in het hart 
of rest-gaatjes. Een opvallende bevinding is, dat 4% van de mensen een pacemaker 
nodig had meer dan 15 jaar na de operatie. Het is daarom nuttig deze mensen af en 
toe nog voor controle bij de cardioloog te laten komen. De helft van de mensen met 
een VSD ondervond problemen bij het afsluiten van levensverzekeringen, terwijl de 
levensverwachting goed is en er weinig late problemen optreden. Mogelijk kunnen de 
resultaten van deze studie bijdragen aan het vaststellen van meer objectief gemeten 
en geïndividualiseerde richtlijnen voor het afsluiten van levensverzekeringen. 
 
Bij de mensen met een Mustard operatie moet de rechter hartkamer al het bloed 
naar het lichaam pompen. Deze is daarvoor niet gebouwd, want normaal doet de 
linker hartkamer dat. In 1990, gemiddeld 15 jaar na de operatie, waren de 
bevindingen eigenlijk verbazingwekkend goed en leek de rechter kamer dit goed vol 
te houden, alhoewel de patiënten wel vaak nieuwe operaties en pacemakers nodig 
hadden. Tussen 1990 en 2001 zien we echter een duidelijke achteruitgang. Dit uit 
zich in hartfalen bij 9% van de mensen, een duidelijk slechtere pompfunctie van de 
rechter hartkamer op echo bij bijna alle mensen, veranderingen op het ECG en een 
afname van inspanningscapaciteit. Dit zijn zeer verontrustende bevindingen en als 
deze ontwikkeling zich voortzet zal een groot deel van deze patiënten binnen 10 a 20 
jaar hartfalen krijgen met het risico van overlijden, dan wel een harttransplantatie 
moeten ondergaan. We concluderen dan ook dat bij deze groep patiënten intensief 
gezocht moet worden naar verdere behandelingsmogelijkheden. 
 
De mensen met een vernauwing van de klep naar de longslagader hebben een 
goede levensverwachting, die slechts iets lager ligt dan bij de algemene bevolking. 
Bij deze groep werden weinig problemen gezien in 1990, echter tussen 1990 en 
2001 heeft ongeveer 10% van de mensen een nieuwe hartklep nodig en 
waarschijnlijk komen daar de komende jaren meer mensen bij. Bij de eerste operatie 
wordt de vernauwing van de klep opgeheven, veelal met behulp van een inzetstukje. 
De hieruit voortvloeiende lekkage van de hartklep wordt jaren goed verdragen, maar 
deze belasting gaat op de lange duur toch een probleem vormen voor het hart. Dit is 
tot nu toe niet beschreven in de literatuur, omdat veel mensen met deze afwijking 
niet meer door een cardioloog worden gecontroleerd. Hieruit blijkt wel het belang de 
hele geopereerde groep op te roepen voor onderzoek. Onze conclusie luidt dat de 
chirurgische techniek op dit punt moet worden aangepast. 
 
Bij de mensen met een tetralogie van Fallot is de levensverwachting redelijk, maar 
niet geheel normaal. Ook deze mensen hebben vaak een nieuwe hartklep nodig 
vanwege lekkage van de longslagaderklep. Het is moeilijk het optimale moment te 
kiezen voor deze tweede operatie. Te lang wachten kan lijden tot schade aan het 
hart, terwijl een nieuwe klep ook maar weer een beperkt aantal jaren meegaat (12-15 
jaar) en voorkomen moet worden dat deze mensen te vaak geopereerd moeten 
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worden. In onze studie hebben we het echo-onderzoek van 1990 als uitgangspunt 
genomen, waarna de mensen goed vervolgd en in 2001 opnieuw bekeken zijn. 
Hierdoor zijn er adviezen voor deze moeilijke problematiek mogelijk geworden. 
Nieuwe diagnostische methoden, zoals MRI zijn ook belangrijk voor de bestudering 
van de kleplekkage, maar er zijn (nog) geen studies die dit over de tijd hebben 
kunnen vervolgen. Ook blijken de mensen met een tetralogie van Fallot op de 
volwassen leeftijd regelmatig last van hartritmestoornissen te hebben. Frequente 
controle in een gespecialiseerd centrum is voor deze patiënten zeker gewenst. 
 
De operatie volgens Fontan wordt uitgevoerd bij mensen die maar 1 werkende 
hartkamer hebben in plaats van 2. Deze operatie biedt patiënten de mogelijkheid 
volwassen te worden. Omdat deze operatie nog niet zolang wordt uitgevoerd waren 
er nog geen resultaten bekend van mensen die met deze operatie de volwassen 
leeftijd hebben bereikt. Uit ons onderzoek blijkt dat het merendeel van deze patiënten 
problemen krijgt. Hartfalen, ritmestoornissen, re-operaties, longembolieen en een 
beperkte levensverwachting komen bij bijna al deze mensen op de volwassen leeftijd 
aan de orde. Deze groep mensen blijkt ook minder goed in staat een normaal leven 
te leiden en de “kwaliteit van leven” is minder dan bij hun leeftijdsgenoten. Deze 
patiënten moeten intensief begeleid worden in een gespecialiseerd centrum. Deze 
groep behelst slechts een paar procent van onze patiënten populatie, maar vormt 
meer dan 50% van de problemen die we bij de dagelijkse praktijk tegenkomen. 
 
Bij patiënten die geopereerd zijn aan een vernauwing in de grote lichaamsslagader 
(coarctatie) is het bekend dat zij op latere leeftijd opnieuw een vernauwing kunnen 
krijgen en dat zij een verhoogde kans hebben op hoge bloeddruk. Bij ons onderzoek 
van de patiënten met een coarctatie vonden we naast deze bekende problemen, dat 
meer dan de helft van de mensen een afwijking krijgt aan de aortaklep. Dit is de klep 
tussen de linker hartkamer en de grote lichaamsslagader (aorta). Bij sommigen gaat 
de klep lekken, bij anderen treed een vernauwing op. Verder zagen we ook 
regelmatig een verwijding van het eerste stukje van de grote lichaamsslagader 
ontstaan. Dit is uitermate belangrijk, want hierdoor ontstaat de kans op een scheur in 
de grote lichaamsslagader, met meestal fatale uitkomst. Ook verderop in de grote 
lichaamsslagader werden afwijkingen gezien. Een coarctatie blijkt niet alleen een 
lokaal probleem maar een veel uitgebreidere ziekte van de hele aorta. Het is 
belangrijk ook deze patiënten levenslang te vervolgen, met speciale aandacht voor 
afwijkingen aan de aortaklep en het eerste deel van de aorta. Het onderliggende 
proces en de erfelijke factor hierin moeten nader onderzocht worden. 
 
Wat betreft de “Kwaliteit van leven” heeft de studie bij de 350 volwassenen die op 
jonge leeftijd geopereerd zijn aangetoond, dat de meesten een normaal leven leiden 
en dat zij prima in staat zijn een baan te krijgen en een carrière op te bouwen. In 
onze studie had 85% van de mensen een betaalde baan. Ook op het gebied van 
sport en vrijetijdsbesteding en het hebben van een relatie wijken zij niet af van de 
algemene bevolking. Een opvallende bevinding is dat er echter minder 
zwangerschappen in deze groep worden gezien. Dit zou verklaard kunnen worden uit 
angst dat de eigen gezondheid zal lijden onder een zwangerschap en angst voor 
aangeboren hartafwijkingen bij de kinderen. Of andere oorzaken, zoals verminderde 
fertiliteit, bijvoorbeeld ten gevolge van de hartziekte of ondergane behandelingen een 
rol spelen moet verder onderzocht worden. 
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Zwangerschap vormt een belasting voor het hart. Tijdens de zwangerschap neemt 
namelijk het rond-te-pompen bloedvolume met 40% toe. Dit wordt door vrouwen met 
een normaal hart meestal goed verdragen, alhoewel ook zij tijdens de zwangerschap 
meer kans hebben op hartritmestoornissen en vocht vasthouden. Bij vrouwen met 
een hartaandoening kan zwangerschap tot problemen lijden. Vooraf moet er met de 
individuele patiënt gesproken worden over de risico’s. Een aantal medicijnen die 
vaak door hartpatiënten worden gebruikt (bloedverdunners, ACE-remmers, A-II 
antagonisten) zijn absoluut verboden tijdens de zwangerschap, omdat deze een 
verhoogde kans op afwijkingen bij het kind geven en ook dit moet bijtijds besproken 
worden. Tenslotte moet er aandacht zijn voor het risico een kind met een 
hartafwijking te krijgen, dit kan variëren van 2 tot 50%. 
 
Een gespecialiseerd team is nodig voor de behandeling van de volwassenen met 
een aangeboren hartafwijking. Gespecialiseerde cardiologen moeten nauw 
samenwerken met kindercardiologen en hartchirurgen. Expertise op het gebied van 
diagnostische onderzoeksmethoden zoals echocardiografie en MRI-beeldvorming, 
op het gebied van electrofysiologie (diagnostiek en behandeling van 
ritmestoornissen) en interventie-catheterisatie en op het gebied van hoog-risico 
zwangerschappen en erfelijkheid moet voorhanden zijn. Meer cardiologen zullen 
opgeleid moeten worden om aan de groeiende vraag naar specialistiche hulp te 
kunnen voldoen. 
 
Concluderend gaat het goed met de meeste volwassenen met een aangeboren 
hartafwijking, maar bij sommige groepen komen nog frequent late problemen voor, 
waarbij levenslange controle aangewezen is. 
 
 
Tabel 1 Resultaten 25 jaar na open hartchirurgie op de kinderleeftijd 
 Lange termijn-
overleving (>25jr) 
Re-operaties Pacemaker Inspannings-vermogen 
ASD uitstekend niet 5% goed 
VSD goed 6% 4% goed 
PS goed 15% 5% goed 
Mustard redelijk 46% 28% matig 
Fallot goed 28% 5% redelijk 
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